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ABSTRACT 
The significantly high consumption of p-lactams exerts considerable selection for 
resistance to these antibiotics. The resistance may occur via one of these mechanisms: 
i) modification of normal penicillin binding proteins, ii) bypassing of the normal 
PBPs, iii) impermeability of outer membranes to drugs, iv) production of P-
lactamases, and v) ability to pump out (efflux). The most common of which is either 
lack of drug penetration, i.e. outer membrane protein mutation & efflux, or production 
of P-lactamases. Increased clinical use of p-lactams has selected for P-lactamase-
producing organisms. The P-lactamase-produced by bacteria have been classified in to 
four classes. Classes A, C, and D are serine P-lactamases, while class B enzymes 
function using a zinc ion to attack P-lactam ring. The clinically important groups are 
class A and Class C P-lactamases. AmpC P-Iactamases belonging to molecular class C 
and functional classification group 1 are among the most abundant P-lactamases on the 
basis of number of organisms that produce these enzymes. These cephalosporinases, 
frequently named as species-specific AmpC enzymes, are often found in most of 
Enterobacteriaceae as chromosomal enzymes. AmpC P-lactamases were originally 
described as chromosomal, inducible enzymes in members of Enterobacteriaceae, 
plasmid-mediated AmpC beta-lactamases were first discovered in late 1980s, and 
have been detected in different regions worldwide since then. AmpC P-lactamases are 
causing great concern because they mediate resistance to broad-spectrum of 
antibiotics comparable to extended-spectrum P-lactamases (ESBLs). The data 
regarding worldwide distribution and prevalence of AmpC mediated resistance is 
fragmentary as compared to that of ESBLs and this may be due to limited number of 
surveillance studies and laboratories also face difficulties in accurate detection of 
these resistance mechanisms (Hanson, 2003). Since the detection method of AmpC P-
lactamase has not been standardized by CLSI (formerly NCCLS), it pose a major 
barrier in defining the actual prevalence and epidemiology of these p-lactamases. 
Failure to detect these p-lactamases has contributed to their uncontrolled spread and 
occasional therapeutic failure. These P-lactamases, now exceeding over 99 different 
variants (http://www.lahev.org/studies/webt.htm'), can be grouped into six clusters 
(Perez-Perez & Hanson, 2002) and have been named, with an inconsistency of 
nomenclature; according to resistance produced to cephamycins (CMY), cefoxitin 
(FOX), moxalactam (MOX), or latamoxef (LAT), according to type of enzyme 
[Ambler class C (ACC), AmpC type (ACT)] or according to the site of discovery 
[Miriam hospital in Providence (MIR), Dhahran Hospital in Saudi Arabia (DHA, 8 
variants)], and BlL-1 was named after the patient (Bilal) who provided the original 
sample (Phillipon et al., 2002). These P-lactamases have global distribution and have 
been identified in Africa, Asia, Europe, the Middle East, North America and South 
America (Jacoby, 2009). Moreover, recently many researchers have reported on 
cefoxitin-resistance and AmpC production (based on phenotypic detection methods) 
from India, but molecular analyses of this type of resistance mechanism is lacking. 
We found only few published reports regarding genotypic characterization of 6/aampC 
gene. BIL-1 like and CMY-4 were reported by M'Zali et al., 1997 and Cao et al., 
2000, respectively. In 2009, Shahid et al., have reported CMY-6 in Enterobacterial 
isolates. Recently, Upadhyay et al. (2010) have also reported presence of CIT, ACC, 
and EBC families of AmpC P-lactamase, whereas Gokul et al. (2010) have reported 
occurrence of ACC-1. 
ESBLs, the enzymes that were recognized shortly after the introduction of *P-
lactamase-stable' cephalosporins and aztreonam, are particularly worrisome. In recent 
years, CTX-M types ESBLs are expanding rapidly. The name CTX reflects the potent 
hydrolyzing activity of these P-lactamases against cefotaxime. Organisms producing 
CTX-M type p-lactamases typically have cefotaxime MICs in the resistant range (>64 
fig/mL), while ceftazidime MICs are usually in the apparently susceptible range (2 to 
8 ^g/mL) (Hawkey, 2008). CTX-M-15 have been found worldwide (Canton & 
Coque, 2006) and also in India (Ensor et al., 2006; Muzaheed et al., 2009; Shahid, 
2010; Shahid et al, 2011). However, CTX-M-14 was found to be the most 
widespread CTX-M-type enzyme in a very wide geographic area including Europe, 
North America, and south Asia and in East Asia (Eckert et al., 2006). Today many 
bacterial pathogens are complex than a decade or two ago. Thus, previously reliable 
susceptible tests may no longer be dependable, for e.g. there are not only new 
resistance mechanisms, such as new world ESBLs, but also isolates that produce 
multiple P-lactamases (Shahid, 2010) have been identified. E. coli and Klebsiella 
isolates harboring TEM, SHV, and CTX-M have recently been reported from India 
during a study conducted in our laboratory (Shahid et al, 2011). Increasing frequency 
of co-existence of blacrx-M and bhampc more specifically /^OCTX-M-IS and blacMY-6 has 
also been reported in Indian E. coli and Klebsiella isolates (Shahid et al., 2009). 
Recently, it has become evident that mobilizing elements like insertion sequences, 
integrons and transposons can be responsible for movement of resistance genes, but 
they fail to explain spread of growing subset of resistance genes. Association of 
ISC/?/ has been reported with blacuY-x subgroup while mobilization of blacuY-i has 
been reported primarily by lS£cp/-mediated. Perhaps the insufficiency of detailed 
analysis of genetic environment of blacM\-2 accounts for it. The transposition and 
expression of the blacuv-i gene by ISEcpl to dififerent plasmid scaffolds may also be 
playing a role in the dissemination of CMY-2. 
Studies regarding prevalence and identification of AmpC P-lactamase are elementary 
from India, and no proper and systematic survey was reported. There is lack of studies 
regarding the molecular characterization of AmpC beta-lactamase-producing 
Enterobacteriaceae isolates, and the association of 6/aampc genes with mobile genetic 
elements. Keeping in mind the above mentioned aspects, the present study was 
conducted on cefoxitin resistance E. coli & Klebsiela pneumoniae isolates that were 
collected from the samples subjected to microbiology department of Jawaharlal Nehru 
Medical College & hospital, Aligarh, for routine culture and susceptibility testing. 
Antibiotic resistance rate and pattern was analyzed as per CLSl (formerly NCCLS) 
guidelines (CLSl, 2005). Modified Three dimensional extract test (MTDET), as 
described by Shahid et ai, (2004), was performed to identify AmpC producers. 
Moreover, bhampc genes were detected by PCR, as described by Feria ct al. (2002) 
with some modifications. Plasmid-mediated AmpC P-lactamases were screened by the 
protocol of Perez-Perez & Hanson (2002). The isolates of this study were also 
screened for the presence of Class A ESBLs , more specifically, blacjxM, blajEM, and 
WasHv by the PCR protocol as described previously (Shahid, 2010). All the study 
isolates were then screened for presence of mobile genetic elements {ISEcp], 1S2(5, 
ISC/?/, Sul-I-type integrons) and were analyzed for integrons by performing PCR for 
amplification of CS region. Epidemiological typing of cefoxitin-resistant isolates was 
done, as described previously (Shahid, 2010), so as to determine whether any specific 
clone is circulating in the hospital environment or to find out any relatedness/diversity 
in blaampc carrying isolates. 
In our study isolates, among 3"^  -Generation cephalosporins, maximum resistance was 
noticed for cefotaxime followed by ceftriaxone and cefixime. Resistance to 
aminoglycosides was noticed comparatively low (38.33% and 55.74% resistance was 
observed for amikacin and gentamicin, respectively), but we observe high resistance 
rate for fluoroquinolones. Resistance to more than one class of antibiotics makes more 
difficult the therapy of infections caused by ESBL-producers. In general, it was 
observed that resistance to 3GC, aztreonam and fluoroquinolones was high in isolates 
obtained from different wards. Unlike ESBLs, the detection method of AmpC P-
lactamase has not been standardized by CLSI and hence it is a major barrier in 
defining the actual prevalence and epidemiology of these P-lactamases. On 
phenotypic detection by MTDET, we observed 60.80% isolates as AmpC-producers, 
26.40% as AmpC-intermediate and 12.80% isolates were found AmpC non-producers 
in a total of 125 cefoxitin-resistant enterobacterial isolates. Thus, although studies 
indicate that screening methods which use cefoxitin in standardized methods to detect 
AmpC-harboring isolates are useftil, they are not perfect (Manchanda et al., 2003). 
we genotypically analyzed our isolates for the presence of blaampc- Out of 60.8% 
(76/125) that were categorized as AmpC-producers, only 52.80% (66; 58 E. coli and 8 
K. pneumoniae) were found to harbour bla^pc- Similarly, out of 26.40% (33/125) 
AmpC-intermediate isolates bia^^pc was detected in 21.6% (27; 26 £ coli and 1 K. 
pneumoniae). Probably, some other enzyme is being produced by bacterial isolates 
that mimics the AmpC P-lactamase, that's why we noticed AmpC production in 
MTDET (phenotypic detection method where crude enzyme extract was used) in 
ASstma 
those isolates found devoid of bloampc gene (as detected by PCR). Surprisingly, 
/^^ ampc gene was observed in 1.2% (14; 13 E. coli and 1 K. pneumoniae) isolates 
while they were categorized as AmpC non-producers. Most likely, 6/aampc gene 
remains unexpressed or it may also be possible that non-fiinctional enzyme was 
produced by these isolates. On characterization for bloampc families by multiplex PCR, 
We have observed the presence of plasmid-mediated AmpC P-lactamase in 44/125 
isolates. Most likely, the mobilization of 6/flampC was of same chromosomal origin so 
it was not detected by the protocol of Perez-Perez & Hanson (2002) and hence we 
observed variation in results of occurrence of 6/aampc noticed in monoplex and 
multiplex PCRs. Among these 44 isolates, the concurrent occurrence of two 6/afampC 
families {blacn and bla^Bc) was noticed in 31/44 isolates. fe/aEBC was observed in 
10/44 isolates while only 3/44 were found to harbour blacxi- In contrast to this 
finding, bla^^c of CIT-family only were noticed to be present in 27.4% of Indian 
Enterobacterial isolates as reported in previous studies from our laboratory (Shahid et 
al., 2009). We were unable to find any report, in our search of the literature, using the 
Entrez PubMed database provided by the National Centre for Biotechnology 
Information (www.ncbi.nlm.nih.gov/entrez) that specifically reported the 
simultaneous occurrence of two bhampc families. In our study isolates, where 
concurrent occurrence of CIT and EBC-family of A/oampc was observed, the 
amplification of blacn was noticed at its expected position but the blasBc fi"agment 
amplifies at 200 bp, however amplified at its expected molecular weight (302 bp) on 
performing monoplex PCR for EBC-family. Based on these observations, we drew 
inference that perhaps the co-existence of two bla^pc families, when present together 
hinders the proper amplification of ZJ/OEBC families. We have also observed that 10/44 
isolate that were showing EBC band at 302 bp (when lysate was used as DNA 
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template in PCR reaction) did not show amplification in multiplex PCR (when 
purified plasmid was used as template). But when we performed blaEsc monoplex 
PCR, an amplified product of 302 bp was observed. This finding is suggestive of the 
situation, that has already been described in the protocol of Perez-Perez & Hanson 
(2002), stating that if the ampC gene is of same chromosomal origin then it could not 
be detected in multiplex PCR. Since more than one plasmid-mediated AmpC families 
were observed in single bacterial isolate in the present study, it denotes an alarming 
state because the present situation is indicating an emerging complexity in the 
bacterial resistance mechanisms by accumulation of antibiotic resistance genes in a 
single organism. Due to selective pressure, bacteria now start evolving in a manner 
accumulating multiple bla genes, which are not only of different resistance 
mechanisms (Class A and Class C) but also by concurrent incorporation of bla genes 
of the related family (blacn and bla^Qc), which is a rarer phenomenon. This is the first 
report describing the simultaneous occurrence of two blusmpc genes in 
Enterobacteriaceae as confirmed through gene sequencing (GenBank Accession 
numbers for CMY-2 is JF918434, and for MIR-1-like is JF918435). This is also the 
premier report describing the frequent presence of bloEBc fi-om Indian subcontinent. In 
the previous studies fi^om our lab, bloampc was detected in 43.5% (20/40) cefoxitin-
resistant isolates and CIT family was observed in 20% (22/110) of total isolates 
studied. It was revealed by the sequence analyses of representative isolates that 
bhaiy^pc carrying isolates were having blacMY.6 (Shahid et ai, 2009). We have 
observed the presence of blOampc in 85.60%) isolates, while among class A ESBLs, 
frequency of blacjx-M genes was highest followed by blasm and blajEu. blacjx-M was 
noticed to be present in 80.8 l%o isolates, blasnv in 48.80% isolates. Least occurrence 
was observed for blajEM as it was noticed in 44.80% isolates. In India, the very first 
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report on the presence of CTX-M |3-lactamase came from New Delhi, where the 
bacterial isolates collected in the year 2000, and only blacrx-u-is was reported (Karim 
et al., 2001). A systematic survey from our lab was performed on 130 3^ ^ Generation 
cephalosporin-resistant enterobacterial isolates collected during 2003-2005 and 
blacxx-u-\5 was reported in 73% isolates (Ensor et al. 2006). Recently, blacxx-u-2% was 
reported for the first time from frvdia (Kingsley & Verghese, 2008). When we 
compare the occurrence of blaesBis in collection of isolates from our lab, we have 
observed a drastic downfall in blacrx-u occurrence (73% in 2003-2005 to 28.8% in 
2007-2008) and then a steep rise was noted in the collection of year 2009 (67.5%) and 
2010 (80.81%). Furthermore, blasnw (13.7%) was more prevalent than blajsM (10.9%) 
in collection of 2007-2008 and 2009-2010 (blasW, 61% and blajEMl 56%), but in 
Citrobacter spp., collected during 2008, blaj^u (40%) was more prevalent than 
6/asHV (25%). 
Moreover, in our study isolates, maximum co-carriage of bloampc was noticed with 
blacTx-M (88.79%) followed by blasm (49.53%) and blajEU (46.73%). These 
observations indicate that the frequency of bla^mpc and other class A ESBLs (*/acTX-M 
blasH\j, i/axEM) is quite high in our area. Even the co-existence of bla^pc with 
^^ E^SBLS is also high. However, the detailed periodic analyses indicate that the 
prevalence of these bla genes and their combination is on decrease that could be due 
to implementation of stringent antibiotic prescription policy. Among Insertion 
Sequences, we observe that 6/aampc-harbouring isolates showed maximum association 
with ISEcpI (68.22%) and it was followed by ISCRJ (0RF5/i). \SEcpl has 
previously been found to be associated with several CMY alleles (CMY-2, CMY-4, 
CMY-5. CMY-7, CMY-12, to CMY-16, CMY-31, and CMY-36) and also ACC-1 and 
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ACC-4 (Jacoby, 2009). However, in previous reports, ISEcpI was described to be 
associated mainly with blocrx-M (Poirel et al., 2003) but we also observed its 
association with isolates harbouring 6/aampc- Moreover, its maximum association was 
noted in the group of isolates possessing bhampc + blacrx-M (73.33%). 
We noticed occurrence of ORF573 in 64.49% of 6/aampC-harbouring isolates. On 
sequence analyses, 0RF5/ i was noticed to be associated with blacuY-i in our isolates. 
The isolates that harbour bloampc alone, showed the association of ORFJii in 75% 
(maximum association among mobile genetic elements) of isolates. Its occurrence 
was noticed highest also in the group possessing combination of blaampc + 6/acTX-M + 
bla-YEu 
We noticed occurrence of integrons (as detected by amplifying 5'CS-3'CS region) in 
55.20% enterobacterial isolates. Sul-I was reported to be present in 3'CS (Carattoli, 
2001), but we also observe 14 isolates (out of 69) that showed amplification for 5'CS-
3'CS region but did not show presence of Sul-1 (when detected by PCR). Similar type 
of results was observed by Jin & Ling (2009). It was suggested by Jin & Ling (2009) 
that using sulfamethoxazole resistance as a marker for integrons could either misses 
the isolates or overestimates the prevalence of integrons. Insertion of dfrA]2-orJF-
aadA2 or orfF leads to excision of qacEAl and Sul-l in 3'CS and hence integron 
without Sul-1 gene were observed. Such excision has been previously reported in 
previous studies in some environmental bacteria (Rosser & Young, 1999). We also 
noticed 22 isolates that were integron-negative but were found to harbor Sul-1 gene. It 
may be possible that the Sul-1 gene detected in these isolates was present in the 
second copy of 3'CS i.e. 3'CS2 which was not detected by integron PCR as we have 
used the reverse primer that is specific for first copy of 3'CS. 
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It has been suggested that the deletion in the 3'CS segment or acquisition of different 
antibiotic resistance genes results in differences observed in molecular weight of 
amplicons. 
It has been reported in the literature that ORFii i get integrated in the Sul-1-type 
integron and thus form a mobilizing genetic structure termed as complex Class 1 
integrons. In the complex Class 1 integrons, downstream of 0RF5/ i can have one or 
more resistance gene cassettes, and Sul-3''CS. 
We observe such intricate structure in 44% (55/125) isolates, of which 48 were E. coli 
and 7 were K. pneumoniae. Complex Class 1 integrons are supposed to be an efficient 
mode for dissemination antibiotic resistance genes that were found associated with it, 
as they have rolling circle transposition which may transpose adjacent DNA 
sequences (Toleman et al., 2006). The occurrence of such situation in clinical isolates 
indicates an evolutionary trend in our bacterial isolates. 
In our study isolates, IS26 was noticed in 33.60% isolates (37 E. coli and 5 K. 
pneumoniae) showing high diversity in molecular size of amplicons (rangmg from 
350 bp to 1500 bp) and even two bands were also noticed in our isolates. We have 
observed the largest fraction of isolates showing amplicon at 800 bp (30.95%; 13/42) 
and the second most prevalent amplicon was observed at 350 bp (19.05%; 8/42). 
Contrary to this, association of IS26 was noticed in 41.7% isolates; moreover, 
amplicons of 650 bp, 750 bp, 850 bp, 950 bp, 1100 bp, and > 1400 bp were reported 
in previous studies (Ensor et al., 2006). Moreover, we observed insertion of IS26 in 
ISEcpI in 21.60% isolates, of which 25 were £ coli and 2 were K. pneumoniae. 
However, we have also noticed occurrence of 1S26 without ISEcpI in 15 isolates (12 
Jlostnict 
were E. coli and 3 were K. pneumoniae) and also 48/125 isolates (44 E. coli &. A K. 
pneumoniae) were observed to harbour ISEcpI but insertion oflS26 was not noticed. 
It has been evident from periodic analysis that the frequency of these mobile elements 
in our clinical isolates is on downfall. 
On performing RAPD-typing, we have observed that untypability of isolates is 
increasing. However, few bacterial isolates from gynaecology, surgery and 
orthopaedics wards displayed similar banding pattern. It can be concluded that 
probably the very same clone is circulating in the gynaecology, surgery and 
orthopaedics wards as these wards are sharing the same building block in our hospital 
and hence the chances of cross-contamination are high. However, variability among 
isolates is still maintained. 
Based on these observations, it can be concluded that: 
• We report here quite high 3''*-generation cephalosporins resistance rate in our 
clinical isolates 
• This is amongst the premier systematic reports from India characterizing the 
occurrence and prevalence of AmpC P-lactamases. 
• Occurrence of Woampc was detected in 85.60% cefoxitin-resistant isolates (by 
monoplex PCR) and 35.2% isolates were found positive for plasmid-mediated 
AmpC beta-lactamases by multiplex PCR. 
• The mobilization of bla^pc was of same chromosomal origin and hence it was 
not detected by the protocol of Perez-Perez & Hanson (2002). Hence, 
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variation in our results for occurrence of 6/aampc was observed (when detected 
by monoplex 8c multiplex PCR). 
• This is the first report describing simultaneous occurrence of two i/flampc 
genes (blacn and 6/aEBc) in Enterobacteriaceae as confirmed through gene 
sequencing. 
• This is amongst the premier reports describing the frequent presence of bla^BC 
from Indian subcontinent. Moreover, blacuY-2 is reported for the first time 
from India. 
• Based on the observations of the present study, we drew an inference that 
perhaps the co-existence of two bla^pc gene families, when present together, 
hinders in the proper amplification ofbla^sc in multiplex PCR. 
• Among Class A ESBLs, maximum co-existence of blaampc was observed with 
blacyx-M, indicating their concomitant carriage on the plasmid of-23 kb. 
• The occurrence of multiple bla genes (^ /OESBLS and 6/aampc) and even the 
identification of two bloampc families in single strain indicate that antibiotic 
resistance genes are accumulating in single organism, hence demonstrating the 
emerging complexity in Indian resistance mechanisms. 
• This is also the first systematic survey in Indian isolates looking for the 
presence of mobile genetic elements {ISEcpJ, IS26, 0RF5/i and Sul-I type 
integrons). 
• We observed that combination oflSEcpI + ORF57i + ^w/-/-integrons was the 
most common combination, followed by a combination of ISEcpl + IS26 + 
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ORFJiJ + iSMZ-Z-integrons in Z>/aampc-harbouring isolates. Probably, these 
were the mobile genetic elements which were responsible for mobilization of 
our clinical 6/aampc-harbouring isolates. 
• To the best of our knowledge, this would be the first report describing 
association ofblacuY-z with ORF513. 
• This is also the first report describing presence of complex class 1 integron in 
Indian Enterobacterial clinical (44%) isolates. 
• Association of 6/aampC with various mobile genetic elements like ISEcpl, 
IS26, ISCR], and Sul-1-type Class 1 integrons observed in this study 
demonstrated that a complex structure carrying combinations of fe/Oampc and 
other resistance genes exist in Indian Enterobacterial isolates. 
• Association of mobile elements including 0RF5/i , Sul-1, ISCRl, and IS26 is 
frequent in our isolates, and reflects the complex evolution of resistance 
mechanism in our isolates. 
• Detailed periodic analyses indicate that the prevalence of A/flampC & bla^sBi 
genes is on decrease that could be due to implementation of stringent 
antibiotic policies in recent past. 
• We also noticed a downfall in the prevalence of mobile genetic elements in the 
year 2010 as compared to 2009. 
• It was evident ft-om RAPD-typing that most patients in our hospital were 
infected with different clades of organisms, thereby demonstrating clonal 
diversity among isolates suggesting horizontal transmission of bla genes. 
• RAPD-typing demonstrated that untypability of isolates is increasing. 
However, few isolates from gynaecology, surgery and orthopedics wards 
displayed similar banding patterns. Most probably, the same clone is 
circulating in these wards as the above described wards are sharing the same 
building block in our hospital and the chances of cross contamination 
increases. 
• The matching of isolates of different wards indicates towards the need of 
stringent sterilization in our hospital wards/operation theaters; however 
variability is still maintained. 
• Surveillance of antimicrobial resistance and use is an essential prerequisite to 
monitor situation, for effective prevention and containment of antimicrobial 
resistance and rational antimicrobial use. 
• Our report suggests that there is an urgent need to implement strict antibiotic 
prescription policy to limit the irrational use of antibiotics (includmg 
cephalosporins) so that antibiotic selective pressure can be minimized. 
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REFERENCES: 
Hanson ND. 2003. AmpC p-lactamases: what do we need to know for the fiiture? J. 
Antimicrob. Chemother. 52: 2-4. 
Poirel L, Decousser JW, Nordmann P. 2003. Insertion sequence ISEcplB is involved 
in expression and mobilization of a blacrx-M P-lactamase gene. Antimicrob. Agents 
Chemother. 47: 2938-45. 
Perez-Perez FJ & Hanson ND. 2002. Detection of plasmid-mediated AmpC P-
lactamase genes in clinical isolates by using multiplex PCR. J Clin. Microbiol. 40: 
2153-62. 
Philippon A, Arlet G, Jacoby GA. 2002. Plasmid-determined AmpC type p-
lactamases. Antimicrob. Agents Chemother. 46: 1-11 
Jacoby GA. 2009. AmpC p-lactamases. Clin. Microbiol. Rev. 22: 161-182. 
M'Zali FH, Heritage J, Gascoyne-Binzi DM, Denton M, Todd NJ & Hawkey PM. 
1997. Transcontinental importation into the UK of Escherichia coli expressing a 
plasmid-mediated AmpC type P-lactamases exposed during an outbreak of SHV-5 
extended-spectrum P-lactamase in Leeds hospital. J. Antimicrob. Chemother. 40: 823-
831. 
Cao VT, Arlet G, Ericsson BM, Tammelin A, Courvalin P & Lambert T. 2000. 
Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of 
plasmid mediated CMY-4 and permeability alteration. J. Antimicrob. Chemother. 46: 
895-900. 
Mstract 
Shahid M, Ensor VM, Hawkey PM. 2009. Emergence and dissemination of 
Enterobacteriaceae with plasmid-mediated CMY-6 and CTX-M-15 beta-lactamases in 
community in North-India. World J. Microbiol. Biotechnol 25: 1439-46. 
Upadhyay S, Sen MR & Bhattacharjee A. 2010. Presence of different beta-lactamase 
classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-
lactamase enzyme. J. Infect. Dev. Ctries. 4(4): 239-242. 
Gokul BN, Menezes GA & Harish BN. 2010. ACC-1 P-lactamase-producing 
Salmonella enterica serovar Typhi, India. Emerg. Infect. Dis. 16(7): 1170-1171. 
Hawkey PM. 2008. Molecular epidemiology of clinically significant antibiotic 
resistance genes. British J. Pharmacol. 153: S406-S413. 
Canton R & Coque TM. 2006. The CTX-M p-lactamase pandemic. Curr. Opin. 
Microbiol 9: 466-475. 
Ensor VM, Shahid M, Evans JT & Hawkey PM. 2006. Occurrence, prevalence and 
genetic environment of CTX-M beta-lactamase in Enterobacteriaceae from Indian 
hospitals./. Antimicrob. Chemother. 58:1260-1263. 
Muzaheed, Doi Y, Adams-Haduch JM, Shivannavar CT, Paterson DL & Gaddad SM. 
2009. Faecal carriage of CTX-M-15-producing Klebsiella pneumoniae in patients 
with acute gastroenteritis. Ind. J. Med. Res. 129: 599-602. 
Shahid M, Singh A, Sobia F, Rashid M, Malik A, Shukla I, Khan HM. 2011. blacrx-M, 
bloTEM, and blasHv in Enterobacteriaceae from North-Indian tertiary hospital: high 
occurrence of combination genes. 412-420. 
JiSstract 
Clinical and Laboratory Standard Institute (CLSI)/NCCLS. CLSI document MIOO-
S15. Clinical and Laboratory Standard Institute; 940 West Valley Road Suite 1400, 
Wayne, Pennsylvania 19087-1898 USA: 2005. Performance standards for 
antimicrobial susceptibility testing; Fifteenth information supplement. 
Feria C, Ferreira E, Correia JD, Goncalves J & Canica M. 2002. Patterns and 
mechanisms of resistance to p-lactams and P-lactamase inhibitors in uropathogenic 
Escherichia coli isolated from dogs in portugal. J. Antimicrob. Chemother. 49: 77-
85. 
Manchanda V & Singh NP. 2003. Occurrence and detection of AmpC beta-lactamase 
among Gram-negative clinical isolates using a modified three-dimensional test at 
Guru Tegh Bahadur Hospital, Delhi, India. J. Antimicrob. Chemother. 51:415-418. 
Jin Y & Ling M. 2009. Prevalence of integrons in antibiotic-resistant Salmonella spp. 
in Hong Kong. Jpn. J. Infect. Dis. 62: 432-439. 
Karim A, Poirel L, Nagarajan S, Nordmann P. 2001. Plasmid mediated extended-
spectrum p-lactamase (CTX-M-3 like) from India and gene association with insertion 
sequence ISEcpl. FEMS Microbiol Lett 201: 237-41. 
Rosser SJ & Young HK. 1999. Identification and characterization of class 1 integrons 
in bacteria from an aquatic environment. J. Antimicrob. Chemother. 44: 11-18. 

Occurrence, prevalence and genetic environment 
of Enterobacteriaceae with special reference to 
AmpC beta-lactamases 
/ THESIS 
SUBMITTED FOR THE AWARD OF THE DEGREE OF 
JBoctor of $I)ilogoplip 
IN 
MICROBIOLOGY 
BY 
FARRUKH SOBIA 
DEPARTMENT OF MICROBIOLOGY 
JAWAHARLAL NEHRU MEDICAL COLLEGE & HOSPITAL 
ALIGARH MUSLIM UNIVERSITY 
ALIGARH (INDIA) 
2011 
T7526 
FACULTY OF MEDICINE 
ALIGARH MUSLIM UNIVERSITY, ALIGARH 
D. No. /FM Dated: August 27, 2011 
CERTIFICATE 
This is to certify that the Ph.D. topic titled "Occurrence, 
prevalence and genetic environment of Enterobacteriaceae with Special 
reference to AmpC beta lactamases" of Dr. Farrukh Sobia, Department 
of Microbiology, JNMC, has been approved by the "Institutional Ethics 
Committee" of the Faculty of Medicine. 
< 7 ^ ^'j-
(Prof. Tariq Mansoor) (Prof. A.K. Verma) 
Convenor DEAN 
Institutional Ethics Committee, Faculty of Medicine. 
Faculty of Medicine, AMU, Aligarh. 
AMU. Aligarh. 
DEPARTMENT OF MICROBIOLOGY 
JAWAHARLAL NEHRU MEDICAL COLLEGE 
ALIGARH MUSLIM UNIVERSITY, 
ALIGARH 
Certificate 
This is to certify that the work and techniques incorporated in 
the thesis entitled "Occurrence, prevalence and genetic 
environment of Enterobacteriaceae with special reference to AmpC 
beta-lactamases" is the bonafide work of Ms. Farrukh Sobio. 
The research work embodied in the thesis has been undertaken 
by the candidate herself under my guidance and direct 
supery\s\on. The observations were carefully checked by me 
from time to time. The work included m the thesis \s original 
and \s suitable for the award of degree of Ph.D. (Microbiology). 
ProfUg^ris M. Khan 
M.D. 
Professor, 
Department of Microbiology 
J. N. Medical College & Hospital, 
A.M.U., Aligarh 
(Supervisor) 
c ^ CMffM Q^kdlid ^ ^ ^ ^ ^ DEPARTMENT OF MICROBIOLOGY 
M.B.B.S., M.D., PhD., FNZIMLS ( N e w K ^ f | M J.N. MEDICAL COLLEGE & HOSPITAL 
A.M.U., ALIGARH-202002, INDIA 
Associate Professor of Microbiology 
TO WHOM IT MAY CONCERN 
This is to certify that I know tks. Farrukh Sobia smce she joined the 
Department of Microbiology os a research scholar in December 
2008. The work and techniques mentioned in the thesis entitled 
"Occurrence, prevalence and genetic environment of 
Enterobacteriaceae with speciol reference, to AmpC bcta-
lactamases" has been undertaken by her \r\ my lab, during my 
\ireser\cz and under my direct supervision A guidance. 
Ms. Farrukh Sobia is hard working and smcere and bears a 
good moral character. She maintained cordial relations with her 
semors and junior colleagues os well as staff members of the 
department. 
I wish her succ^ss in all her future endeavors. 
Dr. Mohd. Shahid 
MD, PhD, FNZIMLS (New Zealand) 
Associate Professor, 
Department of Microbiology 
J. N. Medical College & Hospital, A.M.U,, 
Aligarh 
Email: shahidsahar@vahoo.co.in 
drmohdshahidl23@vahoo.com 
Tel. 00966596540442; E-mail: shahidsahar&>vahoo.co.in,drmohdshahidl23^vahoo.com 
Home address: H. No. 43, Sagar Colony, Anoopshahar Road, Aligarh-202122 
dedicated to 
my ^Parents 
To recaCCandgo Bac^over tfie noSk deeds of esteemed teachers, colleagues <^ friends is, a tas^ 
pCeasuraBle and grueling; pleasuraSle Because expression of gratitude Bring forth nice 
sentiments and grueRng Being my inaBiRty to acknowledge each and every help received from 
them. It is a great pleasure to convey my gratitude to them allin my humBle acknowledgement. 
Jinyways, J shall strive to do so. But first and foremost the providence must Be gratefully 
than^dfor the successful completion of this study. 
In the first place I ta^ privilege to express my indeBtedness and deep sense of 
gratitude to my supervisor (Prof. Haris 9i. Kfian, <Department of "MicroBiology, JawaharCil 
!Nehru Medical College, JlGgarh Muslim Vniversity, Jiligarh for his inspiring guidance, 
constant encouragement and inexfiaustiBle help which was always forth coming at every 
moment. JiBove alCandthe most needed, he provides me undaunted encouragement and support 
in various ways. (Put together, I can't find enough words to ejqn'ess my gratitude to him. 
!My profound gratitude with greatest reverence is offered to <Dr. MoRdi SHaRM, 
Associate (Professor, (Department of MicroBioCogy, JawahartaC !N'ehru Medical College, ^Ugarh 
Muslim Vniversity, Jiligarh for aU his contriBution of time, ideas to ma^ my (Ph. (D. 
experience productive and stimulating. 9fis enthusiasm for research was motivational for me. 
His scientific insight has made him a constant asylum of ideas and passion in science, which 
exceptionally inspire me as a student and a researcher. I would G^ to thaTi^himfor Being the 
first person who teaches me aUthe molecular techniques. "Without his guidance and persistant 
help, this thesis would not have Been possiBU. Suffice it to say that I owe it all to him. 
It is with great privilege that I express my heartful respect and gratitude to <Dr. Indu 
SRu^ (Professor ^ Head, (Department of MicroBiobgy, Jawaharkl!Hehru Mescal College, 
Jiligarh Muslim Vniversity, ^Rgarhfor her wise counsel and ^nd cooperation 
I offer my most sincerefeeRng of gratitude to ^rqf.^Bidd tHoB^ who has always Been 
sympathetic at almost every stage. I would R^ to than^ her for her sustained interest, 
motivation and encouragement. 
/ am tfian^Cto <Dr. Metier ^ (izvi, (Dr. 'Fatima SHujatuOaA, and (Dr. 9fazisfi fatima 
for tfieir usefuCsuggestion, fieCp amfsupport. 
^ tas^ such as this, wouhf not have come through -without the valuable hetp and 
practical suggestions furnished by my seniors and colleagues, of whom, I would specially G^ to 
mention my seniors, C>r. ^tu, ^Dr. iMehnaz, <Dr. Tatima, (Dr. Add, and my colleagues Ayesha, 
!Mehvash, ^azia, Asfia, Sumit, (Pen/ez, Junaid, Zubair, Jlzam Jinsari, yeha. jAbida. 
Shafquat, Shadab, di Mohd ^zam. I express my specialthar^ to my lab colleague, jAnuradha 
Singh, Trivendra Tripathi dE Sana JamaR for their constant support, encouragement and 
cooperation. 
I acknowledge with than^ the cooperation of all the technical aruf clerical staff of my 
department, who helped me in carrying out this study. I than^ iWr. Ji. "Kfialque, !Mr (P. S-
"Uerma, Mr (RahulSharma, Sanjay Sharma, !Ndyab, Asim, Imran, !Najmul Islam, Mehfooz, 
Mustafa, J^ad, !Naqi Imam, ^{athuram, Masroor, Teroz, Sha^l, Osama, SuhaiC Jitiya, 
(Rft^h, Imtiaz, Tarru^ (pan^j, O^aved, (Rfijpal, andAn^ndfor their help and support. 
I wish to than^Vrof. ^DanieC Jonas, (Department of'Environmental Jlea&h Scierues, 
(Breisacher Strafie 115 (B, (D-79106 Treiburg, germany, for very kindly providing the control 
strains harboring bloampo blocvc-M, blontEM, andblasHV-
'What would I be without my famdy? My parents deserve special mentum for their 
inseparable support and prayers. My father, <Dr. M.Asgliar, in the first place is the person who 
put the fundament my learning character, showing me cf intellectualpursuii exersin^e I uas a 
child. My mother, 'Kfluserperveen, is the one who sincerely raisedme with care and gentle love. 
I am beholden to my parents whose affection and encouragement has aRiays been pillar of 
strength in my Rfe. Shoeb, 'Fa^re-Jihm, and Sana, than^for being supportive and caring 
siblings. 
I wouldR^ to than^Mr. Zaheer Ahmad(Limra Computers)for helping me in printing 
wor^ and"iVew (Boo^(Btnding "Wor^'for binding thesis with care. 
r 
/ apologize to all the wonderful people I missed. I A > 
Tami^SoSia 
TABLE OF CONTENTS 
Page No. 
ABBREVIATIONS 
LIST OF TABLES 
LIST OF FIGURES 
1. INTRODUCTION 1-10 
1.1 Aim and Objectives 
2. REVIEW OF THE LITERATURE 11-73 
2.1 Background 
2.2 How bacteria become resistant to antibiotics 
2.3 Classification of broad-spectrum ^lactamases 
2.4 Resistance to cephalosporins: the ''classical" ESBLs 
2.5 AmpC p-lactamase 
2.5.1 History' and chronology' of AmpC ^-lactamases 
2.5.2 Origin and evolution of AmpC p-lactamases 
2.5.3 Epidemiology of plasmid mediated AmpC enzymes 
2.5.4 Relationship of chromosomal and plasmid-encoded AmpC enzymes 
2.5.5 Genetic Environment ofbla,apc gene 
2.5.6 Enzymatic properties 
2.5.~ Susceptibility to difl'erent antimicrobials and mechanisms of resistance 
2.5.8 Detection of AmpC ^lactamases 
2.6 Mobilization of broad-spectrum ^-lactamases 
2.7 Mobilization of Wa„pc gene 
2.8 Impact of mobile Genetic elements as carriers of broad-spectrum p-lactamases on 
epidemiology and co-resistance selection 
2.9 Extended-spectrum ^lactamases 
2.9.1 SHV and TEM p-lactair.ases 
2.9.2 Emergence and origin of CTX-M ESBLs 
2.9.2.1 Dbsemination of blacrx-si genes 
3. MATERIAL AND METHODS 74-88 
3.1 Materials 
3.2 Methods 
3.2.1 Clinical samples collection 
3.2.2 Antimicrobial susceptibility testing 
3.2.2.1 Turbidity standard for inoculum preparation 
3.2.2.2 Disc diffusion susceptibility testing 
3.2.3 Phenotypic detection of AmpC-producers 
3.2.3.1 Phenotypic confirmatory test 
3.2.4 Genotypic characterization of cefoxitin-resistant isolates 
3.2.4.1 DNA template preparation 
3.2.4.1.1 Detection of bla^mpc genes 
3.2.4.1.2 Detection of plasmid-mediated AmpC p-lactamases 
3.2.4.1.3 Characterization of speciflc AmpC type 
3.2.4.2 Analysis of co-carriage of class C and class A p-Iactamases 
3.2.4.2.1 Detection of WacTX-M» WATEM* and WASHV 
3.2.4.3 Characterization of mobile genetic elements 
3.2.4.3.1 Detection of insertion sequences 
3.2.4.3.1.1 Detection oflSEcpl 
3.2.4.3.1.2 Detection oflS26 
3.2.4.3.2 Characterization of integrons 
3.2.4.3.2.1 Detection oiSul-1 type class 1 integrons 
3.2.4.3.2.2 Detection of ISC/?/ (ORF5/i) 
3.2.5 Visualization of amplified product 
3.2.6 Typing of cefoxitin-resistant isolates by RAPD-PCR 
3.2.6.1 RAPD typing 
3.2.7 Plasmid analysis 
4. RESULTS 89-120 
4.1 Bacterial isolates 
4.2 Patients' Demography 
4 3 Sample and wards from where cefoxitin-resistant isolates were obtained 
4.4 Antimicrobial susceptibility testing 
4.4.1 Antibiotic resistance pattern 
4.4.2 Antibiotic resistance rates and pattern from different wards 
4.5 AmpC p-lactamase 
4.5.1 AmpC p-lactamase detection 
4.5.2 Wa.mpc detection 
4.5.3 Sequencing of representative isolates 
4.6 Detection of class A ESBLs and co-production ofblOt^pc and bla^sBLi 
4.6.1 Occurrence of bla genes in isolates obtained from various wards 
4.7 Mobile genetic elements (MGEs) 
4.7.1 Detection of IS2tf elements 
4.7.2 Association of MGEs with bla,^pc 
4.7.3 bla genes and MGEs 
4.7.4 Detection of Conserved Sequence (CS) regions 
4.8 Analysb of d/a.mpc-harboring isolates 
4.8.1 Co-occurrence of various Wa.mpc families with class A ESBLs 
4.8.2 Association otbla^mpc families and various mobile genetic elements 
4.9 Comparative trend of bla genes and MGEs in 2009 and 2010 
4.10 Plasmid analysis 
4.11 RAPD-typing 
5. DISCUSSION 121-135 
6. SUMMARY 136-142 
7. CONCLUSION 143-146 
8. BIBLIOGRAPHY 147-173 
9. ANNEXURES 
ABBREVIATIONS 
NAM 
NAG 
MGEs 
MBL 
pMAmpC 
RCS 
OMPs 
APB 
NPB 
TPB 
CIAT 
MAPCR 
CMT 
CR 
°C 
3'CS 
5'CS 
ATCC 
BLAST 
bp 
CLSI 
DNA 
EDTA 
ESBLs 
EtBr 
EUCAST 
gm 
hr 
Inc 
IntI 
N-acetylmuramic acid 
N- acetylglucosamine 
Mobile Genetic elements 
Metallo p-lactamase 
plasmid-mediated AmpC P-lactamase 
recombination crossover site 
outer membrane proteins 
3-aminophenyl boronic acid 
3-nitrophenyl boronic acid 
2-thiophene boronic acid 
ceftazidime-imipenem antagonism test 
Multiplex Asymmetric PCR 
Complex mutants of TEM 
Common region 
Degree Celsius 
3'Conserved region 
5'Conserved region 
American Type Culture Collection 
Basic local alignment search tool 
Base pair 
Clinical and Laboratory Standards Institute 
Deoxyribonucleic acid 
Ethylene diamine tetra acetic acid 
Extended spectrum beta-lactamases 
Ethidium bromide 
European Committee on Antimicrobial Susceptibility 
testing 
Gram 
Hour 
Incompatibility 
Integase gene 
IS 
ISC/f 
Kb 
M 
mA 
MI 
MIC 
min 
ml 
mM 
MTDET 
NCCLS 
ng 
ORF 
PBPs 
Pc 
PCR 
pH 
RAPD 
RFLP 
rpm 
sec 
SuI-1 
TAE 
ug 
ugA 
ug/ml 
ul 
uM 
Zn2+ 
Insertion sequences 
Insertion sequence common region 
Kilobase 
Molar 
Milli Ampere 
Mobile integrons 
Minimal inhibitory- coDceatration 
Minute 
MUUUtre 
Milli molar 
Modified three dimensional extract test 
National Committee for Clinical Laboratory 
Standards 
Nano gram 
Open reading frame 
Penicillin binding proteins 
Common promoter 
Polymerase Chain Reaction 
The Negative logarithm of H+ concentration 
Randomly amplified poly morphic DNA 
Restriction fragment length polymorphism 
Revolution per minute 
Second 
Sulphonamide resistance gene 
Tris-acetate EDTA 
Microgram 
Microgram per litre 
Microgram per milli litre 
Microlitre 
Micromolar 
Zinc ion 
LIST OF TABLES 
Table 1: Classification scheme for ^-lactamases. 
Table 2: Chromosomal and Plasmid-mediated AmpC ^-lactamasies reported in 
various Gram-negative organisms, their year and country of origin and 
Accession numbers (based on GenBank data). 
Table 3: Primers used for amplification of various genes in the present study. 
Table 4: Age and gender distribution of the patients from which cefoxitin-resistant 
isolates were obtained. 
Table 5: Sample and ward from where cefoxitin-resistant E. coli and K. 
pneumoniae were obtained. 
Table 6: AmpC ^lactamase detection by Modified Three-Dimensional Extract 
Test. 
Table?: blaamvc (by monoplex PCR) and plasmid-mediated ampC genes 
(pMAmpC; by multiplex-PCR) in E. coli and K. pneumoniae isolates 
studied. 
Table 8: bla^mpc, WAESBLJ and co-occurrence of Class C & Class A ESBLs in E. coli 
and K. pneumoniae isolates. 
Table 9: bla^mfC and blofsax- genes' combination and wards from where the bla 
genes harboring £. coli and K. pneumoniae were isolated. 
Table 10: Occurrence of OHF513,SuJ-l, ISEcpl and IS26. 
Table 11: .Association of Na^pc with ORF57J. Sul-l. ISEcpJ and 1S26. 
Table 12: Occurrence of niobik genetic elements (MGEs) in various combinations 
of bla genes noticed. 
Table 13: Genetic organization of integron-positive isolates of E. coli and Klebsiella 
pneumoniae. 
Table 14: Frequencies and combinations of mobile genetic elements (MGEs) noticed 
in the study isolates (n). 
Table 15: bla gene composition in various clusters of E. coli and K. pneumoniae 
isolates. 
LIST OF FIGURES 
Fig. 1: ^-lactam ring opening hydrolysis by p-lactamases 
Fig. 2: Neighbour joining tree (with branch length self drawn) using clustal X 
software, based on thie sequences of various plasmid and chromosomal 
/^a«mpcs available in GenBank. 
Fig. 3: AmpC P-lactamases inhibitors a) RO 48-1220, b) Syn 2190 
Fig. 4: Schematic diagram of plasmid isolation. 
Fig. 5: Antibiotic resistance rates of the E. coli and K. pneumoniae isolates 
studied. 
Fig. 6: Antibiotic resistance rate and pattern of isolates from different wards 
Fig. 7: AmpC detection by modified three-dimensional extract test (MTDET). 
Fig. 8a: Electrophoretograph showing the amplification product obtained for 
*/a.inpc gene 
Fig. 8b: Electrophoretograph showing the amplification product of blacrr and 
blatsc families. 
Fig. 8c. Electrophoretograph (with 2% agarose) showing the representative 
results of pMAmpC ^-lactamases obtained in this study. 
Fig. 9a-c: Agarose gel (2.0%) showing amplification result of PCR for detection 
of A/acR-M* WflTEM, and blasw/-
Fig. lOa-c: Amplicons observed for ISEcpl, ORF5i3 and Sul-1-type class 1 
integron 
Fig 11a: Agarose gel showing 1S26 amplification pattern (single bands). 
Agarose gel showing single and double amplicons of IS26 observed in 
this study. 
2% agarose gel showing single amplicon observed in amplification of 
CS region. 
2% agarose gel showing the amplification pattern of single, double 
and multiple amplicons noticed in amplification of CS region. 
Co-occurrence of various bloampc families with blOfSBhi (blacrx-Mi 
WOTEM & WflsHv)' 
Association of various A/aampc families with integron (Conserved 
Sequence region) 
Association of various 6/aampc families with ISCRl (ORF5iJ) 
Fig. 
Fig. 
Fig. 
Fig. 
Fig. 
Fig. 
l ib : 
12a: 
12b: 
13: 
14a: 
14 b: 
Fig. 
Fig. 
Fig 
Fig. 
Rg-
Fig. 
14c: 
14d: 
15a: 
15b: 
16: 
17a-b: 
Association of various A/aampc families with SuI-1-type Class 1 integron 
Association of various bla^mpc families with ISEcpl. Fig. 14e: 
Association of various blotmpc families with IS26 
Occurrence of bla,mpc and bloESBu (Wacrx-M, WOTEM, and 6/asHv) »n 
the year 2009 and 2010. 
Comparative representation of occurrence of mobile genetic elements 
in the year 2009 and 2010. 
.\garose gel (0.8 %) showing plasmids obtained from E. coli and K, 
pneumoniae isolates. 
RAPD profile of E. coli isolates obtained from the wards of Surgery 
department. 
Fig. 18: RAPD profile of E. coli isolates obtained from the wards of 
Gynaecology department 
Fig. 19: RAPD profile ofE. coli isolates obtained from Orthopaedics wards. 
Fig. 20: RAPD profile of E. coli isolates obtained from Medicine and 
Paediatrics 
Fig. 21: RAPD profile of Klebsiella pneumoniae isolates obtained from 
different wards. 
Fig. 22: Clusters noticed in E. coli and K. pneumoniae isolates obtained from 
various wards of our hospital. 
Introduction 
1. INTRODUCTION 
In the present decade, microbial resistance to current antibiotics has emerged as one of the major health care problem. The overuse and misuse of broad-spectrum antibiotics and the capability of microbes to exchange resistance gene has further 
accentuated the crisis. P-lactam antibiotics are among the most common drugs currently 
prescribed to treat bacterial infections. These antibiotics act by covalently binding to the 
active site of D-alanyl-D-alanine carboxy-peptidase/transpeptidase enzymes that catalysis 
the biosynthesis of bacterial cell wall peptidoglycan, thereby preventing assembly of 
bacterial cell wall and resulting in cell death. Resistance to these antibiotics is conferred 
principally via P-lactamases. which binds the antibiotics in a similar fashion but are then 
able to rapidly hydroly:ze the substrate, thus destroying the antibiotic agent. The 
expression of P-Iactamase enzyme is one of the most common mechanisms of antibiotic 
resistance. These enzymes have been classified into groups, either according to amino 
acid sequence (molecular classification scheme) or according to their inactivating 
properties (functional classification scheme based on hxdroljsis and inhibition profile of 
enzymes). Classes A, C, and D are serine ^-lactamases, and the class B enzymes are 
metallo-P-lactamases (MBLs). The clinically important groups are class A and Class C p-
lactamases. AmpC p-lactamases belonging to molecular class C and fiinctional 
classification group 1 are among the most abundant P-lactamases on the basis of number 
of organisms that produce these enz>Tnes. These ccfrfialo^wrinases, frequently named as 
species-specific AmpC enzymes, are often found in most of Enterobacteriaceae as 
chromosomal enzymes. AmpC P-lactamases were «iginalh described as chromosomal, 
inducible enzymes in members of Enterobacteriaceae, plasmid-mediated AmpC beta-
lactamases were first discovered in late 1980s (Jones, 1998) and have been detected in 
different regions worldwide since then. AmpC p-lactamases are causing great concern 
1 
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because they mediate resistance to broad-spectrum of antibiotics comparable to extended-
spectrum P-lactamases (ESBLs). Extended-spectrum AmpC (ESAC) p-lactamases with 
increased hydrolytic activity against ceftazidime and cefepime have been described in E. 
coli (Mammeri et al., 2008). The broadened substrate activity of these enzymes is due to 
structural modifications in the active site (Mammeri et al., 2008). It has been realized 
now that AmpC ^-lactamase-producing bacteria not only cause fatal infection, but also 
led to a global dissemination of strains carrying plasmid-encoded ampC genes. 
Nevertheless the icnowledge on AmpC is still limited, and hence Hanson has pointed out 
that it would induce serious infections if effective measures to prevent the dissemination 
of these resistance genes are not taken (Hanson, 2003). The data regarding worldwide 
distribution and prevalence of AmpC mediated resistance is fragmentary as compared to 
that of ESBLs and this may be due to limited number of surveillance studies and 
laboratories also face difficulties in accurate detection of these resistance mechanisms 
(Hanson, 2003). Since the detection method of AmpC P-lactamase has not been 
standardized by CLSI (formerly NCCLS), it pose a major barrier in defining the actual 
prevalence and epidemiolog>' of these p-lactamases. Failure to detect these p-lactamases 
has contributed to their uncontrolled spread and occasional therapeutic failure. AmpC p-
lactamases are classified as Ambler class C enzymes and provide resistance to 
cephalosporins of ox>imini-and 7-a-methoxy enzymes group and monobactams too. 
These P-lactamases, now exceeding over 99 different variants 
(http://ww^.lahey.org/studies/webt.htm: last accessed on 12 February 2011), can be 
grouped into six clusters (Perez-Perez & Hanson, 2002) and have been named, with an 
inconsistency of nomenclature; according to resistance produced to cephamycins (CMY, 
64 variants), cefoxitin (FOX, 8 variants), moxalactam (MOX, 8 variants), or latamoxef 
(LAT, 1 variants), according to type of enzyme [Ambler class C (ACC, 4 variants). 
ini.Tvuui,i-ivn 
AmpC type (ACT, 9 variants)] or according to the site of discovery [Miriam hospital in 
Providence (MIR, 5 variants), Dhahran Hospital in Saudi Arabia (DHA, 8 variants)], and 
BIL-1 was named after the patient (Bilal) who provided the original sample (Phillipon et 
al., 2002). These p-Iactamases have global distribution and have been identified in Africa, 
Asia, Europe, the Middle East, North America and South America (Jacoby, 2009). CMY-
2 has been reported with widespread geographic distribution, including recent reports 
from Algeria (Labadene et al., 2009), Canada (Baudry et al., 2009), Spain (Mata et al., 
2010), France (Corvee et al., 2010) and Thailand (Singtohin et al., 2010). Naseer et al. 
(2010), from Norway, have reported the dominance of CMY-2-type plasmid-mediated 
AmpC in 92% isolates, consistent with worldwide observations and they also reported 
DHA-1 enzyme in 5% isolates. Moreover, recently many researchers have reported on 
cefoxitin-resistance and AmpC production (based on phenotypic detection methods) from 
India, but molecular analyses of this type of resistance mechanism is lacking. We found 
only few published reports regarding genotypic characterization of ft/oampc gene. BIL-1 
like and CMY-4 were reported by British and Swedish researchers (M'Zali et al., 1997: 
Cao et al, 2000), while Shahid et al. (2009) reported CMY-6. Recently, Upadhyay et al. 
(2010) have also reported presence of CIT, ACC, and EBC type families of plasmid-
mediated AmpC P-lactamase, and ACC-1 was reported by Gokul et al. (2010) in 
Salmonella isolate. 
ESBLs, the enzymes that were recognized shortly after the infroduction of 'P-
lactamase-stable' cephalosporins and azfreonam, are particularly worrisome. ESBLs were 
origmally identified as common TEM-1 or SHV-1 enzymes' variants, often differing by 
one or two amino acid fix)m parent enzyme. TEM-1 was first demonstrated in 1965 in an 
E. coli isolate from a patient in Athens, Greece, named Temoneira (hence designation is 
TEM) (Datta & Kontomichalou, 1965). In contrast to majority of TEM p-lactamases, 
introauctton 
TEM-1, TEM-3, and TEM-13 are not ESBLs and are able to hydrolyze penicillins. Some 
TEM P-lactamases have been reported to possess reduced affinity for ^-lactamase 
inhibitors and are termed as inhibitor resistant TEM. Progenitor of SHV (Sulphydryl 
variable) enzymes, SHV-1 confers resistance to broad-spectrum penicillins. In 1983, a 
Klebsiella ozaenae strain was isolated in Germany possessing an SHV-2 enzyme that 
efficiently hydrolyzed cefotaxime and to a lesser extent ceftazidime (Paterson & Bonomo, 
2005). Some P-lactamases have hydrolylic profiles similar to those of the TEM and SHV 
mutants but their evolutionary history is different, and these non-TEM and non-SHV 
plasmid-mediated class A ESBLs have been reported as cefotaximases (CTX-M). CTX-M 
P-lactamases preferentially hydrolyze cefotaxime rather than ceftazidime, although some 
enzymes like CTX-M-15 have been reported to possess good activity against ceftazidime 
also (Poirel et al., 2002). The early SHV and TEM variants have now been replaced by 
CTX-M P-lactamases and causes major outbreaks throughout the world (Hawke\, 2008: 
Villegas et al., 2008). The first CTX-M enzymes were identified approximately at the 
same time twenty years ago, in Germany and Argentina, but within such a short period of 
time they became the predominant ESBL type, and hence exemplify one of the most 
successful resistance mechanism that has emerged and spread during recent years <Camon 
& Coque, 2006). It encompasses five groups viz. CTX-M-groupl, CTX-M-group2. CTX-
M-group8, CTX-M-group9, and CTX-M-group26 (Bonnet, 2004). From an evolutionary 
point of view, different Kluyvera species have been recognized as progenitors of ft/ocrx-M 
genes; Kluyvera ascorbata for the CTX-M- group!, and CTX-M- group2 and Kluyvera 
georgina for the CTX-M- group8. The early CTX-M-producers were frequently resistant 
to cefotaxime and ceftriaxone but remain susceptible to ceftazidime as they have strong 
preference for hydrolysis of those cephalosporins. Though some members of CTX-M 
family displayed hydrolysis of all extended-spectrum cephalosporins because of single 
amino acid mutations, and hence results in resistance to all cephaiosporins (Kimura et al., 
2007). It has been speculated that regional diflference in emergence of CTX-M family 
may be due to localized preference of specific cephalosporins as therapeutic regimen. 
Some of the CTX-M enzymes has been reported fixjm specific countries, like CTX-M-9 
and CTX-M-14 from Spain, CTX-M-1 from Italy and CTX-.M-2 from most South 
American countries, Japan and Israel (Bonnet 2004: Ben Ami et al^ 2006), whereas 
CTX-M-15 have been found worldwide (Canton & Coque. 2006) and also in India (Ensor 
et al. 2006; Muzaheed et al.. 2009; Shahid 2010: Shahid ei al.. 2011). However, CTX-
M-14 was found to be the most widespread CTX-M-type enz>Tne in a very wide 
geographic area including Europe, North America, and south Asia and in East Asia 
(Eckert et al., 2006). Spread of CTX-M enzymes follow an allodemic rather than an 
epidemic pattern, which reveals that the increase of CTX-M enzymes has not been due to 
the dissemination of particular clones, but because of the spread of both multiple specific 
clones and mobile genetic elements (Canton et al.. 2003). In recent >ears. a dramatic 
increase in these P-lactamases worldwide may be due to its association with insertion 
sequences participating in gene mobilization, such as ISEcpl and ISCRl. Although 
plasmids carrying blocTK-u genes are widely disseminated among clinical isolates and are 
easily transferred, blocrx-M genes have also been reported on classl iniegrons. 
Surveillance of resistance gene is central in identifving existing and newly 
emerging mechanisms and is important for the control of resistance against therapeutic 
antimicrobials. The therapeutic future of the P-lactam antibiotics is seriously challenged 
and a solution to the problem of bacterial resistance due to ^-lactamase production is 
immediately needed. This challenging task is further complicated by the 'genetic fluidity' 
of microbial population which allows a far-reaching and frightening dissemination of 
resistance genes, and also occurrence of single-point mutations in these P-lactamase-
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coding genes results in the production of an over-expanding number of enzymes with new 
substrate profile (Matagne et al., 1998). 
Today many bacterial pathogens are complex than a decade or two ago. Thus, 
previously reliable susceptible tests may no longer be dependable, for e.g. there are not 
only new resistance mechanisms, such as new world ESBLs, but also isolates that 
produce multiple P-lactamases (Shahid. 2010) have been identified. Before the 1990,s K. 
pneumoniae isolates t>pically produced a single P-lactamase (SHV-1), or occasionally 
two (Sanders ei aL 1988; Liu et al^ 1992; Reig et al., 1993). Isolate of Klebsiella spp. 
producing KPC-2, SHV. and inhibitor-resistant TEM-30 p-lactamases have been reported 
as endemic in New York City (Moland et al., 2007), moreover, recently K. pneumoniae 
isolate from New York City producing up to eight P-lactamases including FOX-like 
AmpC, SHV-12 like, KPC-like. OXA-like TEM-1-like, TEM-30-like, and PSE-1 has also 
been reported (Moland et al.. 2007). E. coli and Klebsiella isolates harboring TEM, SHV, 
and CTX-M have recently been reported from India during a study conducted in our 
laboratory (Shahid et al.. 2011). Increasing frequency of co-existence of A/OCTX-M and 
blosmpc more specifically Z)/flcDC-M-i5 and blocMY-e has also been reported in Indian E. coli 
and Klebsiella isolates (Shahid ei al.. 2009) 
The prevalence of antibiotic resistance is primarily due to the horizontal transfer 
of antibiotic-resistance genes which can take place regardless of similarity between 
donating and recipient molecules (Hal let & Sherratt, 1997; Plasterk, 1995). These genes 
are linked to insertion sequences that have shown integration, mobilization and 
expression functions such as ISCRl (formerly known ORF513) or ISEcpl similar to those 
encountered with other emerging resistance genes. All these sequences are carried on 
transposable platforms such as plasmids, transposons, and site-specific recombination 
systems termed integrons, allowing potential spread within bacterial population. The 
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diversity of genetic vehicles enhances the spread of broad-spectrum p-lactamases. 
Integrons, which could transfer resistance genes to other bacteria and accept genes from 
other organisms, are regarded as an important mechanism of horizontal transmission of 
antibiotic resistance genes. These site-specific recombination elements which insert and 
excise antibiotic resistance gene cassettes may be located on plasmids and/or transposons. 
Class 1 integrons consist of two conserved sequences (CS) flanking a variable central 
region surrounding antibiotic resistance gene cassettes (Hall & CoUis, 1995). The highly 
conserved 5'CS includes an intll gene encoding an integrase, an adjacent recombination 
site attU and a promoter region, while the 3'CS is more variable. Several classes of 
integrons have been identified according to the type of integrase, Class 1 integrons being 
most prevalent. AmpC p-lactamases have been reported to be associated with classl 
integrons for e.g. plasmid-encoded WODHA-I located on Sul-1 type integron was reported 
b> Verdet et al. (2006). The Sul-1-type integron of aacA I-or/G gene cassette was found 
in the upstream region of Z)/acMY-9 by Doi et al. (2002). Naseer et al. (2010) have reported 
association of A/OCMY-Z, and A/OCMY-V with ISEcpl insertion sequence (in 91% of 
Norwegian isolates). They have also reported the linkage of Sul-1 upstream and also 
dowTistream to WaoHA-i gene. Sul-1 type classl integron, containing dfrA12, orfF and 
aiM.U2a gene cassette was identified upstream of WOCMY-H gene and ended with a 3'CS 
(qacEll-suU) (Song et ah, 2010). Association of Woampc and Sul-1-type integron has 
been recently reported in a collection of Citrohacter isolates from our laboratory (Shahid, 
2010). 
Recently, it has become evident that mobilizing elements like integrons and 
transposons can be responsible for movement of resistance genes, but they fail to explain 
spread of growing subset of resistance genes. These genes have been reported to be linked 
to sequences termed as common regions (CRs), which are frequently found beyond but 
close to 3'CS of classl integrons. These CRs are IS9/-like which lack the terminal 
inverted repeat (most common feature of insertion sequences) and transpose adjacent 
DNA molecule by rolling circle transposition mechanism, and have been reported to be 
present on both chromosomes and plasmid. This is unlike other mobilizing elements 
where two copies (one of them should be intact) need to flank the mobilized gene as has 
been observed for IS£cp7-mediated mobilization of 6/acrx-M-i9 (Poirel et al., 2003; Poirel 
et ah, 2005). In rolling circle transposition a single element can mobilize nearby sequence 
and a truncated 3'CS from one integron to the 3'CS of another integron through 
transposition, thus facilitating the formation of complex class 1 integrons. CR embedded 
in the complex classl integrons In<5 and In7 is 2,154 bp long and accommodates an 
ORF573. To show up the property of CRs as insertion sequence, they have now been 
termed as ISCiis. They are aknost always reported to be integrated in complex classl 
integron. Various AmpC p-lactamases like blouHA-i, blocMV-}, blacMv-s to blocMY-n, 
WacMY-19, and blouox-i have been reported to be integrated in such configuration 
(Toleman et al., 2006). Detailed genetic analysis of blac\n-9 has revealed that it was 
located adjacent to a copy oflSCRl, downstream of classl integron and second copy of 
3'CS was deleted as expected when ISCRl get linked to classl integrons (Doi et al.. 
2002). Association of ISCRJ has been reported with ZJ/OCMY-I subgroup while 
mobilization of blacuN-i has been reported primarily by IS^cpZ-mediated. Perhaps the 
insufficiency of detailed analysis of genetic environment ofblacM\-2 accounts for it. 
The promoter sequence found within ISEcplB, which has been shown to drive the 
transcription of blacrx-M-\9, is also found in ISEcpJ upstream of WflcMY-2, however, the 
effects of this putative promoter sequence on transcription of blocMY-i, is unknown and 
necessitate further study. In contrast to what was observed for the relationship of ISEcpIB 
and blacTx-M-i9, no separate inverted repeat was found downstream of WflcMY-2 region as 
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observed by Giles et al., (2004). \%Ecpl has been found to be associated with several 
CMY alleles (CMY-2, CMY-4, CMY-5, CMY-7, CMY-12, CMY-14, CMY-15. CMY-
16, CMY-21, CMY-31, and CMY-36) and also ACC-1 & ACC-4. It was presumed that it 
helps in mobilization of chromosomal ampC genes to plasm ids (Lartigue et al., 2006) and 
it also provide an efficient promoter which in turn results in high level expression of these 
genes (Jacoby, 2009). The transposition and expression of the WOCMYO gene by \SEcp] to 
different plasmid scaffolds may also be playing a role in the dissemination of C\rV-2. 
Indirect transfer of CNfY-2 producing E. coli from cattle and pigs to humans, or vice 
versa, has been reported due to association of this gene with ISEcpI (Naseer et al.. 2009). 
and it highlights the significance of this mobilizing element. 
A Citrobacter freundii derived sequence of 4,252 bp. which included a blac\\\.\3 
gene was observed bounded by two directly repeated IS26 elements made of tnpA gene, 
indicating that this gene may have spread involving IS26-dependent mobilization as was 
also described for blasuv genes (Miriagou et al., 2004). Ktari et al. (2009) from Tunisia 
have reported the presence of bla^cc-] downstream of ISEcpI which itself was disrupted 
due to insertion of IS26. 
Studies regarding prevalence and identification of .AjnpC P-lactamase are elementar> 
from India, and no proper and systematic survey was reported. In a significant proportion 
of Indian studies where prevalence was reported, it was based on phenot>pic detection 
methods only. Due to paucity of literature regarding the molecular characterization of 
AmpC beta-lactamase-producing Enterobacteriaceae isolates, and the association of 
bloamvc genes with mobilizing elements, we designed the present study with the following 
aim and objectives: 
1.1 AIM AND OBJECTIVES 
1. To determine antibiotic resistance rates and patterns in cephamycin-resistant 
clinical E. coli and Klebsiella pneumoniae isolates from J. N. Medical College and 
Hospital, Aligarh. India. 
2. To screen phenot\picall> for the occurrence of .\mpC P-lactamase. 
3. To screen the isolates for the presence of A/flampc genes and their characterization 
for the presence of respective -\mpC-famil>. 
4. To analyze co-resistance of class A p-lactamase genes, especially the blacjx-u-
5. To explore plasmid and genetic elements [ISEcpl, \S26, \SCR1 (ORF573), Sul-l-
type integron] responsible for mobilization of drug resistance genes in our 
isolates. 
(Review of 
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2. REVIEW OF LITERATURE 
2.1 Background: Historically, the discovery of the sulpha drugs in the 1930s and the 
subsequent development of penicillin during World War II lead in a new era in the 
treatment of infectious diseases. Antibiotics, though, are unique among drugs in that their 
use precipitates their obsolescence. ParadoxicalK. these cures select for organisms that 
can evade them, fueling an arms race between microbes, clinicians and drug discoverers. 
There are five major antibiotic targets: the bacterial cell wall, the cell membrane, protein 
synthesis, DNA and RNA synthesis and folic acid metabolism. These bacterial targets are 
different or nonexistent in eukaryotic cells (including those of humans), which means that 
antibiotics are relatively nontoxic drugs. For e.g., the p-lactam antibiotics such as 
penicillins, cephalosporins, and carbapenems block the svTithesis of the bacterial cell wall. 
This structure is absent in higher organisms but is essential for bacterial survival. The 
bacterial ribosome is the target of the tetrac\cltne. aminogNcoside. macrolide, and other 
antibiotics, and is sufficiently different from eukaryotic ribosome and hence cross 
inhibition does not occur. Resistance to antibiotics occurs b> four general mechanisms, 
viz., target modification, efflux, immunit> and b>pass. and enz\me-catal>7:ed destruction. 
Target modification can occur through mutation of targets them>elves (for e.g.. the 
topoisomerases that are the target of the fluoroquinolone antibiotics), or b> the production 
of enzymes that modify antibiotic targets (for e.g.. in ribosomal methylation). 
Vancomycin resistance is an example of target modification where new biosynthetic 
machinery is engaged to alter cell-wall structure. Efflux occurs through a large family of 
protein pumps that eject antibiotics from inside the cell. In immunity, antibiotic or their 
targets are bound by proteins that prevent the antibiotic binding to its target. 
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P-lactam antibiotics exhibit their bactericidal effects by inhibiting enzymes involved in 
cell wall svTithesis. The integrit>' of the bacterial cell wall is essential for maintaining cell 
shape in a hypertonic and hostile environment (Massova & Mobashery, 1998). Osmotic 
stabilit\ is preserved by a rigid cell wall comprised of alternating N-acetylmuramic acid 
(NANf) and N- acetylglucosamine (NAG) subunits. These glycosidic units are linked b> 
transglycosidases. A peniapeptide is attached to each NAM unit, and the cross-linking of 
two D-alanine-D-alanine NAM pentapeptides is catalyzed by PBPs, which acts as 
transpeptidases (GoflRn & Ghu>sen. 1998: Sauvage et al., 2008). This cross-linking of 
adjacent glycan strands confers the rigidit\ of the cell wall. The P-lactam ring is sterically 
similar to the D-alanine-D-alanine of the NAM pentapeptide, and PBPs mistakenly use P-
lactam ring as a building block during ceil wall synthesis (Zapun et al., 2008). This 
results in acylation of the PBPs which renders the enzyme unable to catalyze further 
transpeptidation reaction (Fisher & Mobashery, 2009). As cell wall synthesis slows to a 
halt, constitutive peptidoghcan autolysis continues. The breakdown of the murein 
sacculus leads to cell wall compromise and increased permeability. Thus, the P-lactam-
mediated inhibition of transpeptidation causes cell lysis, although the specific details of 
penicillin's bactericidal effects are still being unraveled (Bayles, 2000; Drawzi & 
Bonomo. 2010;. 
Possibly, the most specific and evolved mechanism of antibiotic resistance are enzymes 
that recognize antibiotics and modify them in such a way that it abolish the fiinctional 
characteristics that enable them to interact with their targets (for e.g., p-lactamases 
hydrolytically cleave the core P-lactam ring that is characteristic of this particular class 
and is essential for antibiotic action). Fig. 1 shows the P-lactam ring opening hydrolysis 
by class A, C, D and class B P-lactamases. 
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Fig. 1: p-Iactam ring opening hydrolysis by p-iactamases. 
-2+ 
a) Zn -dependent activation of hydrolytic water molecule which mediates hydrolysis of 
p-Iactam ring, 
b) Serine nucleophile attacks at the P-lactam carbonyl carbon resulting in covalent 
enzyme intermediate which then undergo hydrolysis. 
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2.2 How bacteria become resistant to antibiotics? 
The large number of natural, semisynthetic and synthetic P-lactam antibiotics can be 
subdivided into six different structural subtypes: 
1) penems (e.g. benzy{penicillin, ampicillin), 
2) cephems which include classical cephalosporins (e.g. cefotiam. cefuroxime), and 
also representatives of third-generation cephalosporins (e.g. cefotaxime, 
ceftazidime), 
3) cephamycins as 7-a-methoxy-cephalosporins (e.g. cefoxitin), 
4) monobactams as monocyclic molecules (e.g. aztreonam), 
5) penems with a 2,3-double bond in the fused thiazoline ring (e.g. faropenem); and 
6) carbapenems (e.g. imipenem) with an unsaturated fused 5-membered ring 
differing from penem structure by possession of a carbon atom at position 1. 
The introduction of 3 '^'-generation cephalosporins (3GC), which started with cefotaxime 
30 years ago. was a milestone in antimicrobial chemotherapy. Antibiotic resistance is the 
e\olutionar> response to the strong selective pressure that results from exposure to these 
compounds. The horizontal dissemination of resistance genes into bacterial species and 
genera that are not themselves intrinsically resistant, as well as the maintenance of 
resistance mutations vertically through populations is likely to be the result of 
contemporary use of these drugs in the clinic and on farms. Support of this hypothesis is 
the infrequency of antibiotic resistance in collections of pathogenic bacteria that pre-date 
the antibiotic era. Given the vast numbers of bacteria on the planet and the massive 
selection pressure provided by antibiotics, the movement of antibiotic-resistance elements 
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from benign, but resistant, microbes into previously susceptible pathogens is simply a 
matter of time and opportunity. The accumulation of bacterial antibiotic resistance is a 
dramatic demonstration of Darwin's dictum of the survival of the fittest, with serious 
practical consequence for treatment failure. The patterns and mechanisms of resistance 
undergo continuous evolution and other resistances are proliferating rapidly, notably 
those to cephalosporins and quinolones among Gram-negative bacteria; and carbapenem 
resistance is emerging too, especially in Acinetobacter spp. For a resistance to succeed, it 
needs to have a mechanism that imposes little fitness burden, along with a biologically fit 
host strain or strains. As a consequence of selective pressure exerted by these 
cephalosporins, resistance in enterobacterial isolates emerged a few years later. 
At that time, two main causes were specified: 
1) expansion of the substrate spectrum of broad-spectrum TEM- and SHV-type P-
lactamase which were already widely disseminated due to plasmid location of 
these genes (Jarlier et al., 1988; Sirot et a/., 1988), 
2) constitutive high level expression of the intrinsic ampC gene, coding for a 
cephamycinase (cefoxitin as a phenotypic indicator substrate) in sjjecies with an 
efficient ampC promoter such as Citrobacter freundii, Enterobacter cloacae, and 
Serratia marcescens (Sanders & Sanders, 1988). 
Since the early 1990s, further p-lactamase-related resistance mechanisms were 
discovered. Quite significant was the mobilization of genes coding for ESBLs fi-om 
environmental genus Kluyvera which led to the rise of CTX-M enzyme (Bonnet R, 2004). 
Cephalosporin resistance in E. coli can also be mediated by hyperproduction of AmpC p-
lactamase caused by promoter mutations, hence increasing ampC transcription rate 
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(Caroff et al., 2000). The introduction of carbapenems in antimicrobial chemotherapy 
resuhed in emergence of carbapenem hydrolyzing p-lactamase. first in P. aeruginosa and 
Acinetobacter spp. and later in Enterobacteriaceae (Bush, 1998). 
23 Classification of broad-spectrum ^lactamases 
P-Laciamases can also be described as bacterial enz>mes that inactivate P-lactam 
antibiotics by hydrolysis, which results in ineffective compounds, ^-lactamases have been 
categorized based on protein sequence analysis [Ambler classification (.Ambler. 1980)] 
and by fiinction [Bush-Jacoby notation (Bush & Jacoby. 2010)]. The .Ambler notation 
separates P-Iactamases into four groups: A. B, C, and D. In general. Class A enzymes are 
susceptible to the commercially available P-lactamase inhibitors (clavulanate. tazobactam, 
and [less so] sulbactam), although the K. pneumoniae carbapenemase (KPC) may be an 
important exception to this generalization (Papp-Wallace ei al.. 2009). The first plasmid-
mediated p-lactamase was identified in E. coli in 1963 (and reported in 1965). and was 
named "TEM" after the patient from whom it was isolated (Datta & Kontomichalou. 
1965). SHV, another common P-lactamase found primarily in Al pneumoniae, was named 
from the term ''sulfhydryl reagent variable". Early studies of SHV-1 showed that p-
chloromercuribenzoate inhibited the hydrolysis of cephaloridine but not that of 
benzylpenicillin (Matthew et al., 1979). TEM and SH\' are common p-laciamases 
detected in clinical isolates of E. coli and A^. pneumoniae pathogens responsible for 
urinary tract, hospital-acquired respiratory tract, and bloodstream infections (Buynak, 
2006; Roy et al., 1985). Class B enzymes are Zn^^-dependent p-lactamases that 
demonstrate a hydrolytic mechanism different from that of the serine P-lactamase of 
classes A, C, and D (Bush et al., 1995). Organisms producing these metallo beta-
lactamases (MBL) enzymes usually exhibit resistance to penicillins, cephalosporins. 
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carbapenems, and the clinically available p-lactamase inhibitors (Walsh et aL, 2005). 
Interestingly, the hydrolytic profile of MBLs does not typically include aztreonam. MBLs 
likely evolved separately from the other classes, which have serine at their active site 
(Massova et al., 1998). The WOMBI genes are located on the chromosome, plasmid, and 
integrons (Garau et al^ 2004: Walsh et al.. 2005). Class C AmpC P-lactamases include 
CMY-2. P99, ACT-1. and DHA-1, \\hich are usually encoded by bla genes located on the 
bacterial chromosome, although plasmid-bome AmpC enzymes are becoming more 
prevalent (Philippon et a/„ 2002). Organisms exp>ressing the AmpC P-lactamase are 
typically resistant to penicillins. P-lactam-^-lactamase inhibitor combinations, and 
cephalosporins, including cefoxitin, cefotetan. ceftriaxone, and cefotaxime. AmpC 
enzymes poorly hydrolyze cefepime and are inhibited by cloxacillin, oxacillin and 
aztreonam (Bush et al.. 1995). Class D p-lactamase were initially categorized as 
oxacillinases because of their ability to hydroNze oxacillin at a rate of at least 50% of that 
of benzylpeniciJiin, in contrast to the relatively slow hydrolysis of oxacillin by class A 
and C (Danel et al.. 2007). In general. OXA enzymes are resistant to inhibition by 
clavulanate, sulbactam, and tazobactam (with some exceptions for e.g. OXA-2 and OXA-
32 that are inhibited b> tazobactam and not b> sulbactam and clavulanate, while OXA-53 
was found to be inhibited by clavulanate) (Danel et al.. 2007; Mulvey et al., 2004; Naas 
& Nordmann. 1999: Poirel & Nordmann, 2002). Phylogenetic analysis reveals that the 
class B metallo-enzymes are distinct from the class A, C, and D Ser proteins. The former 
consist of two discrete structural groups (Bl-2 and B3 subclasses). On the other hand, the 
cJass A and D enzymes are homologous and have diversified from a common shared 
ancestor with the class C enzymes (Hall & Barlow, 2004). In 1986, comparison of the 
three-dimensional (3D) structure of class A enzymes with PBPs revealed conservation of 
3D structure and of biochemical mechanism (Kelly et al., 1986; Massova & Mobashery, 
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1998). The determination of several 3D structures of PBPs and class A, C, and D p-
lactamases in the past 25 years has served to solidify the relationship between cell wall 
metabolizing enz>'mes and drug resistance p-lactamases. p-lactamases share structure and 
fiinction with enzymes associated with cell wall metabolism and general peptidase 
activitN. Ph>iogenetic evidence suggests that that the class A Ser P-lactamases emerged 
2.4 billion \ears ago fh)m a common ancestor of PBPs (Hall & Barlow, 2004). The genes 
encoding these enz>mes and the related class D P-lactamases are widely circulated in 
bacteria through the aegis of mobile genetic elements such as plasmids. Class C enzymes, 
however, are chromosomally encoded (although in the past decade they have begun to be 
associated with mobile genetic elements including plasmids, no doubt a recent event 
linked to antibiotic selection) and diverged from class A and D enzymes approximately 
1.8 billion years ago (based on their association with Gram-negative proteobacteria) (Hall 
& Barlow. 2004). Consistent with the ancient divergence of P-lactamases from PBPs. the 
former have no peptidoglycan biosynthetic activity. Recent evolution has contributed to 
the broadening of the antibiotic substrate specificity of P-lactamases. and the number of 
distinct enz>mes with unique fiinction continues to grow and is now approaching 1000 
entries. These are well documented on the Lahey Clinic website: 
hup: wu-vv • lahcN .org Studies/webt.htm. As these P-lactamases shows diversity in the 
enz>Tnatic characteristics of the P-lactamases, many attempts have been made to 
categorize these enzymes using their biochemical attributes. Several different 
classification schemes have been described. 
Recently, Giske et al. (2009) stretched ftirther the definition of ESBL with a view to 
achieve a balance between scientific and clinical needs. Several points of the Bush 
classification system were reconsidered, as described below. 
18 
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1. Bush et al. (1995) described ESBLs as enzymes that can be differentiated from 
their parental enzymes, which can not hydrolyze extended-spectrum P-Iactams. 
2. Several P-lactamases (e.g. GES-5) that possess a carbapenemase activity are still 
reported in the literature as ESBLs. 
3. The Bush classification system does not make any distinction between .\mpC P-
lactamases of chromosomal and those of plasmid origin. However, plasmid-
mediated AmpC enzymes have greater clinical importance from an infection 
control perspective than do their chromosomal counterparts (i.e. the added risk of 
transferable resistance genes). 
Bush et al. (1995) have written that the classification scheme does not take into account 
the actual importance of phenotypic tests for P-Iactamases. Thus, if scientific researchers 
adopt these points oi the Bush classification system, there is little hope for the clinicians 
being properly informed about the appropriate treatment. Thus by broadening the 
definition of ESBLs the communication with the clinicians and infection control 
practitioners will be largely enhanced (Giske et al., 2009). An updated classification 
scheme is shown in Table 1. 
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Some enteric pathogens may also be cephamycin resistant by virtue of porin mutation. 
Plasmid-mediated AmpC (pMAmpC) enzymes may confer broad resistance to all P-
lactams other than carbapenems and hence pose a major therapeutic challenge. 
Carbapenems are active against strains that harbor these enzymes but several researchers 
have described the emergence of resistance due to a dual mechanism. Bradford et al. 
(1997) described imipenem resistance in Klebsiella pneumoniae isolates from patients in 
New York and these organisms produced multiple P-lactamases, including an AmpC t>'pe 
en2\me >Aith pi of 9.0. .\mpC ^-lactamases are produced by numerous pathogens 
(Bauemfeind et al.. 1998) and are emerging as an increasing cause of resistance in 
Enterobacteria (Ensor et al.. 2006). 
2.4 Resistance to cephalosporins: the ''classicaP ESBLs 
The major cause of resistance to 3'^ '^ -generation cephalosporins in Enterobacteriaceae are 
class A ESBLs. Variants of broad-spectrum P-lactamases, TEM-1, TEM-2, and SHV-1 
that are generated b\ mutations which extend their substrate specificity for 3"^ **-, and 4*-
generation cephalosporins (in particular cefotaxime, ceftazidime, and ceftriaxone) are of 
major concern. .A.t present 185 TEM-1 and TEM-2 variants and 119 SHV-1 variants have 
been recorded (http: \sASM.lahe> .org Studies/webthtm; Last accessed on 28 April 2011). 
The first ESBL t>pes were described in central Europe and France during thel980s 
(Paterson & Bonomo, 2005). At that time, ESBLs were most often associated with 
nosocomial outbreaks in intensive care units due to particular strains of K. pneumoniae. 
This situation changed when ESBL appeared in E. coli leading to a complex 
epidemiological situation involving different clones of E. coli, a variety of ESBLs and 
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different genetic elements carrying bloEssLs respectively (Pitout el al., 2005; Rodriguez-
Bano et al, 2004; Branger et al., 2005; Machado et al., 2005; Jeong et al., 2004). 
2.5 AmpC p-lactamase 
The first bacterial en2yme reported to destroy penicillin was the AmpC P-lactamase of 
Escherichia coli, although it has not been named so in 1940 (Abraham & Chain. 1940). A 
systematic study on genetics of penicillin resistance was performed by Swedish 
researchers in 1965 and they termed mutations with stepwise-enhanced resistance as 
ampA and ampB (Erikkson-Grennberg et al., 1965). A mutation in an ampA strain that 
resulted in reduced resistance was designated as ampC. ampC strains produce little P-
lactamase, suggesting that ampC was structural gene (Burman et al., 1973). Most of the 
ampC nomenclature has changed over years but the designation ampC persisted. 
.Acquisition of the AmpC-type genes by plasmids in E. coli and K. pneumoniae has been 
known since long back to 1980s (Alvarez et al., 2004). Plasmidic ampC genes are 
deri\ed from the chromosomal ampC genes of several (not all) members of the family 
Enterobacteriaceae, including Enterobacter cloacae, Citrobacter freundii, Morganella 
morganii. and Hafnia alvei (Bauernfeind et al., 1998). To meet the challenge of 
resistance due to production of p-lactamases, P-lactams with greater P-lactamase stability, 
including cephalosporins, carbapenems, and monobactams, were introduced in the 1980s. 
Resistance appeared initially in organisms such as Enterobacter cloacae, Citrobacter 
freundii, Serratia marcescens, and Pseudomonas aeruginosa that could, by mutation, 
overproduce their chromosomal AmpC (also termed class C or group 1) p-lactamase, thus 
providing resistance to both oxyimino- and 7-a-methoxy-cephalosporins and 
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monobactams (Sanders, 1992). Later, resistance appeared in bacterial species that lack an 
inducible AmpC enzyme, such as Klebsiella pneumoniae, Escherichia coli. Salmonella 
spp., and Proteus mirabilis, and this resistance was found to be mediated by plasmids 
encoding ESBLs, which are enzymes that arose by mutations in TEM or SHV p-
lactamases of more limited hydrolviic capacit\' (Philippon et ah. 1989; Jacoby & 
Medeiros, 1991; Jacoby, 1994). Such resistance included oxyimino-cephalosporins and 
monobactams but not 7-o-methoxy-cephalosporins and was blocked by clavulanate. 
sulbactam, or tazobactam, which are inhibitors that are generally ineffective against class 
C enzymes (Sanders, 1992; Livermore, 1995). With continuing use of 7-o-methoxy-
cephalosporins (cefoxitin and cefotetan) and the clinical introduction of P-lactamase 
inhibitor combinations, plasmids encoding class C P-lactamases appeared (Medeiros. 
1997). Like their counterpart on the chromosome, such enzymes provided a broader 
spectrum of resistance than ESBLs and were not blocked by commercially available 
inhibitors. Furthermore, in a strain with decreased outer membrane permeability such 
enzymes can provide resistance to carbapenems as well, as has been observed with 
clinical isolates of K. pneumoniae during an outbreak in New York (Bradford et al.. 
1997) and in individual isolates of £. coli in the United Kingdom (Stapleton et al. 199*^  i 
and of A^. pneumoniae in Sweden (Cao et al., 2000). 
2.5.1 History and chronology of AmpC P-lactamases 
P-lactamases, demonstrated or presumed to be chromosomally mediated, have been 
described in Acinetobacter spp., Aeromonas spp., Chromobacterium violaceum, 
Citrobacter freundii, Enterobacter spp., Escherichia coli, Hqfhia alvei, Lysobacter 
lactamgenus, Morganella morganii, Ochrobactrum anthropi, Proteus rettgeri, 
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Providencia stuartii, Pseudomonas aeruginosa, Psychrobacter immobilis. Rhodobacter 
sphaeroides, Serratia marcescens, and Yersinia enterocolitica. In Shigella Jlexneri and 
Shigella dysenteriae, ampC is included in a large deletion (Maurelli et al.. 1998). An 
ampC locus appears on the genetic map of Salmonella (Sanderson et al.. 1995), but the 
evidence for its existence was indirect and its presence has not been contlrmed in the 
sequenced genomes of Salmonella enterica serotypes Typhimurium or Paratyphi 
(Morosini et al., 2000), so that Salmonella is considered to be -\mpC (\Iedeiros. 1997). 
A chromosomal ampC gene is also lacking in Klebsiella spp. (Morosini et al.. 2000) and 
P. mirabilis. Bobrowski et al. (1976) described a plasmid-mediated P-lactamase 
indistinguishable from the AmpC enzyme of E. coli in a strain of P. mirabilis. 
Unfortunately, the original plasmid was lost, there was some doubt about the transfer 
experiments, and molecular studies were not done. Levesque et al.. (1982) reported a 
plasmid-mediated cephalosporinase in Achromobacter spp. Regrettably, the original 
strain was lost, the P-lactamase gene was not sequenced and in retrospect the 
biochemical properties of the enzj'me resembled those of a group 2b broad-spectrum 
enzyme rather than of a group 1 cephalosporinase. In 1983. Knothe et al. reported the 
transfer of cefoxitin resistance from S. marcescens to Proteus or SalmoneUa spp.. but 
resistance segregated on transfer to E. coli and no biochemical or molecular studies were 
done. In 1989, Bauemfeind et al described a K. pneumoniae isolate from South Korea 
that could transfer resistance to cefoxitin and cefotetan as well as to penicillins, 
oxyimino-cephalosporins, and monobactams to E. coli. The enzyme, termed CMY-1 for 
its cephamycinase activity, had an isoelectric point (pi) of 8.0 and was more sensitive to 
inhibition by sulbactam than by clavulanate or tazobactam, suggesting that it might be a 
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class C enzyme. However, the first proof that a class C P-Iactamase had been captured on 
a plasmid was provided by Papanicolaou et al. (1990), who described transmissible 
resistance to cr-methoxy- and oxyimino- P-lactams mediated by an enzyme (MIR-1) with 
the biochemical properties of a class 1 ^-lactamase and showed that part of the MIR-1 
gene was 90% identical to the ampC gene of E. cloacae. Subsequently, plasmid-mediated 
class C P-lactamases has been discovered worldwide (Table 2). They have been named 
with inconsistenc}' t>pical of P-laciamase nomenclature according to the resistance 
produced to cephamycins (CMY). cefoxitin (FOX), and moxalactam (MOX) or latamoxef 
(LAT), to the type of ^-lactamase, such as AmpC type (ACT) or Ambler class C (ACC), 
and to the site of discovery, such as the Miriam Hospital in Providence, R.I. (MIR-1) or 
Dhahran hospital in Saudi Arabia (DHA). BIL-1 was even named after the patient (Bilal) 
who provided the original sample (D. J. Payne, personal communication). 
Bou et al. (2000) analyzed the nucleic acid sequence and reported a new ampC P-
lactamase gene which was closely related to those encoding FOX-1, FOX-2 and FOX-3 
P-lactamases but it"s product had four no\el amino acid mutations at position 11 (M—*T), 
43 (A—E), 233 (V^A). and 280 (Y—Hi. They designated it as FOX-4. Nakano et al. 
(2(K)4) described a no\el plasmid-encoded .AmpC t>pe P-lactamase, CFE-1, with an 
ampR gene derived from Citrobacter freundii. DNA sequence analysis also identified a 
gene upstream of ampC whose sequence was 99% identical to ampR gene from C. 
freundii GC3. In addition a fiimarate operon (fi"d ABCD) and an outer membrane 
lipoprotein {blc) surrounding the ampR-ampC genes in C. freundii were identified and 
insertion sequence (IS26) elements were observed on both sides of sequence identified 
(forming an IS26 composite transposon). They concluded that these results confirmed the 
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evidence of translocation of a P-lactamase-associated gene region from chromosome to 
plasmid. Doi et al. (2002) characterized a novel plasmid mediated cephalosporinase 
CMY-9 and revealed its genetic environment in an E. coli clinical isolate. After deducing 
amino acid sequence, it was found that CMY-9 had a single amino acid substitution (E 85 
D(. the residue reported to be part of the recognition site for Rl side chain of p-lactams, 
compared with amino acid sequence of CMY-8 and also had 78% identity with the amino 
acid sequence of Cep H (chromosomal cephalosporinase of Aeromonas hydrophilia). 
Hujer et al. (2005) identified a new allelic varizmt of Acinetobacter baumanii 
cephalosporinase. ADC-7 P-lactamase. Amino acid composition of this enzyme did not 
match with known class C P-Iactamases and hence they proposed a uniform designation, 
for this family of cephalosporinases, ADC {Acinetobacter derived cephalosporinase) and 
identified enz>me as ADC-7. In the year 2006, Wachino et al. suggested that genetic 
en\ironment of blacu\-\9 was identical to that of blacM\-9 and a single amino acid 
substitution. 1 292 S, adjacent to the H-10 helix region was observed between CMY-9 
and CMY-19. This substitution was suggested to be responsible for the expansion of 
hydrolyzing activity against several broad-spectrum cephalosporins. 
The chK>noiog\ of discovery of AmpC p-lactamases is given below in Table 2. 
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Table 2: Chromosomal and Plasmid-mediated AmpC ^-lactamases reported in 
various Gram-negative organisms, their year and country' of origin and Accession 
numbers (based on GenBank data) 
Organisms/ AmpC 
Variants 
E. coli 
BIL-1 
FOX-2 
LAT-3 
LAT-4 
CMY-3 
CMY-4 
CMY-6 
CMY-7 
FOX^ 
CMY-9 
CMY-11 
CMY-13 
CMY-17 
CMY-18 
CFE-1 
CMY-21 
CMY-22 
CMY-23 
CMY-24 
CMY-28 
CMY-29 
CMY-30 
CMY-20 
CMY-32 
CMY-33 
CMY-43 
ACT-3 
ACT-5 
DHA-1 
CMY-44 
CMY-27 
CMY-40 
CMY-53 
CMY-54 
CMY-55 
CMY-57 
CMY-59 
DHA-6 
Klebsiella pneumoniae 
MOX-1 
MIR-1 
FOX-1 
LAT-1 
CMY-2 
Accession numbers 
X74512 
Y10282 
Y15411 
Y15412 
Y16783 
AJ007826 
AJO11293 
AJ0n291 
AJ277535 
AB061794 
AF381626 
AY339625 
AYS 13266 
AY743434 
AB107899 
DQ139328 
DQ256079 
DQ438952 
EF415650 
EF561644 
EF685371 
EF536872 
AY960293 
EU496815 
EU496816 
FJ360626 
EF125013 
FJ237366 
EU589460 
FJ437066 
EU515250 
EU515251 
HQ336940 
HM544039 
HM544040 
HQ285243 
AB587082 
HQ322612 
D13304 
M37839 
X77455 
X78117 
X91840 
Year reported 
(in chronological 
order) 
1993 
1996 
1997 
1997 
1998 
1998 
1998 
1998 
2000 
2001 
2001 
2003 
2004 
2004 
2004 
2005 
2005 
2006 
2007 
2007 
2007 
2007 
2008 
2008 
2008 
2008 
2008 
2008 
2008 
2009 
2010 
2010 
2010 
2010 
2010 
2010 
2010 
2010 
1992 
1993 
1994 
1994 
1995 
Countrj of origin 
(based on GenBank 
data) 
United Kingdom 
GermaiiN 
Germanj 
Germanv 
-
United Kingdom 
India 
India 
Spain 
Japan 
Korea 
Greece 
China 
Korea 
Japan 
United Kingdoms 
China 
United Kingdom 
Singapore 
Ireland 
New Zealand 
New Zealand 
Republic of South Africa 
USA 
USA 
South Korea 
Korea 
China 
India 
USA 
Spain 
Spain 
Denmark 
Spain 
Spain 
Spain 
India 
Spain 
Japan 
United States 
Argentina 
Greece 
Greece 
Chromosomal/ 
Plasmid-mediated 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid j 
Plasmid j 
Plasmid i 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
PIzismid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
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CMY-I 
ACT-1 
LAT-2 
CMY-8 
MOX-2 
DHA-2 
FOX-6 
CMY-10 
DHA-3 
FOX-7 
CMY-19 
FOX-5 
CMY-31 
MIR-4 
MIR-8 
ACT-7 
CMY-36 
CMY-25 
CMY-56 
Klebsiella oxytoca 
FOX-3 
CMY-5 
CMY-26 
Enterobacter cloacae 
MHNl 
GCl 
K992004.1 
K995120.1 
K99230 
K9911729 
K9973 
K9914325 
MIR-2 
MIR-3 
DHA-7 
Enterobacter asbiiriae 
ACT-2 
Salmonella enteridis 
DHA-1 
Proteus mirabilis 
CMY-12 
CMY-14 
CMY-16 
CMY-15 
CMY-38 
Citrobacter freundii 
CMY-34 
CMY-35 
CMY-37 
CMY-39 
CMY-41 
CMY-45 
CMY-46 
X92508 
U58495 
S83226 
AF167990 
AJ276453 
AF259520 
AY034848 
AF381618 
AY494945 
AJ703795 
AB194410 
AY007369 
EF622224 
EF417572 
FJ237367 
FJ237368 
EU331426 
EU515249 
HQ322613 
Y11068 
Y17716 
AB300358 
X08082 
D44479 
AF411144 
AF411145 
AF411146 
AF411147 
AF411148 
AF411149 
AY227752 
AY743435 
HQ456945 
AM076977 
AJ237702 
Y16785 
AJ555825 
AJ781421 
AJ555823 
AM931008 
EF394370 
EF394371 
AB280919 
AB372224 
AB429270 
GQ351345 
GQ402541 
1995 
1996 
1996 
1999 
2000 
2000 
2001 
2001 
2003 
2004 
2004 
2005 
2007 
2007 
2008 
2008 
2009 
2010 
2010 
1997 
1998 
2007 
1988 
1994 
2001 
2001 
2001 
2001 
2001 
2001 
2003 
2004 
2010 
2007 
1999 
1998 
2003 
2004 
2009 
2009 
2007 
2007 
2008 
2008 
2009 
2009 
2009 
South Korea 
United States 
Greece 
Taiwan 
France 
France 
United States 
Korea 
Taiwan 
ItaN 
Japan 
United Sates 
Switzerland 
China 
China 
China 
Greece 
Spain 
Spain 
Italy 
Sweden 
Japan 
-
Japan 
Korea 
Korea 
Korea 
Korea 
Korea 
Korea 
Portuaal 
Korea 
Spain 
Italv 
France 
France 
Poland 
Italv 
Poland 
Poland 
China 
China 
Japan 
Japan 
Japan 
Republic of Korea 
China 
Plasmid 
Plasm id 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid ' 
Plasmid 
Plasmid 
: Plasmid ! 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
: Plasmid 
Plasmid 
Plasmid 
Plasmid 
Chromosomal ! 
Chromosomal i 
Chromosomal 
Chromosomal j 
Chromosomal ; 
Chromosomal ! 
Chromosomal ' 
Chromosomal 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
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CMY-49 
CMY-47 
CMY-48 
Aeromonas spp. 
AER14 
CEPS 
MOX-3 
MOX-5 
MOX-6 
MOX-7 
Hafnia alvei 
ACC-2 
ACC-3 
ACC-1 
ACC-4 
Serratia marcescens 
SRT-1 
SST-1 
Vibrio fluvialis 
MOX-4 
GQ402541 
HM046998 
HM569226 
ASU10251 
X80277 
EU515248 
GQ152600 
GQ152601 
GQ 152602 
AF180952 
AF180958 
AJ271941 
EF504260 
AB008454 
AB008455 
FJ262599 
2009 
2010 
2010 
1994 
1994 
2008 
2009 
2009 
2009 
1999 
1999 
2000 
2007 
1997 
1997 
2008 
China 
Spain 
Spain 
United States 
United Kingdom 
Spain 
Spain 
Spain 
Spain 
France 
France 
France 
Greece 
Japan 
Japan 
China 
Plasmid 
Piasmid 
Plasmid 
Chromosomal 
Chromosomal 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Plasmid 
Chromosomal 
Chromosomal 
Plasmid 
2.5.2 Origin and evolution of AmpC p-lactamases 
AmpC P-lactamases have been found around the world in nosocomial and non-
nosocomial isolates. Minor differences in amino acid sequence ha\ e given rise to families 
of AmpC p-lactamases. Sbct^  four CMY alleles are currently known 
(http://www.lahey.org/Studies/webt.htm». sequence data can be found in GenBank (some 
of them are unpublished) for eight varieties of FOX and MOX. four varieties of ACC, 
five varieties of MIR. one of LAT. nine of ACT and eight vaneties of DHA. 
CMY have been described twice when evolutionary origins are concerned. It has two 
quite different origins. Six current variants (CMY-1, CMY-8, CMY-9, CMY-10, CMY-
11, and CMY-19) are related to chromosomal AmpC enzyme of Aeromonas spp., while 
the remainder is related to AmpC enzyme of Citrobacter freundii. LAT enzymes have a 
similar origin, but out of the four original LAT enzymes, improved sequencing revealed 
that LAT-2 was identical to CMY-2, LAT-3 was identical to CMY-6, and LAT-4 was 
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identical to LAT-1, which is the only one remaining unique (Barlow & Hall, 2002). By 
observing phylogeny, it was determined that the ampC gene has been mobilized at least 
six times (Barlow & Hall, 2002). The LAT alleles and most of CMY alleles were 
descended from a C. freundii ampC gene. This group includes CMY-3b, which was 
found in the chromosome of P. mirabilis (Bret et al., 1998) and which must ha\e entered 
that chromosome by horizontal transfer from C. freundii. ACT-1 and MIR-1 descended 
from an ampC gene of £. cloacae, whereas, DHA-1 and DHA-2 were descended from 
Morganella morganii ampC (Bamaud et al., 1998; Poirel et al., 1999). An M. morganii 
chromosomal ampC allele that was identical to plasmid-bome DHA-1 allele had been 
reported (Poirel et al., 1999), suggesting that the ampC gene from M. morganii has been 
mobilized twice. ACC-1 was descended from Hafiiia alvei ampC. The FOX alleles were 
descended from an Aeromonas sobria ampC gene. CMY-1, CMY-8 and CMY-9 and the 
MOX alleles were also mobilized from the Aeromonadacaea group. The phylogen> 
showed that although the ampC gene had been mobilized at least six times, with the 
exception of Morganella, it had only been mobilized once from any given species 
(Barlow & Hall, 2002). Hence it was concluded that antibiotic resistance gene from any 
given species was mobilized, it is less likely that the gene will be successfiiUy mobilized 
again from that species than from a different species. Once a gene has been mobilized 
and is free to move horizontally, it will spread through nearby members of that species 
and perhaps other species (Barlow & Hall, 2002). 
2.5.3 Epidemiology of plasmid mediated AmpC enzymes 
The ampC genes are widely distributed among the Enterobacteriaceae (Lindberg & 
Normark, 1986). In typical E. coli and Shigella species, ampC is expressed at such low 
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levels that deletion of ampC does not affect sensitivity to ^-lactams, but in C. freundii 
and Enterobacter cloacae, ampC is inducible both by penicillins,such as ampicillin, and 
by cephalosporins (Lindberg & Normark, 1986). Because of their location on host 
chromosome, ampC genes were not initially subjected to the rapid dissemination allowed 
by the horizontal transmission of plasmid-bome genes. .A. survey of 20 U. S. hospitals 
showed that plasmid-bome ampC genes were more prevalent than TEM-type ESBL 
genes, although they were less common than SH\^-t>pe ESBLs (G. A. Jacoby, P. Han, M. 
Alvarez, and F. Tenover. Program Abstr. 35* Intersci. Conf. Antimicrob. Agents 
Chemother., abstr. C49, 1995). pMAmpC p-lactamases have been discovered most 
frequently in isolates of K. pneumoniae and also in naturally AmpC ~ species like K. 
oxytoca, Salmonella, and P. mirabilis. E. coli can also increase production of its normally 
weakly expressed chromosomal AmpC promoter or attenuator with consequent enhanced 
gene expression (Nelson et al., 1999; Caroff et al.. 2000). Plasmid determined 
cephalosporinase have been found in Africa (.Algeria. Tunisia). Asia (India. Japan, 
Pakistan, South Korea), Europe (France, Germany. Greece. Italy. Sweden. United 
Kingdom), the middle East (Saudi Arabia), North America (L-nited States) and South and 
Central America (Argentina, Guatemala). 
Several geographic clusters have been described (Odeh er al.. 2002). These includes a 
North American cluster (of MIR-1 and ACT-1), a central and South American cluster (of 
FOX-1 and FOX-2), and an Asian cluster (of CMY-2, CMY-2b, LAT-1 and LAT-2). Just 
as with strains producing ESBLs, travel and transfer of patients has allowed importation 
of BIL-1 (CMY-2) enzymes from Indian subcontinent to London (M'Zali et al., 1997), 
several CMY types (CMY-2, CMY-6, CMY-7) from Punjab (India) to London (Cao et 
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aL 2000), CMY-2 from Algeria to France (Koeck et al., 1997), CMY-4 from India to 
Sweden, FOX-2 from Guatemala to Germany, ACC-1 from Timisia to France (Girlich et 
al., 2000; Najdar et al., 2000) and MOX-2 from Greece to France (S. Boyer-Mariotte, L. 
Raskine, B. Hanau, A. Philippon. M. M. Sanson-LePors, and G. Arlet, Program Abstr. 
38^ ^ Intersci. Conf. .Aiitimicrob. Agents Chemother., abstr. C7, 1998). 
AmpC ^-lactamases have been found less frequently than ESBLs among 
Enterobactehaceae. CMY-2 is the .AjnpC enzvmes with the broadest geographic spread, 
being an important cause of p-lactam resistance in nontyphoid Salmonella strains in many 
countries. This t\"pe of resistance is increasing worldwide (Dunne et al., 2000; Batchelor 
et al, 2005; Su et al., 2005). The AmpC phenotype in E. coli is more often due to the 
mcreased production of the chromosomal AmpC p-lactamases, as reported in the few 
prevalence studies (Potz et aL. 2006: da Silva Dias et al., 2008; Mammeri et al., 2008). 
However reports regarding CMY-producing E. coli strains, mainly CMY-2, have also 
been published (Pitout et al.. 2007: Adler et al.. 2008; Li et al., 2008; Pai et al., 2008). As 
described earlier. CMY-t>pe enz>mes are pre\alent and widely distributed (Yan et al., 
2004) \\1iile DH-A-t>pe enz>Tnes ha\e been isolated less often. CMY-2 is the most 
prevalent (pNL\mpCi as well as most widely distributed geographically. It has been 
reported in Algeria, France, Germany. Greece. India, Pakistan, Taiwan, turkey, U.K. and 
U.S.A. (Bauemfeind et al., 1998). First DHA-type enzymes were isolated in Saudi Arabia 
in 1992, and then DHA-2 producing strains of K pneumoniae were isolated in France 
(Fortineau et al., 2001). At the end of 1990s DHA-1 was detected in two K. pneumoniae 
isolates from California and Florida (Moland et al., 2002; Alvarez et al, 2004) while in 
Taiwan, between 1999 and 2001, K. pneumoniae isolates producing DHA-1 were 
33 
reported (Yan et al., 2002). DHA-I was also reported in Seoul, South Korea. Recently 
blaoHA-i has been found in Salmonella enterica serovar Montevideo in Korea (Kim et al., 
2004) and in S. enterica serotype Seftenberg in United Kingdom (Liebana et al., 2004) 
and very recently from an E. coli isolate in India (GenBank Accession No. EU5 89460) 
(Shahid era/., 2008) 
Many strains with plasmid-determined AmpC enzyme also produce TEM-1, TEM-2, 
SH\'-5 (Gazouli et al., 1996; Gazouli et al., 1998; M'Zali et al, 1997) or even CTX-M-
15(Ensorera/.,2006). 
2.5.4 Relationship of chromosomal and plasmid-encoded AmpC enzymes 
A dendrogram of chromosomal and plasmid-encoded AmpC enzymes demonstrated the 
diversit> of chromosomal AmpC genes and the close relationship of some plasmid-
mediated enzymes to chromosomal enzymes of particular organisms. The plasmid-
mediated enzymes could be divided into five or six clusters: the C. Jreundii group with 
LAT t>pes and certain CMY types, the Enterobacter group with MIR-1 and ACT-1, the 
A/, morganii group with DHA-1 and DHA-2, the H. alvei group represented by ACC-1, 
and ihe Aeromonas group with MOX-, FOX-, and other CMY-type enzymes (Philippon 
el al., 2002). The relationship between plasmid-encoded enzymes and certain 
chromosomal p^lactamases was foimd to be very close: there was 100% amino acid 
homology within the M. morganii and H. alvei groups and more than 94% homology 
within the C. freundii group. ACT-1 and MIR-1 shared 91.4% amino acid identity with 
each other but only 85 to 87% identity with most E. cloacae AmpC enzymes. However, 
the enzyme from E. cloacae strain GN7471 (Kuga et al., 2000) had 91.1% identity to 
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ACT-1 and MIR-1, and an environmental strain of Enterobacter was 98% identical, so 
that origin from some Enterobacter species was likely suggested (M. Rottman and G. 
Arlet, personal communication). FOX enzymes have been reported to have 95% or more 
sequence identity within the group, and CMY-1, CMY-8, and CMY-9 are more than 97% 
identical, but either group has only about 74% identitv' with the available Aeromonas 
sobria AmpC sequences, which in turn differ from each other by fiilly 25% (Philippon et 
al., 2002). The AmpC sequence of P. aeruginosa is even more distant, so the origin of 
these enzymes remains uncertain (Phillippon et al., 2002). 
According to PCR and sequencing results, the P-lactamases of £. cloacae K992004.1 and 
E. cloacae K995120.1 were identical to the chromosomal AmpC ^-lactamases of E. 
cloacae MHNl (Bush et al, 1995) and those of E. cloacae K99230, E. aerogenes 
K9911729, £. cloacae K9973, and E. cloacae K9914325 were similar to that of £. 
cloacae MHNl (98.5%, 98.2% and 98.2% identity of amino acid sequence). E. aerogenes 
K9911729 was found to be closely related to CMY-1 and showed 99.7% identity of 
amino acid sequence (Lee et al., 2003). Fig. 2 shows the clonal relationship between 
various plasmid and chromosomal blaampc whose sequences were available in GenBank 
(Last accessed on 12 February 2011). 
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Fig. 2: Neighbour joining tree (with branch length self drawn) using clustal X software, 
based on the sequences of various plasmid and chromosomal Wa,„po available in 
GenBank. (M Shahid, F Sobia, A Singh, A Malik, HM Khan, PM Hawkey, Anwar Haque& 
N Khardori. 2009. Beta-Lactams and Beta-Lactamase-inhibitors in Current- or Potential-
Clinical Practice: A Comprehensive Update. Crit. Rev. Microbiol. 35: 81-108) 
2.5.5 Genetic Environment of bloampc gene 
Some ampC genes are located within or near mobilizing elements, such as transposons or 
integrons (Verdet et al., 2000). Integrons have been implicated in the horizontal transfer 
of class C (3-lactamases, but not as gene cassettes, as has been seen for the Ambler class 
A, B and D ^-lactamases (Hall et al.. 1998). Many resistance genes are located on gene 
cassettes with a downstream 59-base element that acts as a specific recombination site for 
incorporation into integrons (Verdet et al., 2000). Analysis of published sequences 
indicates that ampC genes found on plasmids are not linked to 59-base elements. In fact, 
several ampC genes, such as blauwA-x, bla^ax^, blocMV-t. blacsr,s. and 6/flMox-i- ha\e 
been described in a particular class 1 integron, originally identified in In6 and In 7, which 
contain two copies of the 3' conserved segment (3'-CSl and 3'-CS2) surrounding a 
common region (CR) and an antibiotic resistance gene (Stokes ei al., 1993: Valentine ei 
al., 1994; Philippon et al., 2002; Partridge et al., 2003). The common regions are always 
located downstream of truncated 3'CS of integrons and at the same site approximately 
0.2 Kb downstream of the 3' end of ORF57i. 2.1Kb common regions represent one end 
of an undefined transposon which comprises these unique Su/-I-t>pe integrons with 
resistance gene cassettes. Moreover a variety of genes conferring resistance to aniibiotic> 
such as broad-spectrum p-lactams, chloramphenicol, and trimethoprim are located 
immediately downstream of this putative transposon. It is therefore be speculated that 
these Gram-negative have accimiulated an array of antibiotic resistance genes through 
transposition of putative transposon. Other antibiotic resistant genes has now been 
reported adjacent to the CR of similar integrons, such as qnr in the Ini7, WacTx-M-9 in 
ln60, dfrAlO in In34, dfrAlO in variant Salmonella genomic island (SGIl) from S. 
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enterica serovar Agona, blacM\-9 in pCMXRl from E. coli and catA2 in pAr-32 from 
Aeromonas salmonicida (Verdet et al., 2006). It is therefore speculated that these Gram-
negative bacteria have accumulated an array of antibiotic resistance genes through 
transposition of putative transposon, which carries integrons with gene cassettes 
conferring resistance to aminoglycosides, into the \ icinity of other classes of resistance 
genes, effectively acquiring phenotypes of multidrug resistance. DHA-1 structural and 
regulatory genes are present in an integron which includes a site-specific integrase, two 
copies of qacEAl Sull. an aad.42 gene for aminoglycoside resistance with its 
downstream 59-base element, and orf34L a postulated recombinase (Verdet et al., 2006). 
ampC and ampR genes firom the chromosome of M. morganii (Bamaud et al., 1997; 
Poirel et al., 1999) thus appears to have inserted into a complex ^wZ-l-type integron. 
Nucleotide sequences of In6 and In" have now been updated to contain orf5J3, not 
orf341 (GenBank Accession numbers: L06418 and L06822 respectively). Partridge and 
Hall showed that CRl containing open reading frame (ORF) orf513, CR2 (containing 
orfA), and CR3 (containing orfZ) form a family of genetic elements involved in the 
mobilization of resistance genes in Gram-negative bacteria (Partridge et al., 2003). It has 
been proposed that orf513 cata]> ze> the incorporation oi a resistance gene at the 3' end of 
the CR. The insertion sequence \SEcpl upstream from hla\cc-\ is always present in the 
same orientation but has variable deletions in the 5" end [1,433 bp deletion was noticed in 
SLK54, 1,101 bp deletion in KUS, B952, & MMAS, and 988 bp deletion in S. enterica 
serovar Bareilly] (Doloy et al., 2006). Nevertheless, the length between the end of 
ISEcpl and the ATG codon of bla^cc-x is constant, which suggests that only one genetic 
recombination event has occurred. ISEcpl is known to be involved in both the 
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mobilization and expression of blacix-M genes. Although ISEcpl is always truncated in 
the 5'end and can no longer function in transposition events, however, the possibility of 
its involvement in the initial mobilization of WatAcc-i can not be ruled out. Indeed, ISEcpl 
transposase may recognize a wide range of DNA sequences as inverted right repeats and 
use them as ends in mobilization process involving its adjacent sequences (Poirel et al.. 
2003). The -35 and -10 regions corresponding to putative promoter sequences for 
acquired bla genes were different for the chromosomal 6/aAcc-type of Hafnia alvei. 
Indeed, whatever be the deletion of ISEcpl, the promoter is likely provided by ISEcpl, as 
reported in case of blocTx-M P-lactamases (Cao et al., 2002). The genetic organization of 
plasmid carried WaAcc-i differs beyond ISEcpl and gdha, and was divided into three 
main patterns viz. (a) ISEcpl has a 1,433 bp deletion due to an insertion of an IS26 in the 
opposite orientation. A second copy of IS2<5 (IS2<5L) is present 4,210 upstream of the first 
copy (IS2(5R). Two copies of \S26 were found in opposite orientations, with the 3'end 
facing outwards. Another copy of ISEcpl (ISEcpli) is present downstream of IS26L with 
3" end truncated and the truncation was exactly complementary to that of ISEcplR 
upstream of WaAcc-i- (b) A 1,101 bp deletion due to insertion of an IS2<5 in the same 
orientation was noticed, A second copy of IS26 (IS2<5L) was noticed 2,742 bp 
downstream of blas^cc-]- The two copies of IS26 were in opposite orientations, with the 
3'end facing inwards, (c) This pattern was noticed in S. enterica serovar Bareilly only. A 
deletion of 988 bp was noted due to insertion of orf7 (Hasman et al, 2005). It has been 
proposed by Doloy et al. (2006) that, although the IS2<5 element has been found in 
genetic organization of WAACC-I in several clinical isolates, it is likely that this structure is 
not directly involved in the translocation of the ampC gene from the H. alvei 
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chromosome to different plasmids. Nevertheless, its presence seems to be linked with 
recombination events occurring after the insertion of ISEcpI upstream of bla\cc-\ that 
lead to the deletion of the 5'end oflSEcpI. In all cases ISEcpI was never complete, amd 
its deletion may have led to the stabilization of bla\ccA on different plasmids. Chen et 
al., (2007) revealed the genetic environment of blac\\\^ and revealed that in the integron 
region, the inverted repeat IRt was present at the right end of IS6100 but the IRi was not 
found. The integron was found to be flanked by two complete IS26 elements. In addition, 
a partial duplicate of the 3'Conserved sequence of the integron, including the qacEAI and 
Sul-\ genes, was identified on the left of the integron, followed by an AmpC P-lactamase 
gene, blacM\-&- No inti or gene cassettes were found on the left of the duplicate 3' 
Conserved sequence. The AmpC P-Iactamase blacuy-i was first identified in a 25-kb 
plasmid of ^. pneumoniae epidemic strain fi^om Southern Taiwan (Yan et al., 2000). The 
originally determined 1,973 bp sequence of blocMY-s (GenBank Accession number, 
AF167990), which contains part of the upstream 0RF5/ i and the downstream 
hypothetical ORF, can be aligned perfectly to that of pK29. The association of 6/acM\ -« 
with ORF513 (Toleman et al., 2006) indicates that the blacMY-% gene is mobilized with 
these type-1 integron-associated elements. In pK29, an additional IS26 element was 
identified at the left end of ORF57i. Thus, the 6/acMY-8 region and the nearby type-I 
integron region represent two small composite transposon-like elements, and the entire 
14-kb region bounded by the two external IS26 elements could also be regarded a as a 
large composite transposon. Zioga et al. (2009) have characterized two CMY-2 
derivatives, CMY-31 (Ghi^'^-*Arg) fi-om Salmonella Newport and CMY-36 
(Ala^^-*Cys; Gin ^ —•Glu) fi-om K. pneumoniae. Both cephalosporinases fimctionally 
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resembled CMY-2. They have reported that both CMYs occurred as parts of a putative 
transposon comprised of ISEcplB and a Citrobacter freundii derived sequences carried 
by ColEl-like plasmids similar to CMY-5-encoding pTKHll from K. oxytoca. Based on 
the structure of the Enterobacter cloacae 908 R P-lactamase (PDB entry 1Y54) (Michaux 
et al. 2005), it seems that Arg^'^ is located in the Q loop that is invohed in the 
interaction with p-lactam substrate (Nukaga et al., 2004). They have reported that both 
mutations (substitutions) in CMY-36 occur at positions distant from that acti\e site 
cavity. Plasmids of both CMY-31, and CMY-36 cephalosporinases carried an ISEcpJB-
assocaited C. freundii-derived sequence of 2,088 bp (^/OCMY, blc [encoding lipocalin]. 
and sugE [encoding a small multidrug resitance protein]) flanked by a 5 bp target site 
duplication (5'-GATTA-3'; ntds 604-608 and 4,634-4,638 in CMY-31 and CMY-36 
respectively) and inserted into a ColEl-like backbone of 4167 bp. An OriV (ntds 1599-
1601) was located at a 40 bp distance from the regulatory elements RNAII (511 bp) and 
RNA I (105 bp) (Brantl, 2004). 0RF7 (417 bp), downstream RNA I. resembled a 
remnant (mob B) of the mob gene array of ColEl. A 594 bp of 0RF6 of unknown 
function was located between mob and the exhibiting 81% homology with the transfer 
origin (OriT) from pIP843 and pJHCMJVl (Cao et al, 2002; Samo et al.. 2002. and 266 
bp sequence (ntds 7964-8182) 95% homologous to Cer (ColEl resolution) recombination 
site implicated in plasmid monomerization and stability were also identified. According 
to Zioga et al. (2009), the respective amino acid sequence changes, including 
Gln '^^ —*Arg in the Q-loop, are probably not associated with selective pressure exerted by 
drugs such as ESCs. The common origin hypothesis of the plasmid borne blacMv alleles 
is also in line with the similarity of their genetic environments. The elements from the 
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ColEl-like plasmids, as well as similar CMY-2 encoding transposon from an Inc/ 
plasmid, occur as shorter versions of IS£c/775-associated sequences from a variety of 
plasmids (Giles et aL, 2004; Hopkins et al., 2006; Kang et ai, 2006). The transposon-like 
sequence derived from a conunon element through alterations in the right-hand end that 
may arise during IS£c/775-mediated transposition. Haldorsen et al. (2008) reported the 
occurrence of an IS£cp7-like-6/acMY element in Norwegian isolates. They observed 
genetic linkage of both blacu\.2 and blocwi-.i genes to \SEcpl-\ike element. Experimental 
evidences of IS£cp/-mediated mobilization of blocrx-M genes have been recently 
provided (Lartigue et al., 2006; Poirel et al., 2005). The DN.'\ sequence of the ISEcpl-
blacMY region included blc and sugE genes located immediately downstream, indicating 
that the genetic context of blacMY-i is remarkably conserved in strains from USA, 
Taiwan, and Norway (Kang et aL, 2006; Su et al.. 2006: Holdorsen et al., 2008). An 
insertion of the putative IS element ISEclO in the chromosomal ampC promoter region 
results in increased transcription of ampC genes. ISEcJO belongs to the IS27 family of IS 
elements and harbors two open reading frames, encoding a putative transposase and a 
putative ATP-binding protein. The IS£c70 element probably enhances transcription of 
the chromosomal ampC gene by inserting a new strong -35 box (TTG.ACG). located in 
the IS£c70 IRR, 17 bp upstream of the endogenous -10 box in the ampC promoter. It has 
been reported that the insertion of IS element can increase the expression of downstream 
genes (Mahillon et al., 1998) while upstream insertion of IS977, IS70, and IS2 has been 
suggested to mediate increased transcription of ampC gene in previous studies (Jurian et 
al., 1983; Mulvey et al., 2005). 
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Molecular mechanism of the evolution of resistance plasmids can be best understood by 
studying IncFl plasmids in detail. Antimicrobial drug resistance in IncFl plasmids 
evolved through the acquisition of multiple resistance determinants in few steps, by site-
specific recombination mediated by transposon and integrons. The presence of multiple 
physically linked resistance genes on the same plasmid, conferring resistance to different 
classes of antibiotic, may confer a selective advantage to the host when several 
antimicrobials are simultaneously administered. Such synergy between different co-
expressed resistance genes would allow the recipient host to be selected positively by 
each individual class of antibiotics. Genes for the AmpC enzymes have been located on 
plasmids of sizes varying from 7 to 180 kb (Horii et al., 1994; Stapleton et al., 1999). A 
few of the plasmids have not been self-transmissible but are transferable by 
transformation (Papanicolaou et al.. 1990; Stapleton et al., 1999; Wu et al., 1999) or 
mobilization (Tzouvelekis ^/^A. 1993; Gazouli etal, 1996; Gazouli et al., 1998c; Verdet 
et al.. 2000). Plasmids encoding AmpC enzymes often carry multiple other resistances, 
including resistance to aminoglycosides, chloramphenicol, sulfonamide, tetracycline, 
trimethoprim, or mercuric ion {Papanicolaou et al., 1990; Bauemfeind et al., 1996a; 
Bauemfeind ei al.. 1997; Bradford et al.. 1997; Stapleton et al, 1999). A plasmid 
encoding a FOX-type enzyme e\en carried a gene for fluoroquinolone resistance 
(Martinez-Martinez et al., 1998). Clinical isolates often produce other P-lactamases in 
addition to an AmpC enzyme. The bla genes may be on different plasmids, but often they 
coexist on the same plasmid. For example, the gene for ACT-1 was foimd in clinical 
isolates along with a pi 5.6 ^-lactamase consistent with TEM-10 or TEM-26 and a pi 7.6 
enzyme consistent with SHV-1, and on cloning the ACT-1 gene was found in a 15-kb 
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cluster with genes for a ^-lactamase of pi 5.4, presumably TEM-1, and pi 7.0, possibly 
another SHV-type enzyme (Bradford et al., 1997). Furthermore, an ACT-1 probe 
hybridized to chromosomal DNA of these clinical strains, implying mobility of the gene 
by carriage on a transposon. Indirect evidence suggests that CMY-3 and CMY-4 could be 
transposon-mediated as well: CMY-3 because its gene is located on the chromosome of a 
species {P. mirabilis) lacking a native ampC gene (Bret et al., 1998), and CMY-4 because 
in £. coli clinical isolates from London a CMY-4 probe hybridized to both 7-kb and 45-
kb plasmids, a dual location that could be explained by transposability (Stapleton et al., 
1999). The MIR-1 gene is located near a sequence closely related to an msertion sequence 
transposase, but direct attempts to demonstrate transposability of MIR-1 or BIL-1 (CMY-
2) have not been successful (Fosberry et al, 1994; Jacoby & Tran, 1999). 
Most plasmid encoded AmpC P-lactamases, like CMY-2, CMY-4 and LAT-1 lack the 
ampR gene. Citrobacter spp. and Enterobacter spp. possess ampR and ampC genes, the 
fumarate operon^t/ABCD immediately downstream of the ampR gene, and also outer 
membrane lipoprotein blc immediately downstream of the ampC gene (Bishop et al., 
1995). In contrast M. morganii possesses the ampR and ampC genes but not the fimiarate 
operon (Poirel et al., 1999), hyb¥ is substituted for the fumarate operon upstream from 
the ampC gene. A new type of genetic element QSCR) has been identified as being 
closely linked to the dissemination of the antimicrobial drug resistance genes (Toleman et 
al.. 2006a; 2006b; Walsh, 2006). They have been reported to mobilize many classes of 
antibiotic resistance genes, including dfrAlO, blacuY, blauox-u blaouA-u blacrx-u, 
blay£B-2, blapER-h catA2, and qnr genes located in complex class 1 integrons (Toleman et 
al, 2006a; Toleman et al, 2006b). A recombination crossover site (RCS) [33 bp DNA 
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sequence containing orilS] at which insertion of resistance genes into the complex class 1 
integron containing ISCRl takes place was observed downstream of ISCRl (Bennet, 
2008). A 179 bp region, which was identified between the RCS and the start codon of the 
6/acMY-io gene, has not been identified to any known nucleotide sequence (Lee et ai, 
2003; Lee et al., 2006). The unique region has been first identified in the integron 
(GenBank Accession number, FJ004895) harboring the /^OCMY-IO gene. Furthermore, the 
genetic environment surrounding the 3 ' end of RCS revealed that the upstream sequence 
of 6/acMY-io had an additional 15 bases compared with the upstream sequence of WOCMY-I 
(Bauemfeind et al., 1996). On the other hand, the upstream sequences ofblacMY-9 (Doi et 
al., 2002) and WacMY-8 (Chen et al., 2007) lacked 50 bases compared with the upstream 
sequence of Z»/acMY-i- The nucleotide sequence analysis of 6/acMY-i, blac\i\-s, 6/acMY-9, 
and 6/acMY-io genes indicates that there might be past transposition events by the ISCRl 
element upstream of WOCMY genes because of different genetic environments surrounding 
the 3'end of RCS in these genes. A previous report suggested that this variation is 
indicative of past transposition events (Doi et al., 2002). 
It has been proposed by Miriagou et al. (2004) that the 1S26-5'CS sequence w^s pan of a 
common mobile structure which spread among distinct plasmids and evolved through the 
acquisition of gene cassettes and IS2(J-mediated transposition or recombination events. 
Genes coding for acquired cephalosporinases are usually located in transferable plasmids, 
and several lines of evidence indicate that mobilization of the species-specific 
chromosomal ampC genes is mediated by transposable elements. Among these are 
transposons containing the ISEcpl insertion sequence, found in the vicinity of 5'end of 
various p-lactamase genes, including the ampC-type W^CMY^ gene (P. D. Stapleton, 
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Abstr. 39"' Intersci. Conf. Antimicrob. Agents Chemother., abstr. 1457, p. 132. 1999). 
Literacka et al. (2004) obtained amplicons of 500bp in all test isolates, which indicated 
that ISEcpl was indeed present in the vicinity of all the blocMY genes and that the 
distance between the element and the beginning of the WOCMY coding frames was around 
lOObp. Most probably the mobilization of the blocsp, genes from C freundii to P. 
mirabilis was mediated by a transposon formed by ISEcpl element ISEcpl was found to 
be located at the same distance from the blocMY genes. It has been suggested that there 
had been a single original source of all blocMv genes (Literacka el al.. 2004). 
2.5.6 Enzymatic properties 
pMAmpCs have pi between 6.4 and 9.4. In strains containing several ^-lactamase AmpC 
enzymes can be identified after isoelectric focusing by differential inhibition of nitrocefin 
reactivity with 5 mg of cefoxitin/mL (Papanicolaou et al., 1990). Few plasmids were 
found to carry both ampR and ampC and were inducible (DR,A-1 and DHA-2) but most 
pMAmpCs genes expressed constitutively (MIR-l which expressed constimtiveK e\en in 
the presence of complete system for induction) (Jacob) & Iran. 1999). .Apparent 
molecular size of mature pMAmpCs varies from 38-42 kDa. .Amino acid sequence of 
enzymes revealed an active site Serine in motif Ser-X-X-Lys (X is any amino acid) at 
residues 64 to 67 of mature protein. A Lys-Ser/Thr-Gly motif has been found at residues 
315 to 317 and forms tertiary structure of active site. A tyrosine residue at position 150 
forms part of class C typical motif Tyr-X-Asn and is important for catalysis of P-lactam 
hydrolysis (Oefiier et al., 1990). The plasmid mediated enzymes can be divided into 
following clusters, C freundii group (group with LAT and certain CMY types), 
Enterobacter group (group with MIR-l and ACT-1), M morganii group (group with 
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DHA-1 and DHA-2), and H. alvei group represented by ACC-1 while Aeromonas group 
with MOX, FOX and other CMY types of enzymes. 
2.5.7 Susceptibility to different antimicrobials and mechanisms of resistance 
Strains with plasmid mediated AmpC enzymes are consistently resistant to 
aminopenicillins (ampicillin or amoxicillin) and carboxypenicillins (carbenicillin or 
ticarcillin) and ureidopenicillins (piperacillin). While among penicillins, strains were 
found to be susceptible onl\ to amdinocillin or temocillin. AmpC enzymes provided 
resistance to cephalosporins in the oxvimino group (ceftazidime, cefotaxime, ceftriaxone, 
cefuroxime) and 7-a-methoxy group (cefoxitin, cefotetan, moxalactam). The enzymes 
were also active against the monobactam, aztreonam. Alteration in antibiotic access to the 
enzyme can markedly change the susceptibility profile. Outer membrane of Gram-
negative bacteria has outer membrane proteins (OMPs); one family of OMPs is porins 
which form water filled channels that permits diffusion of small hydrophilic solutes. 
OmpK 36 porins in K. pneumoniae was found to augment resistance provided by ESBLs 
and pMAmpC to include resistance to ox\imino-^-lactams and carbapenems. (Rice et al., 
1999). In E. coli h>73erprDduction of chromosomal .AmpC together with porin loss 
(Martinez-Martinez et ai.. 2(XX)) or in Al pneumoniae porin deficiency alone can give rise 
to cephamycin, and oxyimino-^-lactam resistance. According to the report of Pai et al., 
(2004) pMAmpC are associated with potentially fatal errors of false susceptibility in 
routine susceptibility test. 
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2.5.8 Detection of AmpC P-Iactamases 
The current CLSI documents (formerly NCCLS) do not indicate the screening and 
confirmator>' tests that should be used for the detection of AmpC ^-lactamases. 
Organisms producing enough AmpC P-lactamase will typically give a positive ESBL 
screening test but fail the confirmatory test involving increased sensitivit> with 
calwilanic acid (Bell et al., 2007). The three-dimensional test, originally described by 
Thomson ei al.. (1984) is a more sensitive procedure for the detection of ESBLs. A 
conventional disc diffusion susceptibility assay is carried out with a susceptible strain, E. 
coli 25922, as the lawn and a suspension of the test organism, which is added to a circular 
slit in the agar 3 mm from a disc containing cefoxitin. Distortion of the zone of inhibition 
indicates a positive test, as cefoxitin is hydrolyzed by the presence of an AmpC enzyme 
{Thomson & Sanders. 1992). In subsequent modifications, a radial slit was employed, 
and rather than using intact cells, the test organisms were concentrated by centrifugation, 
and the pellet was freeze-thawed five to seven times to release ^-lactamase (Coudran et 
al. 2000; Manchanda & Singh, 2003). Shahid et al, (2004) modified conventional Three 
Dimensional E.\tract Test (TDET) to identify AmpC-producers. Briefly, 10-15 mg of 
bacterial wet weight was scraped from culture plate and suspended in 0.5mL of peptone 
water in a sterile micro-centrifuge tube and incubated at 37°C for one hour. Crude 
enzyme extract was prepared by repeated freezing-thawing. To ensure complete 
membrane lysis, the freezing-thawing may be carried out five times. Lawn culture oi E. 
coli ATCC 25922 was prepared on MH Agar plate and was incubated at 37°C so that 
plate can dry properly. Cefoxitin discs (30^g) were placed on dried MH Agar plate. With 
a sterile scalpel a linear trench (3cm x 1mm) was prepared in agar at a distance of 5mm 
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from edge of disc in an outward radial direction. 50|xl of enzyme preparation was 
dispensed in trench and overfill was avoided. The inoculated media was incubated 
overnight at 37°C. Enhanced growth of the surface organism at the point where trench 
intersected the zone of inhibition towards the cefoxitin disc was interpreted as evidence 
for the presence of AmpC P-lactamase. Direct spot-inoculation of the test organism 7 to 8 
mm from the cefoxitin disc has also been used successfully (Shahid et al., 2004). Lee et 
al. (2005) have streaked the heavy inoculum radially from the cefoxitin disc on the agar 
surface without using slit, although this method missed some CMY-2 and DHA-1-
producing strains. In a further modification, the test organism has been applied to a filter 
paper disc containing Tris-EDTA to enhance membrane permeability, with the disc then 
placed onto lawn of £. coli ATCC 25922 adjacent to cefoxitin disc by Black et al. (2005) 
which was fovmd to be simple, convenient and accurate means of detection of pMAmpCs 
in organisms lacking chromosomal AmpC ^-lactamase. The test accurately distinguished 
between cefoxitin insusceptibility caused by AmpC production and non-^lactamase 
mechanism like reduced outer membrane permeability (porin mutation) but this test was 
found unable to discriminate between positive results due to up-regulated chromosome 
mediated AmpC and those due to pMAmpCs. The presence of an AmpC p-Iactamase was 
indicated by a distortion of the inhibition zone around the cefoxitin disc. Later, in the 
same year Black et al. (2005) described the diagnostic utility of AmpC p-lactamase 
inhibitors, LN-2-128, RO 48-1220 (Fig. 3a), Syn 2190 (Fig 3b) in combination with 
cefotetan or cefoxitin in disk test for detection of clinical isolates of Klebsiella spp. 
producmg pMAmpCs. LN-1220 is a C-3 substituted cephalosporin-derived inhibitor with 
a broad spectrum of inhibition and inhibits both class A (TEM and SHV) and class C 
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(AmpC type) p-lactamases, RO 48-1220 is a 2p alkenyl penicillanic acid sulfone inhibitor 
also with a broad spectrum of inhibition and Syn 2190 is a monobactam derivative 
containing 1,5-dihydroxy-4-pyridone as a C-3 side chain and is a potent inhibitor of class 
C P-lactamases. The combination of Syn 2190 and cefotetan (CTT) was found to have 
sensitivity of 91% and specificitv' and reproducibint\' of 100% respectively. 
Fig. 3a. RO 48-1220 Fig 3b. S>TI2190 
Suspected AmpC-producers can be studied further for cephamycin hydroK sis with three-
dimensional extract test. Cloxacillin can be used to block AmpC activity selectively after 
isoelectric focusing. Lack of inhibition of activity against ox>iniino-P-lactams or 
cephamycins by clavulanate is indirect evidence for presence of .AmpC enz>Tne but some 
AmpCs were found unusually susceptible to inhibition by tazobactam (Black ei ai.. 
2005). A double-disc test with a 500 i^g cloxacillin disc placed between disc containing 
ceftazidime and cefotaxime on a lawn of the test organism has been explored using 
fifteen AmpC-producing strains, all of them showed synergy. The central cefoxitin disc 
produced synergy with ceftazidime and cefotaxime only with ACC-1 P-lactamase and 
also revealed the mducibility of enzymes like DHA-1 (Ruppe et al, 2006). A variation in 
the three-dimensional test was described by Nasim et al. (2004), where the sensitive 
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indicator strain was plated on agar containing 4fig/mL cefoxitin and freeze-thawed cell 
extract of test isolate was added to a well in the plate. After incubation, growth around 
the well indicated the presence of a cefoxitin-hydrolyzing enzyme. This method was 
reported to be just as sensitive and specific as the three-dimensional test for AmpC 
detection, is easier to perform, and allows testing of multiple sample per plate (Nasim et 
al., 2004). Partially derepressed strains could be missed as .AmpC producer if they are 
tested in absence of inducer, cefoxitin. Jacoby et al. (2006) have proposed disc based 
method that could be used to detect various ^-lactamase in E. coli and K. pneumoniae. 
Recently, a test for AmpC type p-lactamases that involves augmentation of the inhibition 
zone aroimd ceftazidime and cefotaxime discs by boronic acid compound has been 
proposed by Yagi et al. (2006). Testing is complicated by the fact that the pattern of 
resistance may be altered by porin loss. Researchers have used commercially available 
boronic acid compounds, APB (3-aminophenyl boronic acid). NPB (3-nitrophenyl 
boronic acid), and TPB (2-thiophene boronic acid) and found .APB as most practical 
candidate among specific inhibitors of class C ^lactamase because NPB and TPB were 
found to have antibacterial activity by themselves at concentration of about 300 ^g/mL 
leading to misinterpretation of the change in diameter of gro\Mh inhibitory zone. 
Enlargement of zone of inhibition by >5 mm was adopted as positive result with APB 
inhibited ceftazidime and cefotaxime resistance in AmpC producing strains. The 
exceptions found were ACT-1 and MOX-2 producing strains which failed with 
ceftazidime plus APB and DHA-1 and FOX-1 producing strains which failed with 
cefotaxime plus APB. A positive response to APB indicates production of an AmpC P-
lactamase but not necessarily a plasmid mediated enzyme since in E. coli strains this 
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phenotype may result as well from an over expression of chromosomal ampC gene. Some 
bacterial species may produce inducible AmpC P-lactamase that can be overlooked by 
routine susceptibility tests. Contarelli et al. (2007) described a new test based on strong 
inducible effect of imipenem on AmpC and consequent antagonism with ceftazidime. 
CIAT (ceftazidime-imipeDem antagonism test) can be used to confirm the presence of 
known, as well as new. indiKible enzymes, among Enterobacterial strains. However, 
methods of detecting ESBL producing bacteria have been evolving for more than a 
decade, beginning with the description of the disk approximation test by Brun-Buisson et 
al. (1987) and subsequently described by Jarlier & colleagues (1988). Phenotypic tests 
cannot distinguish among the various families of plasmid-mediated AmpC ^-lactamase 
and may also overlook chromosomally determined AmpC P-lactamases with an 
extended-spectrum (Mammeri et al.. 2008). For these purposes, and as a gold standard 
for plasmid-mediated .AmpC ^lactamase detection, genetic testing can be done by using 
multiplex PCR (for AmpC) as described by Perez-Perez & Hanson (2002). One can 
identify family specific .\mpC ^lactamase genes through this method, in which six sets 
of ampC-specific primers resulting in amplicons that range from 190-520 bp that can be 
distinguished b\ gel electrophoresis. A seventh pair for CFE-1 P-lactamase could also be 
added (Nakano et al.. 2004 >. This PCR-based assay differentiated multiple genes within 
one reaction. Chromosomal blasmpc did not interfere in testing strains of K. pneumoniae, 
E. coli, P. mirabilis, or S. enterica but could be a problem with ft/flampc genes in one of 
the genera from which the plasmid-mediated enzymes are derived. WAVE DNA 
fragment analysis was performed in order to shorten time required for analysis and it 
increases sensitivity of multiple gene assay (Perez-Perez & Hanson, 2002). WAVE 
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technology is a high pressure liquid chromatography-based nucleic acid analysis and 
peaks are observed where each peak had a retention time equivalent to retention time 
observed in the single template amplification and hence amplified PCR products can be 
compared with chromatogram obtained in WAVE analysis. To determine genetic 
environment of bla genes, standard PCR amplification and sequencing anaKses were 
performed with sets of primers, which were designed on the basis of nucleotide sequence 
deposited in EMBL/GenBank/DDBJ databases. Lee et al. (2002) developed DNA chips 
for simultaneous detection of various P-lactam antibiotic resistant genes. Further in 2007, 
Zhu et al. developed Multiplex Asymmetric PCR-(MAPCR) based Oligonucleotide 
Microarray for detection of 10 known ESBLs and pMAmpC ^-lactamase genes in Gram-
negative bacteria. MAPCR is based on a two round reaction to promote the accumulation 
of single stranded amplicon amenable for microarray hybridization by employing 
multiple universal unrelated sequence-tagged primers and elevating annealing 
temperature at second round of amplification. SDS-PAGE whole cell protein profile 
analysis was used for the fu-st time by Costas et al. (1990) for typing clinical isolates of 
Klebsiella aerogenes. In India, Manchanda et al. (2005) used this technique as an 
etTecti%e adjunct to other methods of typing of isolates of AmpC-producing K. 
pneumoniae. This study also demonstrated the usefulness of SDS-PAGE and ribotyping 
as epidemiologic typing techniques, the later being more discriminatory. 
2.6 Mobilization of broad-spectrum ^-lactamases 
bla genes have mainly have been reported in Enterobacteriaceae and are associated with 
mobile genetic elements (MGEs), such as insertion sequences (ISs), integrons, 
transposons, plasmids, and phage-related elements. It has to be noted that ISs and 
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transposons can jump from the chromosome to a plasmid or between plasmids or back to 
the chromosome within a bacterial cell, but require a conjugative element (plasmid or 
conjugative transposon) or phage to be mobilized between bacterial cells. Integrons are 
genetic elements able to acquire and rearrange open reading frames (ORFs) embedded in 
gene cassette units and convert them to functional genes by ensuring their correct 
expression. They were originally identified as a mechanism used by Gram-negative 
bacteria to collect antibiotic resistance genes and express multiple resistance pheDot\"pes 
in synergy with the discovery of chromosomal integron structures in the genomes of 
hundreds of bacterial species. All integrons are composed of a stable platform, which 
contains the functional element required for the system operation associated with a 
variable array of discrete gene cassettes encoding accessory functions. 
a) The functional platform: The principle component of the integron functional 
platform is the int gene which encodes a site specific recombinase. It catalyzes the 
specific excision and integration of dedicated and discrete genetic element, known 
as gene cassette (Stokes & Hall, 1989). The integration cassette essentially occurs 
at a specific locus lying immediately adjacent to iniJ, referred to as the primary 
recombination site attl. A majority of cassettes are promoteriess. The expression 
of genes they cany is then ensured by a dedicated Pc promoter, which is 
embedded either in the inti gene or in the attl site and oriented towards the 
integration point. By itself, the fimctional platform is stable and non-mobile. 
b) The cassette array: Successive integration at the attl site results in the streamlined 
assembly of different gene cassette array. This cassette array constitutes the 
variable part of integron. Gene cassettes are minimal functional element intended 
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to be mobilized by the integrase. They are generally constituted by a single open 
reading frame (ORF) immediately followed by a combination site termed attC 
(formerly called 59-base element), which is specifically recognized by Intl. 
Cassettes-borne genes are generally promoterless and their expression is 
conditioned by the proximit> of external promoter, essentially Pc. Accordingly, 
the ORFs in cassettes are usually oriented towards the attC site. The excision of 
cassettes by the inti integrase leads to non-replicative, covalently closed circular 
intermediates. 
Mobile integrons correspond to functional platforms that are physically associated with 
mobile DNA elements (transposons), which can be carried by conjugative plasmids. 
These elements can be used as natural genetic vehicles, enabling efficient transmission 
between bacterial individuals of the same or different species. Mobile integrons contain 
only a few cassettes that appear to be of heterogenous origin and were probably collected 
successfully in different genomics backgrounds. The longest array identified consists of 
eight cassettes (Naas et al., 2001). Contrasting with their apparent heterogenous origins, 
cassettes associated with an integron display a striking functional homogeneity, as they 
were mostly involved in antibiotic resistance. Togetlier. these cassettes provide resistance 
to most classes of antibiotics including ^-lactams, amiogiycosides, chloramphenicol, 
trimethoprim, streptothricin, rifampin, erythromycin, fosmomycin, lincomycin, 
quinolones, and antiseptics of the quaternary ammonium compounds. Class 1 integrons 
are the most widespread and clinically important, as they are detected in 22% to 59% of 
Gram-negative clmical isolates (Labbate et al., 2009) and they have also been 
occasionally identified in Gram-positive bacteria (Shi et al, 2006). Class 2 integrons are 
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exclusively associated with Tn7 derivatives and show a dozen different cassette arrays 
(Biskri et al., 2005). The integrase gene of class 2 integrons, intI2 generally contains a 
nonsense mutation in codon 179 that yielded a nonfunctional protein, which can be 
rescued by a single mutation (Hanson et a/., 2002). Class 3 integrons are also thought to 
be located in a transposon and are less prevalent than class 2 (Collis et al., 2002). The 
diversitv' of these genetic vehicles enhances the spread of broad-spectrum p-lactamases. 
bloT^si are carried by three of the earliest described bacterial transposons namely Tn7, 
Tn2. and Tni. These transposons contain the transposase and resolvase genes, tnpA and 
tnpR, as well as res (a resolution site). They are about 99% identical, with most of the 
differences confined to the res site (Partridge & Hall, 2005). Most of structures 
surrounding the blojEM genes are Tni-like transposons possessing 38 bp inverted repeats 
(Heffron et al.. 1979). 6/flsHv originate from the chromosome of K. pneumoniae and are 
spread together with K. pneumoniae chromosomal DNA fragments from the chromosome 
to a plasmid within a bacterial cell, follow IS2<5-dependent mobilization. Their presence 
on conjugative element allows them to spread between Gram-negative bacteria (Chiaretto 
et al.. 2008: Poirel et al.. 2008: Rodriguez-Bano et al, 2008; Tian et al, 2009). Several 
genetic elements such as \SEcpl. ISCRl, and phage related elements have been foimd to 
be involved in the mobility of blacn-M (Canton & Coque, 2006; Bae et al., 2007; Poirel 
et al., 2008). lS£c/77-like elements belong to the 1SJ380 family and have been identified 
in association with 6/acrx-M-i, blacvx-M-z, and WflcTx-M-25 (Fernandez et al., 2007; Liu et 
al., 2007; Shen et al., 2008). Another, rather specific IS element found in association with 
blacvx-M gene is the IS common region (ISCRl) formerly known as ORF513 (Stokes et 
al., 1993; Partridge & Hall, 2003). The IS91-like ISs afs^S^S3^(^^musual IS elements 
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that differ from most other IS element both the structure and in the mode of transposition. 
The horizontal gene transfer of antibiotic resistance genes among bacteria was found to 
be driven by multiple systems involving both cell-to-cell transfer and gene transfer from 
one DNA molecule to another. Later one can take place regardless of similarity between 
the donating and recipient molecules (Hallet & Sherrat. 1997; Plasterk, 1995) and 
includes transposons and site-specific recombination system termed integrons (Bennet, 
2004; Collis & Hall, 1995). These systems can accoimt for much of the movement of 
resistance genes between DNA molecules but they fail to explain the spread of a 
substantial and growing subset of resistance genes. These resistance genes were found to 
be linked to sequences termed 'Common Regions' (CRs), which are often found beyond 
but close to 3'Conserved Sequence (3'CS) of class 1 integrons. When these CRs were 
analyzed in detail, then it came to know that these are related to each other and resemble 
an atypical class of Insertion Sequences (ISs) designated as ISPi-like. IS97 and like 
elements differ from the typical insertion sequence model in that they lack the terminal 
inverted repeats and are thought to be transposed by a mechanism termed rolling circle 
transposition (Mahillion & Chandler, 1998). Consequently, they can transpose adjacent 
DNA sequences mediated by a single copy of the element (Tavakoli et al., 2000). This is 
contrasting to most IS elements, where two copies (one of which must be intact) were 
needed to flank the mobilized gene (Bennet, 1992), as observed in the mobilization of 
blacTX-M mediated by ISEcpl (Poirel et al., 2003; 2005). Now it has been established that 
CRs are responsible for the mobilization of almost every class of antibiotic resistance 
gene, including those encoding ESBLs, carbapenemase, enzymes conferring broad-
spectrum aminoglycoside resistance, florfenicol/chloramphenicol resistance, and 
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resistance to trimethoprim and quinoiones. In the case of ln6, the CR is found 
immediately upstream of a chloramphenicol resistance gene {catAll), while CR in the In 7 
was found to be associated with a novel trimethoprim resitance gene {drfAlO). The 
striking feature of these two CR-associated resistance genes is the fact that they were not 
found linked to 59be (tjpical for the resistance genes integrated in class 1 integrons). In 
the past, transposons were considered as main vehicle for transfer of gene between DNA 
molecules. Later on, it was discovered that structure of transposon is not fixed and 
another mobile genetic elelement, termed as 'integron' was identified that capture and re-
assort individual genes (Liebert et al., 1999). Structure of an integron comprises of a gene 
/«/ (a site-specific recombinase termed as integrase), an adjacent site atti at which 
resistance genes in the form of gene cassettes can be specifically inserted. Integrons can 
be considered as potentizd elements responsible for much of the spread of antibiotic 
resistance among Gram-negative bacteria. A DNA sequence, termed as '0RF5/J" has 
recently been reported to be associated with a number of antibiotic resistance genes, most 
of which are closely associated with Class 1 integrons. This sequence is an example of a 
Common region (CR) element belonging to family of unusual IS elements, typified by 
IS97, which are distinctive as they replicate by rolling circle replication for transposition 
(RC transposition) (Garcillan-Bracia et al., 2002). The first CR element (now ISC/?) was 
discovered and reported in the early 1990s as a sequence of DNA of 2154 bp, 
incorporating ORFii J inserted beside the Sul-1 gene of class 1 integrons, In6 and In? 
(Stokes et al, 1993). The sequence was termed 'CR' so as to distinguish it from the 5'CS 
and 3'CS of Class 1 integrons. In subsequently discovered complex Class I integrons, the 
CR sequence was located between truncated and fiill length sequence of 3'CS together 
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with resistance gene. Another distinctive feature of these ISC/? is that the ISC/?/-Iinked 
antibiotic resistance genes are not associated with 59 base elements (site-specific 
recombination sequences that define gene cassette) and hence these elements can not be 
acquired as gene cassette (Bennett, 1999). ISCR elements are distributed worldwide on 
plasmids and bacterial chromosomes in both Gram-negati\ e and Gram-positive 
organisms (Arduino et al., 2003). It has been proposed by Toleman et al. (2006) that 
ISCi? elements mobilize resistance genes by transposing next to them and then co-
mobilizing them by another extended transpositicsi episode (Toleman ei al. 2006). It can 
be concluded that ISCR elements are powerful genetic tools and can mobilize any gene 
from any location, without the need for element duplication (as for most IS elements). 
These elements are unusual in that it is almost always found in complex Class 1 integrons 
besides the same truncated version of 3'CS. At some time in the past, possibly in the first 
half of twentieth century, the \SCR1 progenitor transposed into a site close to the 3'CS of 
a classl integron. This was followed by a deletion that started within the 3'CS region of 
the integron (removing orf5 and orf6) and thus created ISCRl. It then mediates a series of 
secondary transposition events that transposed \SCR1 and various lengths of the attached 
Class 1 integrons into sites next to a variei> of other resistance genes, such as cat A. dfrA. 
qnr and various blocMV genes. Circular entities carrying ISC/?/, the truiKated 3'CS and 
linked resistance genes were generated. These were then rescued by homologous 
recombination into 3'CS sequence of other Class 1 integrons. Recombination into 
stranded Class 1 integrons created complex integrons (such as In6 and InT) which carry a 
single copy of ISCRl beside an internal truncated copy of 3'CS. Alternatively, 
recombination into a class 1 integron already attached to a copy of ISC/?/ would generate 
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a direct duplication of the 3'CS sequence, a particular arrangement that has been reported 
by Mammeri et al. (2005). ISCRJ has been found to be closely associated with many 
antibiotic resistance genes and not necessarily within an integron context. ISCRI was 
noticed in association with antibiotic resistance genes encoding resistance to 
chloramphenicol (catAII). trimethoprim {dfrAlO, dfrA19, dfrA23, dfrASb), 
aminoglycosides {armA). and with Class C (WOCMY-I, blocM^s, blacMY-9, blacuy-xo, 
bloMox-i, blooHA-i) and Class A ^-lactamase (6/acTX-M-2, blacrx-M-9, blacrx-M-io, blapER.3. 
blavEB-i)- qnr. gene that confers resistance to quinolones is also reported to be associated 
with ISCR] (Mammeri et al.. 2005). The association of ISCR elements with genes 
encoding mobile AmpC-type ^-lactamases, extended-spectrum ^-lactamases (ESBLs), 
and metallo ^-lactamases is of particular concern regarding further spread of these 
resistance genes. 
According to the sequence anah ses of transposase encoded by ISCR elements, 19 
groups have been proposed (\SCR1 to \SCR19) of ISCR family 
(http://wA\As.cardi£f.ac.uk/medic/aboutu&'departments/medicalmicrobiology/genetics 
iscr/iscrelements.html) (Toleman & Walsh. 2008). A temporary and non-systematic 
nomenclature was proposed where two subgroups oi\SCR5 {\SCR5a and \SCR5b) were 
designated. WTien amino acid sequences were analyzed, \SCR5b showed a difference of 8 
amino-acid as compared to that of ISC/?ia. Furthermore, more than 20 ISCRl genes have 
been reported in Australia, Argentina, Italy, and Republic of Korea (Toleman & Walsh, 
2008). Sohn et al. (2009) proposed four subgroups of ISCRJ (variants showing four 
different types of missense mutations). In the nomenclature system proposed by Sohn et 
al. (2009), ISCRIa was named for ISCRl (Accession number, L06822) [Stokes et al.. 
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1993]. ISCRlb (ISCRle or ISCRIJ) was named for ISCRl with one (four of five) amino 
acid substitutions as compared to ISCRIa. \SCR]c (or ISCRld) with two (or three) 
differences has not been detected in clinical isolates. ISCRlbj {lSCRlb2 or ISCRlb^) was 
named for the subgroup of ISCRJb where amino acid change was noticed for the first 
(second or third) position. ISCRlai has been identified in 78% oflSCRl variants and is 
the predominant group detected in Enterobacterial isolates. ISCRlbi, lSCR]b2, and 
ISCRlbs showed one amino acid substitution (Ala393Val, Glu292Lys, and His452Pro 
respectively). ISCRJe showed Ilell2Val, ProllTLeu, Asnl87Ser, and Tyr329His 
substitutions. ISCRlf had five substitutions (GlnlSArg, Val383Ala, Asn384Tyr, 
Arg407Gln, and Pro426Leu). This nomenclature system of ISCR variants was also 
applied to other 18 groups (1SCR2 to ISCR]9) of ISCR family. The previously described 
lSCR5b has been recently renamed as ISCRSi as it showed eight amino acid substitutions. 
Because gene products of ISCR] variants are more than 95% identical to each other 
(Toleman et al.. 2006b), more than 5% amino acid differences in a newly identified ISCi? 
as compared to ISC^y mean that it is a new group (e.g. ISCR20 and so on) of ISCR. 
2.7 Mobilization of bloampc gene 
a) ISEcpl had been first identified upstream of the plasmid-mediated cephalosporinase 
gene /)/ac.MY-4 from E. coli isolate from the United Kingdom [Accession number, 
AJ242809] (Stapleton PD. The 39"' Interscience Conference on Antimicrobial Agents and 
Chemotherapy, San Fransisco, CA, 1999. Abstract 1457). However this IS element has 
been frequently found to be associated with several blacrx-M (Munday et al., 2004; Karim 
et al., 2001; Cao et al., 2002; Poirel et al., 2003; 2005; Saladin et al., 2002; Eckert et al., 
2004; Lartigue et al., 2004; Ensor et al., 2006). ISEcpl has been identified in association 
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with blacMY genes, including the WocMV-a (Hossain et ai, 2004; Literacka et al., 2004; 
Hopkins et al., 2006; Toleman et ah, 2006) and WflACC-i & bla\cc-i (Partridge et ai, 
2007). ISEcpl plays a dual role, it is not only responsible for mobility of a transposition 
unit including itself along with the resistant determinant, but also provide efficient 
promoter for the high level expression of neighboring genes (Hossain et al.. 2004). Other 
ampC genes, such as ^/OCMY-I, WOCMY-S, WacMY-9, WOCMY-IO, blacuY-i), *'atMY-i9, WADHA-
1, blauox-\ has been foimd downstream of an ISCRJ involved in the mobilization in class 
1 integrons (Toleman et ai, 2006). A Citrobacter Jreundii derived sequence of 4252 bp, 
which included a blacuH-xi gene and was bound by two directly repeated \S26 elements, 
was noticed on an InciV plasmid from E. coli, indicating that this gene may have spread 
from the chromosome to a plasmid within a bacterium, following IS26-dependent 
mobilization as was also described for blasw/ genes (Miriagou et al., 2004). 
b) It appears that ISCRI played a significant role in the mobilization of 6/aampc genes into 
pathogenic organisms via plasmids and other mobile genetic elements. They have been 
reported to be present adjacent to various cephalospoinase genes, including blaoHA-i 
[Accession nxmiber, AJ237702] (Verdet et al., 2000), ft/ocMV-i [Accession number. 
X92508], blacMY-s [Accession number, AF167990], blacMV-9 [Accession number. 
AB061794], WflcMY-io [Accession nimibers, AF381618, AF536519], blacuY-ii [Accession 
number, AF381619 & AF357600], (Bauemfeind et al., 1996; Doi et ai, 2002; Lee et al., 
2002; Yan et al., 2000) and a variant of blacwf-type gene, blauox-i [Accession numbers, 
D13304 & AY220558] (Horii et al., 1993). blacuv^ and W^DHA-I have been sequenced 
and studied in detail. WflcMY-9 was identified in an £. coli isolate, HKYM68 (collected in 
Japan in 1995) and was found to be plasmid-mediated. Sequencing analysis of an 8 kb 
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region around blacM\-9 revealed that the gene of interest is located adjacent to ISCi?7 and 
downstream of class 1 integron but the second copy of 3'CS was missing, and this is the 
usual configuration when ISCRl is linked to class 1 integrons. It is interesting to note that 
all blocMY genes, that were found to be associated with ISCRl, belongs to CMY-1 
subgroup and no ISC/? CMY-2 subgroup genes have been found. Instead, these genes are 
noted to be associated with another insertion sequence ISEcpl. 
2.8 Impact of mobile Genetic elements as carriers of broad-spectrum ^lactamases 
on epidemiology and co-resistance selection 
Broad-spectrum p-lactamase encoding genes can be carried by a variety of mobile genetic 
elements such as ISs, transposons, and plasmids. These genetic elements may have 
different potentials in the dissemination of resistance, such as ISEcpI which seems to 
mobilize and transport genes onto plasmids quite easily and efficiently (Bae et al., 2006; 
Eckert et al, 2006; Liu et al, 2007; Navon-Venezia et al, 2008: Shen et al, 2008). The 
success of spread of specific p-lactamase vsdll be determined by mobile elements in terms 
of selection and dispersion of these enzymes (Smet et al. 2010). for e.g. ^/OTEMO: ^as 
found to be located on a Tni-like transposon which is located on a large stable 
conjugative Inc/i plasmid, and surprisingly until now, no other resistance gene ha%e been 
reported to be associated with this plasmid. This may be probably due to its broad host 
spectrum and the possibility of its spreading internationally (Cloeckaert et al, 2007; Smet 
et al, 2008). Similarly 6/acTx-M-i5 has been found mainly associated with ISEcpl. This 
gene has been found on a multitude of plasmids of different sizes and with different Inc 
groups such as Inc/7 and JncFIJ (Karisik et al, 2006; Hopkins et al, 2006). This 
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indicates that the association with ISEcpI is important in the spread of this gene among 
different plasmids (Smet el al., 2010). 
The blacMy.2 gene has been found to be located on Inc/ or an IncA/C plasmid 
(Hopkins et al., 2006). These plasmids seem to very promiscuous and have been reported 
all over United States (Zhao et al.. 3008). This gene is like ft/ocrx-M-is gene associated 
with an IS£cp7-like element which makes the spread of this gene possible between 
plasmids and within bacterium. Therefore dissemination of this gene could not be 
explained in terms of the clonal spread of 6/acM>-2-probucing bacteria, but rather in terms 
of different plasmids carrying it (Naseer et al., 2009). 
2.9 Extended-spectrum p-lactamases 
The term 'E.xtended spectrum ^lactamases (ESBLs)' was originally applied to the TEM 
and SHV derivatives that can hydrolyze oxj imino-cephalosporins. The definition of 
extended-spectrum of acti\it> is to have a hydrolytic activity against oxyimino-
cephalosporins or aztreonam at more than 10% of that against benzylpenicillin. 2be 
enzymes cannot hydrolyze cephamycins or carbapenems efficiently and are inhibited by 
p-lactamases inhibitors such as ciaMolanate. Discover) of several novel enzymes have 
blurred the original definition of ESBLs (Livermore. 2008). First, several P-lactamases 
with activity similar to those of TEM and SHV ESBLs, albeit with different origin has 
been reported (e.g. CTX-M). Second, some TEM mutants (e.g. TEM-7 and TEM-12) 
have only slightly increased hydrolytic activity against oxyimino-cephalosporins and do 
not meet the strict definition of ESBL mentioned above. 
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2.9.1 SHV and TEM p-Iactamases 
SHV-1 is a ^-lactamase that possesses activity against penicillins and narrow-spectrum 
cephalosporins such as cephalothin and cephaloridine (Matthew et al., 1979). blasH\-\ 
and related genes are integrated into the bacterial chromosome in most of Klebsiella 
pneumoniae (Livermore, 1995; Babini & Livermore, 2000). SHV-1 is also common as 
plasmid-mediated ^-lactamase among Gram-negative bacteria. The first plasmid-
mediated resistance mechanism for oxyimino-cephalosporins was demonstrated in 
clinical isolates of Klebsiella pneumoniae, Klebsiella ozaenae, and Serratia marcescens 
in 1983 (Knothe et al.. 1983). The new enzyme was designated SHV-2 because of a 
significant homology between the gene encoding new enzyme and blasnv-i (Kliebe et al., 
1985). Sequencing of the structural genes showed that the difference between two 
enz>Tnes was only one amino acid substitution of Gly238Ser. A number of SHV variants 
with ESBL activity have been described thereafter (Heritage et al., 1999). Most of them 
have Gly238Ser substitution in common. In addition, a number of variants related to 
SHV-5 also have a Glu240Lys substitution. Ser-238 is crucial for cefotaxime hydrolysis 
v^bereas additional Glu240Lys substitution increases the hydrolytic activity against 
ceftazidime (Hulerskv et al.. 1993). It was suggested that blasnv originated fi"om the 
chromosome of K pneumoniae and an IS26 element played a role in the mobilization of 
WflsHv to plasmid (Ford & Avison, 2004). Indeed, some reports illustrated the presence of 
blasHv-s between two IS26 elements together with the sequence identical to part of K 
pneumoniae chromosome (Miriagou et al., 2005; Preston et al., 2004). 
TEM-1, first reported m 1965 from an Escherichia coli isolate, has substrate and 
inhibition profiles similar to those of SHV-1 (Datta & Kontomichalou, 1965). Ampicillin 
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resistance in clinical isolates of E. coli is due to the production of TEM-1 in most 
instances. TEM-2 has a single amino acid substitution Gln39Lys from TEM-1 and has an 
almost identical hydrolytic profile with TEM-1. It only differs from TEM-1 by having a 
different isoelectric point (Bardford, 2001). Since the first TEM variant was reported, 
more than 185 TEM-type P-lactamases have been described. Most of these enzymes have 
ESBL activity, whereas other TEM variants reveal the characteristics of inhibitor-
resistant P-lactamases (Canton et al., 2008). Mutations in several key amino acid residues 
(e.g. Glul04Lys, Argl64Ser, Gly238Ser, and Glu240Lys) are crucial for ESBL activity, 
similar to those observed for SHV ESBLs. Although inhibitor-resistant TEM enzymes 
generally do not have a substantial activity against oxyimino-cephalosporins, a few 
enzymes have hydrolytic activity against oxyimino-cephalosporins together with inhibitor 
resistance (Canton et al., 2008). These enzymes are referred to as complex mutants of 
TEM (CMT). A CMT enzyme possesses both of the amino acid substitutions observed in 
TEM ESBLs and in inhibitor-resistant TEMs. For e.g. TEM-125, a CMT enzyme 
reported recently combines the amino acid substitutions of TEM-12 (ESBL) and those of 
inhibitor-resistant TEM-39 (Robin et al., 2006). CMT-type P-Iactamases poses a 
challenge in detection of ESBLs in clinical laboratories because phenotypic methods used 
in detection of ESBLs depend on the inhibition of ESBL by p-lactamase inhibitor such as 
clavulanate, which is absent in CMT-type p-lactamases. 
2.9.2 Emergence and origin of CTX-M ESBLs 
In 1989, a clinical E. coli isolate that produced a non-TEM, non-SHV ESBL was 
recovered and the enzyme was designated as CTX-M-1, denoting its hydrolytic activity 
against cefotaxime (Bauemfeind et al., 1990). The amino acid sequence of P-lactamase 
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from clinical E. coli isolate MEN exhibiting resistance phenotype similar to the E. coli 
isolate producing CTX-M-1 enzyme was determined and the enzyme was designated 
MEN-1 in 1992 (Barthelemy et al., 1992). In the same year, a new plasmid-mediated 
cefotaximase, designated CTX-M-2, with a pi different from that of CTX-M-1, was 
described from multidrug-resistant Salmonella enterica serovar T\phimurium 
(Bauemfeind et al., 1992). In 1995, Ishii et al. reported a novel enzyme, TOHO-1 
(renamed as CTX-M-44 later), which was highly homologous to MEN-1. Since then, 
emergence of new variants has been reported continuously. Till date >100 variants are 
assigned in Lahey Clinic database (http://www.lahey.org/Studies/webt.htm: Last accessed 
on 28 April 2011). They have been clustered into five subgroups based on similarities in 
amino acids sequences. Chromosomal gene of different environmental Kluyvera spp. 
especially K. ascorbata and K georgina serves as natural ancestor of each 
lineage/subgroup of CTX-M ^-lactamase. CTX-M group-1 (represented by CTX-M-1. 
CTX-M-3, CTX-M-15, CTX-M-23, CTX-M-28, CTX-M-32, CTX-M-54, and CTX-M-
58) and CTX-M group-2 type ESBL ( represented by CTX-M-2, CTX-M-35. and CTX-
M-42) have kluAl-11 genes of Al ascorbata as their probable progenitor. Wiale CTX-M 
group-9 (represented by CTX-M-14. CTX-M-16, CTX-M-19. and CTX-M-27i. CTX-M 
group-8 (CTX-M-8, CTX-M-40, and CTX-M-63), and CTX-M group-25 (CTX-M-25. 
CTX-M-26, and CTX-M-26) have kluGl gene K. georgina as their common progenitor 
[the variants of blacvx-u shown in parenthesis are selected examples of CTX-M-types in 
Enterobacteriaceae]. Possibly, the heterogeneity of blacrx-M genes among clinical 
enterobacterial isolates reflects that the gene have been captured from different sources 
within the genus Kluyvera by multiple events (Barlow et al., 2008). Li & Li (2005) 
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reported five novel CTX-M-type ESBLs with one to three CTX-M-14 point mutations. 
These isolates were designated as CTX-M-42 (136 G^A) , CTX-M-43 (92 G->A), CTX-
M-44 (136 G-^A, 151 G^C) , CTX-M-45 (151 G-^C). and CTX-M-46 (92 G-^A; 102 
G-^A; 151 G^C) . 
The determination of whether a specific ESBL is present in a clinical isolate is related to 
TEM and SHV enzymes is a compUcated process because point mutations around the 
active sites of the TEM and SHV sequences have led to amino acid changes that increase 
the spectrum of activity of the parent enz>Tnes- such as TEM-1, TEM-2, and SHV-1 
(Bradford, 2001). The molecular methods that are commonly used include PCR 
amplification of gene with oligonucleotide primers, followed by sequencing. DNA 
sequencing is essential to discriminate between the non-ESBL parent enzymes (e.g. 
TEM-1, TEM-2, or SHV-1) and different variants of TEM or SHV ESBLs. Several other 
molecular methods where there is no use of sequeiKing have been developed to 
characterize ESBLs and include PCR with RFLPs (.\rlet et al., 1995), PCR with single 
strand conformational poKmorphism (M'Zali et al.. 1996). ligase chain reaction (Kim & 
Lee, 2000), restriction site insertion PCR (Chanawong ei al.. 2(X)1), and real time PCR 
(Randegger & HachJer. 2001). Hov^ever. the increasing number of additional subtypes 
within each ESBL family has placed strict limitations on these techniques wdth regard to 
their ability to cover the whole range of variants with different point mutations. PCR 
amplification followed by nucleotide sequencing remains the gold standard for the 
identification of specific point mutation of blajEu or blasnv ESBL genes (Fluit et al., 
2001). However, this is not always straightforward and cost effective because clinical 
isolates often have multiple copies of ESBL genes. Genetic methods for detection of 
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TEM and SHV types of ESBLs are thus complex and challenging because of the diversity 
of different point mutations. The lase of genetic methods to identify the different types of 
TEM and SHV ESBLs is mainly restricted to reference laboratories and to molecular 
surveillance studies. Hopefiilly, recent molecular developments, such as microarrays and 
rapid-cycle sequencing, v i^ll make genotypic detection more readily available and cost 
effective for diagnostic laboratories to identify these types of ESBLs in a real-time 
fashion (Surnis^ord e( al., 2004). Several recent studies have described various molecular 
approaches for the rapid screening of ESBL-positive organisms for the presence of 
different blocrx-si genes, for e.g. PCR assays that use four sets of primers to amplify 
group-specific CTX-M ^-lactamases (Pitout et al., 2004), amplification of a universal 
DNA fragment specific for most of the different groups of CTX-M P-lactamases 
(Batchelor et al., 2005). duplex PCR (Pitout et al., 2007), multiplex PCR (Woodford et 
al.. 2006). real-time PCR (Birkett et al., 2007), pyrosequencing (Naas et al., 2007), and 
re\erse-line hybridization (Ensor et al., 2007). Molecular techniques imdoubtedly have 
the potential to play an essential part in the laboratory setting for the screening, tracking, 
and monitoring of the spread of large niraibers of organisms producing CTX-M enzymes 
fro— communit> and hospital settings in real time (Pitout & Laupland, 2008). 
.Although a number of genetic mechanisms have apparently been involved in the 
assimilation of blaax-M genes, insertion sequences (ISEcpJ, IS26 and ISCRl) in 
association with class 1 structures have played a prominent role in dissemination of these 
genes. New CTX-M variants possessing an extended substrate spectrum can result from 
convergent evolution vkathin each blocrx-M subgroup. Recently, two genes identical with 
6/acTx-M-3 and 6/acTx-M-i4 were detected in the chromosome from a K ascobata strain 
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from Argentina and from a K. georgina isolated in Guyana, respectively (Rodriguez et 
al., 2004; Olson et al., 2005). 
2.9.2.1 Dissemination of Wacrx-ivi genes 
Spread of blacrx-M is facilitated by three major strategies: (a) clonal dissemination of the 
bacterial strain that acquired resistance gene (b) spread of a particular plasmid and or 
transposon between a variety of different strains, and (c) translocation of resistance genes 
between different mobile genetic elements. Plasmid-mediated /^OCTX-M-IS was supposed 
to be originated from fe/acTx-M-3 vvhich spread in Poland recently. The Polish 6/acTx-M-3 
gene, however, is located at different distance fi-om ISEcpI than blacT\-M-\s in isolates 
from UK, France, Turkey, Canada, and India (Livermore et al., 2007). Furthermore, it 
remains unclear why CTX-M group-9 eniymes (CTX-M-14, CTX-M-16, CTX-M-19, 
and CTX-M-27) are predominant in Spain and Group 1 enzymes (CTX-M-1, CTX-M-3, 
and CTX-M-15) in most of other parts of Europe (Livermore et al., 2007). 
*/acTX-M-i and blocrrx-M-is were found to be associated with plasmid of different 
incompatibility groups (InsN, Incll, IncFII). The analysis of their genetic environment 
indicated the integration of an IS26/CTX-M element into different plasmids. Because of 
their similar genetic neighborhood either hot spots for IS integration or exchange of a 
particular larger blacrx-u containing module can be supposed (Cullik et al., 2010). 
Different elements may be involved in the mobilization and expression ofblacTx-M genes. 
In clinical isolates, CTX-M encoding genes have been found on a number of plasmids; 
some of them are part of transposons or constitute cassettes in integron (Bonnet, 2004). 
Insertion sequences, especially ISEcpl, have repeatedly been found adjacent to genes 
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encoding some of these enzymes. Insertion sequence such as IS26 and IS903 have also 
been found flanking the open reading frame region of the bhcrx-M genes (Cao et ai, 
2002; Saladin et al., 2002). CTX-M-9-encoding genes have been recently characterized 
as a part of a novel complex Sul-1-tyipQ integron designated In60, including the bla gene 
and its downstream nucleotide sequence (Sabate et al.. 2002). ^/OCTX-M-: and the 
surrounding DNA, which includes ORF575, have been reported in the complex Sul-]-
type integrons, designated InS27 and IniJ (Di Conza et al., 2002; Arduino et ai. 2002; 
Power et al., 2005). 
ISEcp] insertion sequences have been observed 42-127 bp upstream of the ORFs 
encoding the CTX-M enzymes. All variants of the CTX-M-1 cluster were characterized 
by a 48 bp region (W sequence) upstream of the bla gene. Different additional fragments 
(V or X sequence) were also noticed by Eckert et al. (2006) in some of the isolates. The 
blacTx-M-i5 containing isolates were characterized by the presence of the W sequences, 
and the blacjx-M-3 carrying isolates were characterized by the presence of V sequence. 
Sequencing analysis of the downstream DNA of the blacTx-\i-9 gene from E. coli TN05 
revealed the presence of ORFiiP from the chromosome of K. georgina as recently as 
recently described (Olson et al., 2005). 
ISEcpl element contained typical -35 and -10 putative promoter region could mobilize 
such genes (Cao et al., 2002; Poirel et al., 2003; Poirel et al., 2005). Interestingly, this IS 
element was found to be disrupted by another insertion sequence, IS7, or IS70. A similar 
organization was reported for blacrx-u-is with an insertion sequence (\S50) disrupting 
ISEcpl (Munday et al., 2004). It is interesting to note that ISIO was identified upstream 
of the blacrx-MS (Accession number, AF189721) and may play role in mobilization and 
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hence in the dissemination of bla genes. Another insertion sequence, IS2(5, was noticed 
upstream oibla genes and was found disrupting ISEcpJ. This organization (1826 and end 
of ISEcpl) was also found in its entirety upstream of the bla genes encoding ft/oACC-i and 
upstream of some CTX-M P-lactamase [Accession number, AY462238] (Olson et al., 
2005; Saladin et al., 2002: Eckert et ai, 2004: Nadjar et al.. 2000). 
blacTx-M-2 and fe/acTX-M-9 were reported to be inserted in novel complex class 1 integrons 
lnS21, IniJ, lnll6, and In60 (Munday et al.. 20O4: Sabate et al.. 2002: Di Conza et al., 
2002; Arduino et al., 2002; Power et al., 2005). This unusual integron contains a partial 
duplication of the 3'conserved segment, and a region that includes /^OCTX-M and the 
ORF5J3 between both 3'conserved segment. In addition, integrons bearing blacTx-M-2 
have resistance cassettes including aac(6')-lb-oxa-2orfD [IniJ, ln52/, and lnI16] (Di 
Conza et al., 2002; Arduino et al., 2002; Power et al.. 2005). Among the ESBLs, the 
cefotaximases (CTX-M) constitute a rapidly growing group of enzymes. Analysis of the 
promoter regions in organisms producing plasmid-mediated p-Iactamases revealed 
mobile insertion sequences such as 1S26, IS903. and ISEcpl. These elements could play 
an important role in the spread of such ESBLs as has been demonstrated for ISEcpl (Cao 
et al., 2002; Poirel et al.. 2003). CTX-M ^lacumases ha\e been mobilized from 
Kluyvera chromosomes in the form of composite transposons by the IS/i<^0-Iike element 
ISEcpl (Chandler & Mahillon, 2002). Unusually, however, these composite elements 
contain only one copy of ISEcpl as a terminal sequence, which provides transposition 
function and the IR sequence at one end of transposed sequence. The other terminal IR 
sequence needed for transposition originates not from a second copy of ISEcpl, but from 
a sequence that is foimd fortuitously on the Kluyvera chromosome, close to the blacix-M 
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gene, where it is mistaken for an ISEcpllR sequence by the transposase (Poirel et al., 
2003). These insertion sequences ensure the transfer of the resistance genes from the 
bacterial chromosome to the plasmids. Other mobile genetic elements, for e.g. integrons 
may be implicated in the transfer of these genes. Integrons are very sophisticated site-
specific recombination s> stems that capture various gene cassettes, between their 5'and 
3"Conserved Segments. Thus ISEcpl and integrons can be considered as efficient tools 
for mobilization and expression of P-lactamases. A recent study demonstrated the 
presence of a phage-related sequence immediately upstream of WOCTX-M-IO in several 
CTX-M-10-producing isolates (01i\er et al.. 2005), suggesting that bacteriophage might 
be involved in an acquisition of blacrx-M-w- It has been proposed that the associated 
\SCR1 element was involved in sequestering this particular section of chromosomal DNA 
ofK. ascorbata or a near relative into a plasmid carried by the host cell (Humeniuk et al., 
2002). Similar organization was found in an isolate of Salmonella enterica serovar 
Infantis harboring blacTx-\A-2 gene. blacTx-M-2 gene was found on 73 kb plasmid along 
with 266 bp of Kluyxera DNA upstream of the ^-lactamase gene and adjacent to a copy 
of ISC/?/ in a complex class 1 integron (Di Conza et al., 2002). The association of blocrx-
S1-: and ISCR] has been demonstraied in ten different Gram-negative pathogens including 
Acinetobacter spp.. Emerobocier cloacae. E. coli, P. mirabilis, Pseudomonas 
aeruginosa. Salmonella spp., and Serratia mercescens, K. pneumoniae, M. morganii. In 
addition blocrx-M-i in association of ISCRl has also been reported in Gram-positive 
isolates including Enterococcus faecium and serogroup G Streptococcus agalactiae. In 
Europe, blacxx-u-9 was most frequently reported to be associated with \SCR1 element. 
blacrx-M^ with respect to genetic context was analyzed in an £. coli isolate from Spain in 
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1996 (Sabate et al., 2000). The blacTX-M-9 gene and its downstream sequence share 81% 
md 78% identity respectively with WAKLUA-I P-lactamase gene and an adjacent sequence, 
orf3, from the chromosome ofK. ascorbata (Sabate et al., 2002). Moreover, the blacjx-w-
) allele was observed next to a copy of ISC^7, which together comprise part of a complex 
:la&s 1 integron, ln60. The isolates harboring bIacTx-M-9 were also isolated from Paris and 
Southwestern France, in the former location MOCTK-MS was found to be mostly associated 
*\ith the insertion sequence ISEcpl rather than ISCRJ, although evidence of ISCRl 
icti\ ity in the form of short ISCRJ terminal sequence was identified upstream of blocrx-
kj.9. Further analysis should elucidate whether these short sequences reflect intact copies 
jf ISC^7 or simply fiugments. Z)/acTX-M-9-harboring isolates from Southwest France were 
solated from both humans and poultry sources, suggesting an animal reservoir of ISCRl 
ind blocTx-si allele. 
In nutshell, resistant bacteria are emerging worldwide as a threat to favorable outcome of 
:ommon infections in hospital and community. P-lactamase production by Gram-negative 
especially members of Enterobacteriaceae) and some Gram-positive organisms is 
perhaps most important resistant mechanism however other mechanisms include porin 
OSS. AmpC p-lactamase production or carbapenemase production are also markedly 
ncreasing. AmpC-type resistance in the hospital setting is not primarily due to the 
lissemination of clonal strains or the spread of resistant plasmids but is due to the 
emergence of resistant strains in patients, possibly through antimicrobial selective 
)ressure. 
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3. MATERIAL AND METHODS 
3.1 Materials 
Culture Media 
Nutrient Agar (Hi-Media, Pvt. Ltd, Mumbai. India) 
Mueller-Hinton Agar (Hi-Media, Pvt. Ltd, Mumbai. Indial 
Luria Bertani Broth (Hi-Media, Pvt. Ltd, Mumbai, India) 
Peptone Water (Hi-Media, Pvt. Ltd, Mumbai, India) 
Mc Farland Standard 
BaCb (SRL, India) 
H2SO4 (SRL, India) 
Antibiotics 
Antibiotics discs used are listed below and the concentration is given 
in parenthesis. All the antibiotics discs were purchased from Hi-
Media, Pvt. Ltd, Mumbai, India. 
Cefoxitin 
Ceftriaxone 
Cefoperazone 
Cefixime 
Ceftazidime 
Cefepime 
Cefpirome 
Gentamicin 
Amikacin 
Ofloxacin 
Gatifloxacin 
Aztreonam 
Imipenem 
(30^g) 
OO i^g) 
(75Hg) 
(30^g) 
(30^g) 
(30^g) 
(30^g) 
(lO i^g) 
(lO^g) 
(5^g) 
(5^g) 
(30^g) 
(lO^g) 
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PCR reagents 
2X premixed Master Mixture 
[Consist of 0.05 u/^L Tag DNA 
Pol>Tnerase, reaction buffer, 4mM 
MgCh, 0.4 mM of each dNTP (dATP. 
dCTP, dGTP. and dTTP] 
DNase/RNase free water 
0.2 mL thin walled propylene tubes 
(Fermentas Life sciences. USA) 
(Permentas Life sciences. USAi 
(Bangalore Genei, India) 
Plasmid Isolation 
All the chemicals were purchased from SRL, India. >i-DN.A double 
digested with EcoRI and Hindlll was procured from Fermentas Life 
sciences (USA) and Ethanol from E. Merck (India). 
STE (Saline + TE Buffer): 
NaCl 
Tris-Cl 
EDTA 
Sol I (pH 8.0): It can be prepared in batches of approximately lOOmL. 
autoclaved and stored at 4°C 
Glucose 
Tris-Cl 
EDTA 
Sol II: 
NaCl 
SDS 
Sol III: 
Potassium acetate 
Glacial acetic acid 
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Saturated phenol: 
Crystalline phenol 
Hydroxyqu incline 
Chloroform:isoamyl alcohol (24:1) 
Ethanol 
>.-DNA double digested with EcoRI and Hindlll 
Agarose Gel Electrophoresis 
Agarose (Low EEO) 
Ethidium Bromide 
(Bangalore Genei, India) 
(Bangalore Genei, India) 
IX TAE Buffer: Chemicals were purchased from SRL, India. 
[4.85 gm/L Tris-CI. 0.35 gm/L EDTA. 
1.14 mL/L Glacial acetic acid, pH 7.9] 
6X Tri-Gel loading dye 
High Range DNA ruler 
O'Range Ruler 100 
bp + 500 bp DNA Ladder 
(Bangalore Genei, India) 
(Bangalore Genei, India) 
(Fermentas Life sciences, USA) 
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3.2 Methods 
3.2.1 Clinical sample collection ''N^^'fmljn***!^ 
A total of 14, 129 samples were subjected to department of microbiology, J. N. Medical 
College, Aligarh Muslim University, Aligarh, for routine culture and susceptibility testing 
in a period of 18 months (January 2009 to June 2010). Of these Gram-negative organisms 
among which 1610 isolates were identified as E. coli and 455 as K. pneumoniae by 
standard microbiological techniques (Collee et al., 1996; Holmes & Aucken, 1998). A 
total of 109 E. coli and 16 A^. pneumoniae (that were found resistant to cefoxitin) were 
randomly selected in order to illustrate the prevalence of AmpC p-lactamases and for 
detailed genotypic characterization. Demographic details of the patients were also noted. 
All these cefoxitin-resistant isolates were obtained from pus, urine, drain, semen, cervical 
swabs, CSF, naso-pharyngeal aspirate, vault, and abdominal fluid. 
3.2.2 Antimicrobial susceptibility testing 
3.2.2.1 Turbidity standard for inoculum preparation: To standardize the inoculum 
density for a susceptibility test, the BaS04 turbidity standard equivalent to 0.5 
McFarland standard was used (Andrews et al., 2004). A 0.5 mL aliquot of 
0.048 M BaCb (1.175% BaCl2.2H20) was added to 99 mL of 0.18 M 
H2SO4 ( 1 % v/v) with constant stirring. The correct density of the 0.5 
McFarland standard was verified by determination of absorbance at 625 
nm with a 1 cm path length and was found to be 0.08 to 0.10. The 
turbidity standard was stored in aliquots of 4-6 mL and can be stored for 
up to six months. 
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3.2.2.2 Disc diffusion susceptibility test: Antimicrobial susceptibility testing was 
performed and interpreted as per CLSI (formerly NCCLS) guidelines (CLSI, 2005). 
Briefly, disc diffusion susceptibility test was performed on Mueller Hinton (MH) Agar. 
Bacterial inoculum was prepared by mixing few colonies of the test strain in the test tube 
containing 1.5 mL of sterile nutrient broth. The density of suspension was standardized 
by dilution with sterile broth to a density visually equal to 0.5 McFarland units. It results 
in a suspension containing approximately 1.5x10* CFU/mL. NfH Agar plates were 
inoculated with a sterile cotton swab dipped in test inoculum, surplus of it was removed 
by rotating swab against the wall of test tube, then spreading on dried surface of MH 
Agar. This procedure of streaking on agar plate was repeated at least three times by 
rotating plate approximately 60° each time to ensure even distribution of inoculum. The 
antibiotics discs were applied with the help sterile forceps. The plates were inverted and 
placed in an incubator set at 37°C and were incubated overnight. The zone diameters were 
measured including the diameter of disc. Following antibiotics (all purchased from Hi-
Media, Pvt. Ltd, Mumbai, India) were tested; cefoxitin (30ng), ceftriaxone (30fig). 
cefoperazone (75ng), cefixime (30^g), ceftazidime (30ng), cefepime (30jig), cefpirome 
(30ng), gentamicin (lOjig), amikacin (lOfig), oflo-xacin (5fig), gatifloxacin (5fig). and 
aztreonam (30^g), Imipenem (lOjig). E. coli ATCC 25922 was used as a control strain. 
3.2 J Phenotypic detection of AmpC producers 
3.2J.1 Phenotypic confirmatory test: Modified Three dimensional extract test 
(MTDET), as described by Shahid et ah, (2004), was performed to identify AmpC 
producers. Briefly, 10-15 mg of bacterial wet weight was scraped from culture plate and 
suspended in 0.5mL of peptone water in a sterile micro-centrifiige tube and incubated at 
37°C for one hour. Crude enzyme extract was prepared by repeated freezing-thawing. To 
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ensure complete membrane lysis, the freezing-thawing may be carried out five times. 
Lawn culture of E. coli ATCC 25922 was prepared on MH Agar plate and was incubated 
at 37°C so that plate can dry properly. Cefoxitin discs (30fig) were placed on dried MH 
Agar plate. With a sterile scalpel a linear trench (3cm x 1mm) was prepared in agar at a 
distance of 5mm from edge of the disc in an outward radial direction. 50ul of enz>ine 
preparation was dispensed in trench and overfill was avoided. The inoculated media WBS 
incubated overnight at 37°C. Enhanced growth of the surface organism at the point where 
trench intersected the zone of inhibition towards the cefoxitin disc was interpreted as 
evidence for the presence of AmpC P-lactamase. 
3.2.4 Genotypic characterization of cefoxitin-resistant isolates 
3.2.4.1 DNA template preparation: Bacterial isolates were cultured on Nutrient Agar 
plates and were incubated overnight at 37 °C. Template DNA was prepared from freshly 
cultured bacterial strains by scraping 2-3 colonies and suspending them in 50 (J.L of 
molecular grade water. The bacterial suspension was then heated at 95 °C for 5 rain, and 
then immediately cooled to 4 °C. 
3.2.4.1.1 Detection of bla^mpc genes: bla^pc genes were detected by PCR. as described 
by Feria e/ al. (2002) with some modifications. Briefly, the gene of interest %^25 amplitled 
in a total reaction volume of 25 jil containing 0.05 \i\ each of primer ampC-f and ampC-r. 
12.5 |j.L master mixture, 9.9 jiL DNase/RNase free distil water. 2.5 \iL of template DNA 
was added to 22.5 ^L of master mixture. The reaction mixture was placed in MJ-mini 
Bio-Rad thermal cycler (Bio-Rad, USA). The PCR amplification cycle was performed 
with cycling conditions consisting of an initial denaturation step at 95 °C for 15 min, 
followed by 35 cycles consisting of final denaturation step at 94°C for 60 sec, annealing 
at 58°C for 2 min, extension at 72°C for 3 min, and the process was completed with final 
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elongation step at 72°C for 10 min. Sequence of ampC-f and ampC-r primers is shown in 
Table 1. 
3.2.4.1.2 Detection of plasmid-mediated AmpC p-lactamases: All isolates were tested 
by multiplex PCR for detection of family-specific plasmid-mediated AmpC p-lactamase 
genes by using method as described by Perez-Perez & Hanson (2002). Reaction mixture 
was prepared by mixing 12.5 |iL master mixture. 7.44 ^JL DNasc/RNase free distil water, 
0.24 nL each of forward &. reverse MOX. CFT. and DRA primers, 0.20 ^L each of ACC 
and EBC forward & reverse primers and 0.16 |J_ each of forward & reverse FOX primer. 
2.5 )iL of template DNA was added to 22.5 fiL of master mixture. Samples were placed in 
MJ -mini Bio-Rad thermal cycler (Bio-Rad, USA). PCR was earned out with an initial 
denaturation step at 94°C for 3 min, followed by 30 cycles consisting of final denaturation 
step at 94°C for 30 sec, annealing at 64°C for 30 sec. extension at 72°C for 1 min. PCR 
was completed with final elongation at 72°C for 10 min. Sequences of the primers used in 
AmpC multiplex PCR are shown in Table 1. 
3.2.4.U Characterization of specific AmpC type: Representative isolates were 
selected for DNA sequencing so as to define presence of specific AmpC type. The primer 
CIT-F (5'-TGG CCA G.AA CTG ACA GGC AAA-3> and EBC-F (5-TCG GTA -AAG 
CCG ATG TTG CGG-3'). as used in muhiplex PCR protocol, was used as primers for 
sequencing of CIT and EBC amplicons respectively. The cycling conditions for 
amplifying CIT and EBC amplicon consist of an initial denaturation step at 95°C for 3 
min, followed by 30 cycles consisting of final denaturation at 95°C for 60 sec, annealing 
at 55°C for 60 sec, and extension at 72°C for 60 sec, and a final elongation at 72°C for 5 
min. 
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CIT amplicons were also amplified by using primer ISEcpJ PROM+ as forward primer in 
order to obtain whole ORF of blacn. Reaction mixture for PCR comprise of a total 
reaction volume of 25 1^ containing 0.05 1^ each of primers ISEcpl PROM+ and CIT-R, 
12.5 ]iL master mixture, 9.9 ^L DNase/RNase free distil water. 2.5 ^L of template DNA 
was added to 22.5 fxL of the master mixture. The cycling conditions consist of an initial 
denaturation step at 95°C for 5 min, followed by 39 cycles of 95°C for 60 sec, 58°C for 60 
sec, and 72°C for 60 sec, and a final elongation at 72°C for 10 min. Sequencing primers 
are shown in Table 1. 
Sequencing was performed by the courtesy of Chromous Biotech, Ltd, Bangalore, India. 
Analysis of sequenced PCR amplicons was done by comparing sequence to the GenBank 
database of the National Centre for Biotechnology Information BLAST network. 
3.2.4.2 Analysis of co-carriage of class C and Class A ^-lactamase: 
3.2.4.2.1 Detection of WacTx-M5 WOTEM* and blasay: The isolates of this study were also 
screened for the presence of Class A ESBLs , more specifically, blacrx-u, blajEM, and 
6/asHv by the PCR protocol as described previously (Shahid, 2010). Briefly, PCR 
Reaction mixture was prepared by mixing 12.5 ^L master mixture, 9.9 fxL DNase/RNase 
free distil water, 0.05 ^L each of forward and reverse primer. 2.5 fiL of template DNA 
was added to 22.5 pL of master mixture. PCR cycling conditions consist of initial 
denaturation at 94*'C for 7 min, followed by 35 cycles consist of 94°C for 50 sec, 50°C 
for 40 sec. and 72°C for 2 min. and a final elongation at 72°C for 5 min. An amplicon of 
593bp was obtained indicating the presence of 6/acTX-M-
bloTEM, and blasuv were detected by using the protocol as used in previous studies from 
our laboratory (Shahid, 2010). The cycling condition for detection of both genes were 
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same, comprising with an initial denaturation step at 95°C for 15 min; followed by 35 
cycles comprised of final denaturation at 94°C for 1 min., annealing at 58°C for 2 min., 
extension at 72°C for 2 min. and final elongation at 72°C for lOmin. The amplified DNA 
of 936bp and 930bp were obtained for WofEM and blasnv respectively. Details of primers 
used in detection ofblocrx-M, blojEM, and A/OSHV are given in Table 1. 
3.2.4.3 Characterization of mobile elements 
3J.4J.1 Detection of Insertion sequences 
3.2.4J.1.1 Detection of ISEcpl: All 125 isolates (109 E. coli and 16 K. pneumoniae) 
were characterized for insertion sequence ISEcpI which is known to mobilize mainly 
blocTx-M genes and recently it has been reported associated with various AmpC types also 
(Jacoby, 2009). The forward primer used was ISEcplUl while reverse primer was P2D. 
Reaction mixture was prepared by mixing 0.05 jil each of primers ISEcplUl & P2D, 12.5 
^L master mixture, 9.9 |iL DNase/RNase free distil water. 22.5 \iL of the master mixture 
was aliquoted in PCR tubes and 2.5 ptL of template DNA was added to it. Amplified 
product of ~1100 bp was obtained when PCR product was electrophoresed on 2% agarose 
gel. PCR cycling conditions for amplification of ISEcpl consist of an initial denaturation 
step at 95 "C for 3 min, followed by 30 cycles comprised of final denaturation step at 
QST for 60 sec, annealing at 55°C for 60 sec. & extension at 72°C for I min. and the 
process was completed by a final elongation step at 72°C for 10 min. Sequences of 
primers used in the PCR reaction is shown in Table 1. 
3.2.4.3.1.2 Detection of IS26: All test isolates were then looked for another insertion 
sequence IS2<5 as diversity and its insertion in tnpA and ISEcpl gene have been reported 
previously (Ensor et al., 2006). To determine association of IS26 with bla^pc, PCR was 
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performed with primer set consist of IS26-F and SHA as forward and reverse primer 
respectively. PCR reaction mixture was prepared in a total volume of 25 jiL (0.05 ^l each 
of primers IS26-F and SHA, 12.5 jiL master mixture, 9.9 ^L DNase/RNase free distil 
water. 22.5 |iL of the master mixture and 2.5 |iL of template DNA was added to it), 
dispensed in PCR tube and placed in MJ-mini Bio-Rad thermal cycler (Bio-Rad. US.A). 
PCR cycling condition for amplification of IS26 comprise of an initial denaturation step 
at 94°C for 5 min., followed by 35 cycles consisting of final denaturation step at 94 "C for 
25 sec, elongation at 52 °C for 40 sec, extensicw) at 72 °C for 50 sec, and process was 
completed by a a final elongation step at 72 °C for 6 min. Amplified products of different 
molecular weight were observed. Primers Sequences used in the PCR reaction are shown 
in Table 1. 
3.2.4 J.2 Characterization of integrons: cefoxitin-resistant E. coli and K. pneumoniae 
isolates were also looked for the presence of integrons in order to illustrate the location of 
antibiotic resistance genes (especially Woampc)- Presence of integrons was demonstrated 
by PCR amplification, using primer set 5CS-FI and 3CS-R as forward and reverse 
primers respectively. PCR reaction mixture was prepared in a total volume of 25 jiL 
comprising of 0.05 \i\ each of primers 5CS-F1 and 3CS-R, 12.5 jiL master mixture. 9.9 
|j.L DNase/RNase free distil water and 2.5 ^L of template DNA. The reaction mixture so 
prepared was dispensed in PCR tube and placed in MJ-mini Bio-Rad thermal cycler (Bio-
Rad, USA). PCR cycling conditions consist of an initial denaturation step at 95°C for 3 
min., followed by 30 cycles of 95 °C for 1 min, 58 °C for 1 min, 72 °C for 2 min, and a 
fmal elongation step at 72 °C for 10 min. Sequences of the primers used are shown in 
Table 1. Amplified products were obtained at various positions corresponding to different 
molecular weights. 
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3.2.4.3.2.1 Detection of ^uZ-l-type class-1 integrons: Sul-\-typc class 1 integrons were 
detected in bacterial isolates by using primers Sul 1A and Sul IB as forward and reverse 
primers, respectively. Reaction mixture for PCR comprised of 0.05 |il each of forward 
and reverse primer, 12.5 |iL master mixture, 9.9 pL DNase/RNase free distil water and 
2.5 |iL of template DNA. An amplified product of 420 bp indicates presence of 5w/-I 
gene in the test isolate. Cycling conditions comprises of an initial denaturation step at 95 
°C for 3 min., followed by 30 cycles of 95 °C for 1 min. 63 °C for 1 min. and 72 "C for 2 
min.. and a final elongation step at 72 °C for 10 min. Details of Ae primers used are 
shown in Table 1. 
3.2.4J.2.2 Detection of ISCSl (ORFJii): ISCRl, which was previously knowTi as 
ORF5/3, was detected in a collection of test isolates by PCR protocol as described 
previously (Shahid, 2010) using ORF513 D3 and ORF513 D5 as forward and reverse 
primers. PCR was performed in a total reaction volume of 25 jil containing 0.05 pi each 
of forward and reverse primer, 12.5 nL master mixture, 9.9 jiL DNase/RNase fiiee distil 
water. 2.5 \iL of template DNA was added to 22.5 \iL of master mixture. The reaction 
mixture was placed in MJ-mini Bio-Rad thermal cycler (Bio-Rad. US.A). PCR cycling 
conditions were as follows: initial denaturation at 95 'XT for 3 min„ folioued by 35 cycles 
of 95 T for 1 min, 58 °C for 1 min, 72 T for 2 min. and fmal elongation at 72 '^ for 10 
min. An amplified product of 600bp demonstrates the presence of ORF5/i. Sequences of 
the primers used in the protocol are shown in Table 1. 
3.2.5 Visuaiization of amplified PCR product: 
PCR products were separated by electrophoresis for 2-3 h at 75 V using 1X TAE running 
buffer (4.85 gm/L Tris-Cl, 0.35 gm/L EDTA, 1.14 ml/L Glacial acetic acid. 
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pH 7.9). After electrophoresis DNA fragments were visualized and photographed by 
Bio-Rad Gel documentation system (Bio-Rad. USA). 
3.2.6 Typing of cefoxitin-resistant isolates by RAPD-PCR: 
3.2.6.1 RAPD typing: Epidemiological typing of cefoxitin-resistant isolates was done, as 
described previously (Shahid. 2010). so as to determine whether any specific clone is 
circulating in the hospital environment or to find out any relatedness/diversity in 6/aampc 
carrving isolates. Briefly, bacterial isolates were grown on Nutrient agar plate and 
incubated for overnight at 37 °C. Template DNA was prepared by suspending 3-5 
colonies in 50 ^L molecular grade water and heating it to 95 "C for 5 min. and then 
immediate cooling to 4 °C. 25 pmol of primer ERIC-2b (5'-AAG TAA GTG ACT GGG 
GTG AGC G-3') was used. Reaction mixture was prepared by mixing 12.5 |iL of master 
mix, 10.25 \iL of distilled water. 025 jiL of primer and 2.0 \iL of template DNA. The 
PCR amplification was attained b> placing reaction mixture containing tubes in MJ-mini 
Bio-Rad thermal c>cJer (Bio-Rad. USA). PCR cycling conditions consist of an initial 
denaturation step at 94°C for 2 min., followed b> 35 cycles of 94 °C for 1 min, 25 °C for 1 
min, 72 °C for 4 min. and a final elongation step at 72 °C for 8 min. The results were 
anahzed by using Bio-Rad Gel documentation s>stem (Bio-Rad, USA) and clustering 
was performed b> Quantity One software provided by gel documentation system. Isolates 
of same species were t>'ped in same batch and isolates of different wards were compared 
together to identify clonal spread. 
3.2.7 Plasmid analysis: 
Plasmid isolation was done in all test isolates by large scale alkaline lysis method, with 
some modifications as described previously (Shahid et al., 2003). Briefly, the bacterial 
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isolates were inoculated in 250 mL of Luria-Bertani Broth and incubated at 37°C for 18 
hours. 2 mL of the culture was transferred into microfiige tube and was centrifuged at 
10,000 rpm for 5 minutes at 4°C. Bacterial cell pellet was dissolved in 0.5 mL of STE 
(sucrose + TE buffer) buffer, in order to remove the cell-wall components of bacteria that 
may be present in medium, and were re-centrifiiged at 10,000 rpm for 5 minutes at 4°C. 
Supernatant was discarded and the pellet was dissolved in 200 ^L of ice-cold solution I 
(50mM glucose, 25mM Tris-CI, and lOmM EDTA) and contents were mixed by vigorous 
vortexing. 400 ^L of freshly prepared solution II (0.2N NaOH and 1% SDS) was then 
added. The tubes were stored on ice. Then 300 fiL of ice-cold solution III (5M potassium 
acetate, glacial acetic acid, and distilled water) was added and the tubes were stored on 
ice for 10 minutes. Contents were centrifuged at 10,000 rpm for 5 minutes at A'C. 
Supernatant will contain most of plasmid with RNA and protein as contaminant. 
Supernatant was transferred to a sterilized fresh tube and pellet was discarded. Equal 
volume of phenolxhloroform was added and the content were mixed by vortexing. The 
microfijge tubes were centrifuged at 10,000 rpm for 2 minutes at 4°C to separate aqueous 
and organic phases. Aqueous phase was removed and transferred to a fresh tube and 
pellet was discarded. Double-stranded DNA was precipitated by adding 2 volumes of pre-
chilled ethanol, and then centrifuged at 10,000 rpm for 5 minutes at 4°C to pellet DNA. 
Supernatant wjis discarded and the tubes were inverted on paper towel so as to allow the 
fluid to drain away. The pellet of nucleic acid was dissolved in 40 ^L of autoclaved 
double-distilled water. 10 jiL of plasmid samples were electrophoresed in 0.8% agarose 
gel containing ethidium bromide. X DNA double-digested with EcoRI and Hindlll 
(Bangalore Genei, India) was used as molecular weight marker. 
86 
JfLl*^^ I H**- J-L • 
Centrifuge 2 mL of bacterial culture at 10,000 rpm for 5 min at 4°C 
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Fig. 4 Schematic diagram of plasmid isolation. 
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4. RESULTS 
4.1 Bacterial isolates: A total of 14, 129 samples that were subjected to department of 
microbiology, J. N. Medical College, for routine culture and susceptibilit> testing during 
a period of 18 months and out of these. 1610 isolates were E. coli and 455 were K. 
pneumoniae as identified by standard microbiological techniques (Colke et al^ 1996: 
Holmes & Aucken, 1998). A total of 109 £. coli and 16 K. pneumoniae (tiiat were found 
resistant to cefoxitin) were randomly selected in order to illustrate the prevalence of 
AmpC p-lactamases and for detailed genotypic characterization. 
4.2 Patients' Demography: Maximum number of cefoxitin-resistant isolates was 
obtained from the patients of age group 20-29 years (38.40%) followed by 30-39 years 
(19.20%), while least (only single patient) was obtained from age group 70-79 \ears 
(0.8%). Male: female ratio was 1.08:1. Table 4 shows the detailed demographic 
information. 
Table 4: Age and gender distribution of the patients from which cefoxitin-
resistant isolates were otrtained 
Age Gender 
Range Male(%) Female (%) Total (%) 
0-9 yrs 
10-19 yrs 
20-29 yrs 
30-39 yrs 
40-49 yrs 
50-59 yrs 
60-69 yrs 
70-79 yrs 
6 (4.80) 
7 (5.60) 
18(14.40) 
16(12.80) 
6 (4.80) 
4 (3.20) 
7 (5.60) 
1 (0.8) 
5(4) 
4 (3.20) 
30 (24) 
8 (6.40) 
4 (3.20) 
6 (4.80) 
3 (2.40) 
-
11 (8.80) 
11 (8.80) 
48 (38.40) 
24(19.20) 
10(8) 
10(8) 
10(8) 
1 (0.8) 
Patients 65 (52) 60 (48) 125 (100) 
89 
lifsults 
4.3 Sample and wards from where cefoxitin-resistant isolates were obtained: In the 
isolates obtained from surgery ward, maximum were isolated from pus samples (35/56; 
62.50%), followed by urine (12/56; 21.43%) and then drain sample (7/56; 12.50%) while 
least were obtained from abdominal fluid, fri contrast to this, largest fraction of isolates 
was obtained from urine (21/30; 70%) in the isolates obtained from gynecology ward. It 
was followed by pus sample (4/30; 13.33%), then cervical swab (3/30; 10%). One isolate 
each was obtained from vault and semen samples respectively. All the 22 isolates 
obtained from orthopedics ward were from pus sample. h\ the isolates obtained from 
medicine ward, six out of thirteen (46.15%) isolates were obtained from urine, four 
(30.77%) from pus, two (15.38%) from semen and one (7.69%) was isolated from CSF 
sample. In a total of 125 isolates, maximum were isolated from pus sample (66/125; 
52.80%) followed by urine (40/125; 32%) and then drain (7/125; 5.60%). Details are 
shown in Table 5. 
Table 5: Sample and ward from where cefoxitin-resistant E. coli and K. pneumoniae 
were obtained 
Ward 
Surgery 
Gynecology 
Orthopedics 
Medicine 
Pediatrics 
TOTAL 
Pus 
35 
(28%) 
4 
(3.20%) 
22 
(17.60%) 
4 
(3.20%) 
1 
(0.80%) 
66 
(52.80%) 
Urine 
12 
(9.60%) 
21 
(16.80%) 
-
6 
(4.80%) 
1 
(0.80%) 
40 
(32%) 
Drain 
7 
(5.60%) 
-
-
-
-
7 
(5.60%) 
Semen 
-
1 
(0.80%) 
-
2 
(1.60%) 
-
3 
(2.40%) 
Cervical 
swab 
-
3 
(2.40%) 
-
-
-
3 
(2.40%) 
CSF 
-
-
-
1 
(0.80%) 
-
1 
(0.80%) 
Naso-
pharyngeal 
aspirate 
-
-
-
-
2 
(1.60%) 
2 
(1.60%) 
Vault 
-
1 
(0.80%) 
-
-
-
1 
(0.80%) 
Abdominal 
fluid 
2 
(1.60%) 
-
-
-
-
2 
(1.60%) 
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4.4 Antimicrobial susceptibility testing 
4.4.1 Antibiotic resistance pattern: The 125 (109 E. coli and \6 K. pneumoniae) 
cefoxitin-resistant isolates were also found resistant to any of the third-generation 
cephalosporin. When analyzed for individual antimicrobial agent, maximum resistance 
was observed for cefotaxime (94.40%) followed by ceftriaxone (93%) and then cefixime 
(88.07%). Resistance to ceftazidime was noticed in 80.80% isolates and to that of 
cefoperazone was observed in 84.62% isolates. Resistance against aztreonam was noted 
in 92.63% isolates. Among fourth-generation cephalosporins, resistance against cefepime 
was noted in 64% isolates while resistance to cefpirome was observed in 79.61% isolates. 
Resistance to aminoglycosides was also analyzed and it was found considerably low 
(resistance to amikacin in 38.33% isolates and to gentamicin in 55.74% isolates) in our 
study isolates. Furthermore, it was observed that resistance to fluoroquinolones is high as 
resistance against gatifloxacin was noted in 85.45%, and 89.47% isolates were observed 
resistant to ofloxacin. Details are shown in Fig. 5. 
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Fig. 5: Antibiotic resistance rates of the E. coli and K. pneumoniae isolates studied. 
4.4.2 Antibiotic resistance rates and pattern from different wards: All the isolates 
were found resistant to cefoxitin. Moreover, when the resistance rate was analyzed for 
cephalosporins, aminoglycoside and fluoroquinolones then it was found that in isolates 
obtained from gynaecology ward, maximum resistance was observed for cefotaxime 
(95.45%) followed by cefixime (88.46%) and then ceftriaxone (87.50%). Resistance to 
aztreonam was found to be 84.21 %, however resistance to aminoglycoside was noted 
comparatively low (amikacin, 33.34%; gentamicin, 60%). Resistance pattern of isolates 
obtained from surgery ward was found to be somewhat different from that of 
gynaecology ward, where maximum resistance was observed for cefotaxime (95.45%) 
followed by ceftriaxone (93.48%) and then cefixime (89.13%). Interestingly, all the 
isolates obtained from gynaecology ward showed resistance to aztreonam. Detailed 
antimicrobial resistance rates and pattern noticed in various wards of our tertiary care 
hospital are shown in Fig. 6. 
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Fig. 6: Antibiotic resistance rate and pattern of isolates from different wards 
Antibiotic key: Cn=Cefoxitin; Cs=Cefoperazone; Cfx=Ceflxime; Ce=Cefotaxime; 
Ca=Ceftazidime; Ci=Ceftriaxone; Cfp=Cefpirome; Cpm=Cefepime; Ao=Aztreonam; 
Gf=Gatifloxacin; Of=Ofloxacin; G=Getamicin; Ak=Amikacin; 1= Imipenem. 
4.5 AmpC ^-lactamase 
4.5.1 AmpC p-lactamase detection: Modified three-dimensional extract test was done to 
detect phenot>picalIy the production of AmpC p-lactamases. Out of 125 cefoxitin-
resistant isolates, 76 (60.80%) showed maximum zone distortion and were interpreted as 
.\mpC-producers. 33 (26.40%) were noticed as AmpC-intermediate and 16 (12.80%) 
isolates showed no distortion in zone diameter and hence were interpreted as AmpC non-
producers. Among the isolates noted as AmpC-producers, 65 were E. coli and 11 were K. 
pneumoniae isolates. While, AmpC-intermediate isolates includes 29 E. coli and 4 K. 
pneumoniae. Besides, AmpC non-producers comprises of 15 E. coli and I K. 
pneumoniae. 
Out of 76 isolates that were detected as AmpC-producers by modified three-dimensional 
extract test, onlv 66 (58 E. coli, 8 K. pneumoniae) were found to harbor bla^mpc gene and 
10 (7 £. coli. 3 K. pneumoniae) were found negative for the same. Moreover, among 
.\mpC-intermediate (33) isolates, 27 (26 E. coli, 1 K. pneumoniae) were noted to harbour 
/^^ ampc gene and the gene was not detected in 6 (3 E. coli, 3 K. pneumoniae) isolates. 
InterestingN. 14 (13 £. coli, 1 K. pneumoniae) isolates (out of 16) were found to harbour 
bla:^-:^ gene uhiie they were categorized as AmpC non-producers when detected by 
Modified three-dimensional extract test. Detailed results are shown in Table 6. The 
various patterns observed in modified three-dimensional extract test (MTDET) are shown 
in Fig. 7. 
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Fig, 7: AmpC detection by modified three-dimensional extract test (MTDET), where 
isolate A showing maximum distortion of zone of inhibition (AmpC-producer), B 
indicating minimal distortion (AmpC intermediate t>pe) and C indicates no distortion 
(AmpC non-producers). PC is positive control. 
Fig. 7 
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Table 6: AmpC ^-lactamase detection by Modified Three-Dimensional Extract Test 
Bacterial 
Isolates 
E. coli 
K. pneumoniae 
TOTAL 
Number of 
Isolates 
109 
16 
125 
Modifled Three Dimensional Extract Test (MTDET) 
AmpC-producers 
65 
(59.63%) 
11 
(68.75%) 
76 
(60.80%) 
AmpC-intermediate 
29 
(26.61%) 
4 
(25%) 
(26.40%) 
AmpC non-producers 
15 
(13.76%) 
1 
(6.25%) 
16 
(12.80%) 
4.5,1 Wflampc detection: When the ampHfication reaction was performed for the detection 
of Wflampc gene by monoplex PCR then it was found that a total of 85.60% (107) isolates 
showed the presence of 6/oampc, out of which 97 were E. coli and 10 were Klebsiella 
pneumoniae. Fig. 8a shows the amplification product obtained for Z>/aampc gene. 
In multiplex PCR, 44 (35.2%) out of 125 cefoxitin-resistant isolates were found p>ositive 
for plasmid-mediated AmpC beta-Iactamases (pNlAmpC). 38 isolates were E. coli and 6 
were K. pneumoniae. Two distinct bands (PCR-amplicons) were obtained in 31 isolates 
(27 E. coli & 4 K. pneumoniae). Fig. 8b shows the amplification product of blacrr and 
bloEBC families. 
hi the isolates showing two bands in multiplex PCR, the upper band corresponded to the 
CIT family, and on performing monoplex PCR an amplified product of 450bp 
corresponding to the CIT family was obtained. Whereas, the lower band was obtained at 
200bp corresponding to the expected position of the FOX family; but on performing 
monoplex PCR for the FOX family, no amplification product was obtained. Then to know 
what exactly the lower fi-agment represents, we performed monoplex PCR for all the 
9A 
Fig. 8a: Electrophoretograph showing the amplification product obtained for 
blaampc gene. Lanes marked as M shows molecular weight markers [High range DNA 
Ladder (Bangalore Genei, India)] along with their sizes (in bp). Lane 1 shows positive 
control strain {Citrobacter Dl) for bla^mpc gene. Lane 2 shows negative control. Lane 3-
10 shows blosmpc amplicons (634 bp) from clinical isolates while lane 11-13 shows 
negative clinical samples. 
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Fig. 8b: Electrophoretograph showing the amplification product of blacn and bloEBc 
families. Lanes marked as M shows molecular weight markers [High range DNA Ladder 
(Bangalore Genei, India)] along with their sizes (in bp). Lane 1 & 2 shows positive 
control strain {Citrobacter Dl) for blocu and bla^Bc respectiveK. Lane 3 shows negative 
control. Lane 4-9 shows blocn amplicons (450 bp) fk>m clinical isolates while lane 10-11 
shows bloEBC Lane 12-13 shows negative clinical samples. 
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families of AmpC P-lactamases and we obtained amplified product of 302bp that 
corresponded to the EBC family. However in 3 isolates (2 E. coli & 1 K. pneumoniae) we 
observed amplification for CIT family only. 10 isolates (9 E. coli & 1 K. pneumoniae). 
out of 44, displayed single band corresponding to EBC in multiplex PCR and when we 
performed monoplex PCR with EBC primers, we observed the amplicon of 302bp 
proving it to be from the EBC family. The detailed results of monoplex and multiplex 
PCR done for detection of A/oampc genes and the families of ampC ^-lactamases are 
shown in Table 7. 
In order to analyze the presence of these genes on plasmid. we performed PCR by using 
purified plasmid as a template DNA as performed earlier. The isolates that were showing 
two bands (of CIT and EBC) when lysate was used as a template for PCR cycle, also 
displayed similar amplification pattern in the experiments where purified plasmid was 
used as a template. But when monoplex PCR was performed for CIT and EBC. 
amplification was observed for CIT-family only. This represents that bla^Bc was present 
on the chromosome and not on the plasmids. However, in two isolates we observed bands 
corresponding to both CIT- and EBC-family which denotes that in these isolates hJacn 
and bla^BC both were present on the plasmids. Tne isolates that were showing single band 
for EBC in multiplex PCR (when lysate was used as template) did not show any 
amplification in multiplex PCR (when plasmid was used as template), but the same 
isolates displayed EBC bands in monoplex PCRs performed using lysate and purified 
plasmids, respectively. Fig. 8c shows the electrophoretograph of the blacn, blasBc and 
combination of blacn + 6/aEBc-
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Fig. 8c. Electrophoretograph (with 2% agarose) showing the representative results 
of plVLVmpC p-lactamases obtained in this study. Lanes marked as M shows the 
molecular weight markers [High range DNA Ladder (Bangalore Genei, India)] along with 
their sizes. Lane 1 shows the multiplex PCR result of a representative isolate showing two 
bands (crude lysate was used as a source of DNA template). Lanes 2 & 3 shows the CIT 
and EBC monoplex-PCR results of the same isolate, respectively. Lane 4 shows the 
multiplex PCR of a representative isolate where purified plasmid was used as a DNA 
template. Lane 5 (CIT-positi\e) & 6 (EBC-negative) shows CIT and EBC monoplex-PCR 
results, respectively, of the same isolate when plasmid was used as a template. Lane 7 
shows the amplified product obtained in multiplex-PCR from a representative isolate 
giving single amplicon of WOEBC- and Lane 8 shows the EBC monoplex-PCR 
amplification result of the same isolate (crude lysate was used as DNA template in both 
these cases). Lane 9 & 10 sho%\s the the multiplex and EBC-monoplex PCR results of 
same the isolate but with purified plasmid as templates. Lanes 11 & 12 shows PCR 
negative samples. 
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Table 7: Waampc(by monoplex PCR) and plasmid-mediated ampC genes (pMAmpC; 
by multiplex-PCR) in E. coli and K. pneumoniae isolates studied. 
Bacterial 
isolates 
E. coli 
K. pneumoniae 
TOTAL 
Total number 
of isolates 
studied 
109 
16 
125 
% WflampC 
positive by 
monoplex 
PCR (n) 
88.99 (97) 
62.50(10) 
85.60(107) 
Total 
% pMAmpC 
(n) 
34.86 (38) 
37.50(6) 
35.2 (44) 
pMAmpC (multiplex PCR) 
% CIT(n) only 
1.83(2) 
6.25(1) 
2.4(3) 
% EBC 
(n) only 
8.26 (9) 
6.25 (1) 
8(10) 
% CIT and 
EBC (n) 
24.77 (27) 
25.00 (4) 
24.80(31) 
4.5.2 Sequencing of representative isolates: Sequencing of representative isolates 
confirmed the presence of blacMY-2, ^/OMIR-I like AmpC p-lactamases (GenBank 
Accession numbers for blacMY-i is JF918434 and for Z>/aMiR-i-like is JF918435) (See 
Annexure I and II for sequence details). 
4.6 Detection of class A ESBLs and co-production of Wflampc and WOESBLS: bloampc 
was detected in 85.60% (107; 97 E. coli and 10 K pneumoniae) cefoxitin-resistant 
« 
isolates. These isolates were further analyzed for the presence of Class A ESBLs (i/ocrx-
M, blciTEM, and blasuv)- It was found that A/OCTX-M was present in maximum number of 
isolates (80.81%; includes 91 E. coli and 10 K. pneumoniae), followed by blasuv 
(48.80%) where 49 were E. coli and 12 were K. pneumoniae isolates. Least occurrence 
was observed for WOTEM, it was noticed in 44.80% isolates (47 E. coli and 9 K. 
pneumoniae). Sequence ofblacrx-M is shown in Annexure-m. 
When these isolates were looked for co-occurrence of Class C and Class A ESBLS 
(6/flESBLs)» then Z>/acTX-M (88.79%) were found to be in maximum co-occurrence with 
96 
bla^mpc followed by blasHw (49.53%) and least was noted for A/OTEM (46.73%). Similar 
pattern was noticed when E. coli and K. pneumoniae isolates were analyzed individually 
for co-occurrence of Woampc and /^OESBLS- Details are shown in Table 8. Amplification 
product of Z)/acTx-M» blojEM, and blasnv are shown in Fig. 9a-c. 
Table 8: bloampCj WAESBLS and co-occurrence of Class C & Class A ESBLs in E. coli 
and K. pneumoniae isolates. 
Organisms 
E. coli 
(n=109) 
K. pneumoniae 
(n=16) 
TOTAL 
J 
Wa.mpC 
97 
(88.99%) 
10 
(62.50%) 
107 
(85.60%) 
W«CTX-M 
91 
(83.49%) 
10 
(62.50%) 
101 
(80.81%) 
W^TEM 
47 
(43.12%) 
9 
(56.25%) 
56 
(44.80%) 
WflsBV 
49 
(44.95%) 
12 
(75%) 
61 
(48.80%) 
Occurrence of NotsBLi in blo.mfC-
hartKHiring isolates 
WflcTX-M 
87 
(89.69%) 
8 
(80%) 
95 
(88.79%) 
WaTEM 
44 
(45.36%) 
6 
(60%) 
50 
(46.73%) 
WflsHV 
45 
(46.39%) 
8 
(80%) 
53 
(49.53%) 
4.6.1 Occurrence of bla genes in isolates obtained from various wards: The 
occurrence of bla genes was analyzed in the samples isolated from different wards. Eight 
isolates were found to harbor fe/oampc gene only, and seven (87.50%) of them were 
isolated from surgery ward and the remaining one (12.50%) was isolated from 
gynaecology ward. Thirty isolates showed the combination of Zj/oampc and blacTx-M genes 
and twelve isolates were obtained from surgery ward. A comparable fraction (eleven 
isolates) was isolated from gynaecology ward while six isolates were obtained from 
orthopaedics ward and one isolate was obtained from medicine ward. One isolate each 
were found to possess the combination of A/oampc + blorEu and d/oampc + blasw/, and they 
were isolated from orthopaedics and surgery ward respectively. The combination of 
*/«ampc, blacTK-M and bloTEM was observed in 15 isolates and of them six (40%) isolates 
97 
Fig. 9a: Agarose gel (2.0%) showing amplification result of PCR for detection of 
*'acTx-M. 2% agarose gel showing amplified products of blocrx-M (lane 3-10), lane 1 and 
2 showing positive and negative control for Z^ /OCTX-M (593 bp) respectively, and lanes 
marked as M are showing molecular weight marker (100 bp high range DNA ladder: 
Bangalore Genei, India). 
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Fig. 9b: Agarose gel (2.0%) showing amplification result of PCR for detection of 
WfljEM. 2% agarose gel showing PCR results for amplification of Z)/OTEM (936 bp). Lane 1 
& 2 shows positive and negative control respectively, while lanes 3-9 are showing clinical 
samples positive for blajEM Lanes marked as M shows molecular weight marker 
(Bangalore Genei, India). 
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Fig. 9c: Agarose gel (2.0%) showing amplification result of PCR for detection of 
A/flsHV- Agarose (2%) gel showing PCR results for amplification of blasm' (930 bp). 
Lanes 3-10 are showing clinical samples positive for blasuv- while lane 1 & 2 showed 
positive and negative control respectively. Lanes marked as M shows molecular weight 
marker (Bangalore Genei, India). 
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were obtained from surgery ward, three (20%) from gynaecology ward, three (20%) from 
orthopaedics and two (13.33%) isolates were obtained from medicine. Only one isolate 
was obtained from paediatrics ward. When the isolates showing combination of Waampc, 
blocTK-u ^"'^  blasHv was analyzed, it was observed that out of 17 isolates, eight (47.06%) 
were obtained from surgery ward (the finding similar to that observed in isolates 
possessing various other combination of bla genes discussed above). BuL medicine ward 
contributes second most prevalent fraction with five isolates (29.41%). while two 
(11.76%) isolates each were obtained from gynaecology and orthopaedics wards. Wounpc. 
blitxEM and blasnv combination was noticed in two isolates and they both were obtained 
from surgery ward. The largest fraction of Z»/a-harboring isolates posses the combination 
of bla^mpc + blacTx-M + bloj^M + blasuv (33 isolates) and 13 (39.39%) of them were 
obtained from surgery, eight (24.24%) from gynaecology, six (18.18%) from 
orthopaedics, five (15.15%) from medicine and one (3.03%) isolate was obtained from 
paediatrics ward respectively. In general, when the total isolates studied were analyzed 
than it was observed that surgery ward contributes maximum number of isolates followed 
by gynaecology and then orthopaedics ward. But, when the percent occurrence of various 
combinations of bla genes was analyzed with respect to total number of isolates obtained 
from the respective ward, it was found that all isolates obtained from medicine ward 
harbors one or more bla genes (100% Z>/o-harboring isolates). Moreover. 87.50*'b bla-
harboring isolates were obtained from surgery ward. It was followed by gynaecology 
ward with 83.33% (25/30), then orthopaedics ward (81.82%) and least was noted for the 
isolates of paediatrics ward (50%). Details are shown in Table 9. 
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Table 9: A/flampc and A/assBL genes' combination and wards from where the bla genes 
harboring E. coli and K. pneumoniae were isolated. 
Wflainpc-harboring isolates (n=107) 
WflampC 
WflampC + blacTX-M 
bla^fC + WflTEM 
Wfl«iipC + WflsHV 
*'a»npc + blacn-M + '^flTEivi 
Wa^pc + WflcTX-M + WasHv 
WflMiipC+ WflTEM + 6'flSHV 
Wfl™pc+ blacTx-M + blOTtM + *'asHv 
TOTAL 
Total number 
of isolates 
8 
30 
I 
1 
15 
17 
2 
33 
107 
Surgery 
(n=56) 
7 
(87.50%) 
12 
(40%) 
-
1 
(100%) 
6 
(40%) 
8 
(47.06%) 
2 
(100%) 
13 
(39.39%) 
49/56 
(87.50%) 
Gynaecology 
(n=30) 
1 
(12.50%) 
II 
(36.67%) 
-
-
3 
(20%) 
2 
(11.76%) 
-
8 
(24.24%) 
25/30 
(83.33%) 
Wards 
Orthopaedics 
(n=22) 
-
6 
(20%) 
1 
(100%) 
-
3 
(20%) 
2 
(11.76%) 
-
6 
(18.18%) 
18/22 
(81.82%) 
Medicine 
(n=13) 
-
1 
(3.33%) 
-
-
2 
(13.33%) 
5 
(29.41%) 
-
5 
(15.15%) 
13/13 
(100%) 
Paediatrics 
(n=4) 
-
-
-
-
1 
(6.67%) 
-
-
1 
(3.03%) 
2/4 
(50%) 
4.7 Mobile genetic elements (MGEs): 
When these mobile genetic elements were analyzed in total study isolates then it was 
observed that Sul-]-type integron was present in 64.80% isolates. This frequency of 
occurrence was followed by ISEcpl (60%), and presence of ORFi/J (58.40%) was found 
almost comparable to that of ISEcpl. Furthermore, least association of the study isolates 
was noticed with \S26 (33.60%). Combination of ORF573 and Sul-1-type integron was 
noticed in 44% isolates and that of ISEcpJ + IS26 was observed in 21.60% isolates. 
Amplicons observed for ISEcpl, ORF57i and Sul-1 are shown in Fig. lOa-c. 
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Fig. 10a: Amplicons observed for ISEcpl. Agarose gel (2.0%) showing Molecular 
weight marker (High range DNA Ladder: Bangalore Genei, India) in Lanes marked as M. 
Lane 1 & 2 shows positive and negative control strains respectively. Lane 3-9 shows 
ORf 573 amplicons (1100 bp) from clinical isolates. Lane 10-13 shows negative clinical 
samples. 
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Fig. 10b: Amplicons observed for ORF5iJ. Agarose gel (2.0%) showing Molecular 
weight marker (High range DNA Ladder; Bangalore Genei, India) in Lanes marked as M. 
Lane 1 & 2 shows positive and negative control strains respectively. Lane 3-9 shows 
ORFi/i amplicons (600 bp) from clinical isolates. Lane 10-13 shows negative clinical 
samples. 
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Fig. 10c: Ampiicons observed for Sul-1-type class 1 integron. Agarose gel (2.0%) 
showing Molecular weight marker (High range DNA Ladder; Bangalore Genei, India) in 
Lanes marked as M. Lane 1 & 2 shows positive and negative control strains respectively. 
Lane 3-9 shows ORF513 ampiicons (420 bp) from clinical isolates. Lane 10-13 shows 
negative clinical samples. 
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Moreover, the presence of mobile genetic elements was analyzed in cefoxitin-resistant E. 
coli and K. pneumoniae. Among E. coli, maximum number of isolates was found to 
harbor Sul-l-ty'pQ integron (66.97%), followed by ISEcpI (63.30%). Association of 
ORF573 was observed in 58.72% isolates and least was noted for IS2(5 (33.94%). 
Occurrence of IS26 in K. pneumoniae (31.25%) was found almost similar to that 
observed in E. coli. In K. pneumoniae, ORF573 was noted in maximum number of 
isolates (56.25%), followed by Sul-1-type integron. 
Detailed results are shown in Table 10. 
Table 10: Occurrence of ORF575, Sul-1, ISEcpl and 1S26 
Organisms 
E. coli 
(n=109) 
K. pneumoniae 
(n=16) 
TOTAL 
ORF57i 
64 
(58.72%) 
9 
(56.25%) 
73 
(58.40%) 
Sul-1 
73 
(66.97%) 
8 
(50%) 
81 
(64.80%) 
ISEcpl 
69 
(63.30%) 
6 
(37.50%) 
75 
(60%) 
1S26 
37 
(33.94%) 
5 
(31.25%) 
42 
(33.60%) 
ORt513 +Sul-1 
48 
(44.04%) 
7 
(43.75%) 
55 
(44%) 
ISEcpl + IS26 
25 
(22.94%) 
2 
(12.50%) 
27 
(21.60%) 
4.7.1 Detection of IS26 elements: On performing amplification for IS26, amplicons of 
variable size was noticed in 33.60% (42/125). The amplicons of 350 bp, 500 bp, 650 bp, 
700 bp, 800 bp, 900 bp, and 1500 bp were obtained in our study isolates. The fragment of 
800 bp was found to be most common amplicon noticed. Out of 42 isolates, eight showed 
the amplicon at 350 bp. Amplified product of 500 bp was noticed in six isolates, while 
amplicon of 650 bp was found to be present in five isolates. Amplicon of 700 bp was 
observed in five isolate. Moreover, largest flection of isolates (13/42) showed amplicon at 
800 bp. Amplification at 900 bp was also noted m single isolate only. The largest IS2<5 
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Moreover, the presence of mobile genetic elements was analyzed in cefoxitin-resistant E. 
coli and K. pneumoniae. Among E. coli, maximum number of isolates was found to 
harbor 5u/-/-type integron (66.97%), followed by \SEcpl (63.30%). Association of 
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K. pneumoniae 
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TOTAL 
ORFSJ3 
(58-:%) 
4 
i58 4i:r«.i 
Sttl-1 
73 
(66.97%) 
8 
(50%) 
81 
(64.80%) 
ISEcpl 
69 
(63.30%) 
6 
(37.50%) 
75 
(60%) 
\S26 
37 
(33.94%) 
5 
(31.25%) 
42 
(33.60%) 
OH¥513+Sul-l 
48 
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4.7.1 Detection of IS26 elements: On performing amplification for IS2<5. amplicons of 
variable size >*as mMiced in 33.60% (42/125). The amplicons of 350 bp, 500 bp, 650 bp, 
700 bp. 800 bp, 900 bp. and 1500 bp were obtained in our study isolates. The fragment of 
800 bp was found to be most common amplicon noticed. Out of 42 isolates, eight showed 
the amplicon at 350 bp. Amplified product of 500 bp was noticed in six isolates, while 
amplicon of 650 bp was found to be present in five isolates. Amplicon of 700 bp was 
observed in five isolate. Moreover, largest fraction of isolates (13/42) showed amplicon at 
800 bp. Amplification at 900 bp was also noted in single isolate only. The largest IS2<5 
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fragment was observed of 1500 bp and it was noted in two isolates. 1S26 amplification 
pattern (single bands) is shown in Fig. Ua 
Two bands were also noticed when PCR was performed for IS26 amplification. One 
amplicon was noted at 250 bp while other one was observed at 350 bp. Such 
amplification pattern was observed in two isolates only. Fig. l ib shows the single and 
double amplicons of IS26 observed in this study. 
4.7.2 Association of MGEs with 6/a.mpc: In a total of 125 cefoxitin-resistant isolates 
studied, 107 were found to harbor fe/oampc genes. The association of various mobile 
genetic elements with 6/aampC-harboring isolates was analyzed. The association of Sul-1-
type integron (71.03%) was found to be highest in Z>/aampC-harboring isolates, followed by 
ISEcpl (68.22%) which was almost comparable to that of Sul-J-type integron. 
Association of ORF573 was noted as 64.49% and least was observed for ]S26 (35.51%). 
The combination of ORF5I3 and 5'M/-7-type-integrons associated with bla^pc was 
noticed in 50.47% of Z>/aampc-harboring isolates. Whereas, the association of bla^pc with 
ISEcpl + IS26 combination was observed in 23.36% A/aampc-harboring isolates. 
Morever, maximum occurrence of mobile genetic elements in Woampc-harboring isolates 
was noticed for ISEcpl (71.13%) in E. coli, while it was for SuJ-1-type integron (80%) in 
K. pneumoniae isolates. Presence of 5'M/-/-type integrons was observed in 70.10% (68) 
isolates and ORF513 was noted in 63.92% (62) in E. coli. Least occurrence was noticed 
for IS26 (34.02%) in E. coli, a finding similar to that noted for presence of IS26 in all 
study isolates (including both E. coli and K. pneumoniae), but it was observed that in K. 
pneumoniae isolates IS26 was not present in least number of isolates [it was observed in 
50% isolates]. Least occurrence was observed for ISEcpl (40%) in K. pneumoniae 
isolates. Combination of ORF57i + Sul-I-type integron in WaampC-harboring isolates was 
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Fig 11a: Agarose gel showing IS26 amplification pattern (single bands). 2% agarose 
gel showing variation in amplification results of IS26 insertions. Lanes marked as M 
shows molecular weight markers (Bangalore genei. India). Lanes 1 to 13 shows the 
amplified products (single amplicon) of diverse molecular weight observed in clinical 
samples. 
M 1 3 4 5 6 8 9 10 11 12 13 M 
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Fig. 11a 
Fig. l ib: Agarose gel showing single and double amplicons oflS26 observed in this 
study. Lanes marked as M shows molecular weight markers (Bangalore genei, India). 
Lanes 1 to 11 shows the single ampiicon of diverse molecular weight observed in clinical 
samples. Lanes 13-14 shows the double amplicons noticed in IS26 amplification in 
clinical isolates. 
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Fig. l i b 
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observed in almost equal frequency in E. coli (50.52%) and K. pneumoniae (50%) and a 
similar pattern to a certain extent was observed for ISEcp] + IS26 combination (23.71% 
in E. coli and 20% in K. pneumoniae). Details are shown in Table 11. 
Table 11: Association ofbla^^pc with ORF57i, Sul-1, ISEcpl and IS26 
Organisms 
E. coli 
(n=97) 
K. pneumoniae 
(n=10) 
TOTAL 
ORr5/3 
62 
(63.92%) 
7 
(70%) 
69 
(64.49%) 
Sul-1 
68 
(70.10%) 
8 
(80%) 
76 
(71.03%) 
ISEcp/ 
69 
(71.13%) 
4 
(40%) 
73 
(68.22%) 
IS26 
33 
(34.02%) 
5 
(50%) 
38 
(35.51%) 
bla^fC + ORF5ii + 
Sul-1 
49 
(50.52%) 
5 
(50%) 
54 
(50.47%) 
Wflwnpc + IS£'cp7 + 
ISifi 
23 
(23.71%) 
2 
(20%) 
25 
(23.36%) 
4.7.3 bla genes and MGEs: When the association of mobile genetic elements with 
various combinations of class C and class A p-lactamases was analyzed, it was noticed 
that Sul-1 is associated with maximum number (71.03%) of A/aampC-harboring isolates, 
while ISEcpl was noticed next to it with 68.22% isolates. Least association was noted 
with IS26 (35.51% isolates) and ORP573 was found to be associated with 64.49% 
isolates. It can be observed that the frequency of association of ISEcpl, Sul-1, and 
ORF5J3 is almost comparable. The most common combination of bloampc with class A P-
lactamase observed was that of bla^mpc + blacvx-u + blomA + A/«SHV [30.84% (33/107)], 
followed by 6/aampc + blocrx-u [28.04% (30/107)] and then bla^pc + blacrx-u + bla^m 
[15.89% (17/107)]. Least common combination observed was that of 6/oampc with blomA 
(1/109) and blasuv (1/109). In the isolates harboring only blaampc (8/107), maximum 
frequency of association of mobile genetic elements observed was that of ORF5/3 
followed by Sul-1, while ISEcpl and IS2<5 were found to be associated in equal nimiber 
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(50% of Wflampc-harboring isolates). The isolates having combination of 6/aampc + blacrx-
M showed different pattern for association of the studied mobilizing elements. \SEcp] was 
noted with maximum frequency, followed by ORF513, and then Sul-1 and least was 
noted for IS26. The combination of bloampc + WOCTX-M + blajEM displays a pattern of 
mobilizing elements different fk>m that observed in above described combinations of bla 
genes. ORFJ7J contributes maximum (80%), ISEcpl and Sul-1 contribution was noticed 
equal (66.67%) while association of \S26 was observed in 33.33% isolates. AVhen the 
combination of bloampc + blacn-u + blasHv was analyzed, ISEcpI was found to be 
associated with maximum number of isolates (12/17 i.e. 70.59%). Sul-1 was noted in 
11/17 (64.71%) isolates, ORF573 was observed in 7/17 (41.18%) isolates and the least 
contribution was that of IS26 (similar to that observed in other groups of bla genes). 
Surprisingly, in the combination of bloampc + blojEM + blasnv, none of the above screened 
mobilizing element was noticed to be associated with the p-lactamase genes. The group 
including maximum number of isolates (33/125) has combination of W<%nipc + blocrx-M + 
blaj^M + blasH\ and among mobilizing element Sul-1 was noted to be associated with 
maximum number of isolates (78.79%), followed by ISEcpl (72.73%), then ORF513 
(63.64%) and least was noted with IS26 (36.36%) similar to that observed in most of 
groups. The pattern observed in this group is similar to that observed for overall 
occurrence of mobile genetic elements. Table 12 shows the occurrence of mobile genetic 
elements in various combinations of bla genes. 
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Table 12: Occurrence of mobile genetic elements (MGEs) in various combinations of 
bla genes noticed 
W a^mpc-harbouring isolates (n=107) 
bla^oc 
bla^^ + WocTx-M 
bla^ac + blartM 
bla^ac + WasHv 
*/<JamDC + bhcTX-U + blOj^ 
bldamoC + blacYX-M + blOsm 
blOunoC + blOjEM + WOSHV 
i/OjmoC + W^CTX-M + WOTEM + ^'^SHV 
TOTAL 
Total number 
of isolates 
8 
30 
1 
1 
15 
17 
2 
33 
107 
ISEcpI 
n (%) 
4(50) 
22 (73.33) 
1 (100) 
10 (66.67) 
12 (70.59) 
24 (72.73) 
73 (68.22) 
1S26 
B (%) 
4(50) 
8 (26.67) 
I (100) 
1 (100) 
5 (33.33) 
7(41.18) 
12 (36.36) 
38(35.51) 
Sul-1 
n (%) 
5 (62.50) 
20 (66.67) 
I (100) 
1 (100) 
10 (66.67) 
11(64.71) 
28 (78.79) 
76(71,03) 
ORF5/i 
n (%) 
6(75) 
21 (70) 
I (100) 
1 (100) 
12 (80) 
7(41.18) 
21 (63.64) 
69 (64.49) 
4.7.4 Detection of Conserved Sequence (CS) regions: 41 isolates showed single 
amplification band when P*CR was performed to amplify CS region. Out of these, three 
isolates showed amplification at 400 bp (lowest one), 11 isolates showed the amplicon at 
800 bp, while three isolates showed the amplification of product at 900 bp. A major part 
of isolates, comprising of 24 isolates showed the amplification product at 1500 bp. It was 
the most common amplicon noted in our isolates. Out of three isolates that showed the 
amplicon at lowest position, two isolates were found negative for Sul-1 gene. One isolate 
was found to carry blasnw only along with insertion sequence IS25. The other two isolates 
harbor bloampc, blocTx-u, A/OTEM. and WOSHV- As far as mobilizing elements are concerned 
(IS2<5, ISEcpl, and ORF575), the S'l/Z-i-harboring isolates also carried 1S26 while the 
other one do not bear any of the insertion sequence. 
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Among 11 isolates showing amplification for CS region at 800 bp, nine isolates were 
noticed to harbor Sul-1 gene and two were found negative for the same. When analyzed 
for bla genes, three isolates were noted to carry combination ofbla^mpc, bhcTX-M, blojEM, 
ft/osHv, but these three isolates cany different array of mobile genetic element. Sul-1 was 
noticed to be present in all three isolates, ORF513 was observed in two, and ISEcpl was 
found to be present in one isolate. IS26 was also noticed in one isolate. The combination 
of /^oampc, blocTx-M, and ft/oTEM ^ 25 observcd in two isolates, where, IS26, ISEcpl, Sul-1, 
and ORF513 were present in one and the other three mobilizing elements except ISEcpl 
were noticed in another isolate. SimilarN. blchmpc- blocjx-w. and blasnv combination was 
noticed in two isolates where ORF513 was noticed to be absent in one isolate while rest 
of the three mobilizing elements were observed in both isolates. The combination of 
bloampc and /^OCTX-M was observed in two isolates and Sul-1 was found absent in one of 
them. 0RFi7i was present in both isolates, and the isolates that do not bear Sul-I showed 
the presence of ISEcpl however, \S26 was absent in both isolates. Single isolate that 
harbors only bloampc was found to carr> all the four mobilizing elements. One isolate 
shows the amplification for CS region, but carries only ORP5/5 and rest of the genes 
including bla genes and mobile genetic elements (screened in the present study) were 
found absent. 
Three isolates showed CS amplification band at 900 bp. out of which Sul-1 was noted 
only in one isolate. 5M/-7-positive isolate harbors all the four bla genes studied i.e., 
blaampc, blocTx-M, bloxEM, and bhsm- While, among mobilizing elements ORFJ/i and 
ISEcpl were present while IS2<5 was found absent. In the remaining two isolates, one 
carries only bloampc along with ORF513, ISEcpl, and IS2<5. The other Sul-1-negative 
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isolate carries combination of blawnpc, blocxx-M, and blasnw whilst other mobile genetic 
elements were absent. 
The most common amplicon that was observed in amplification of Conserved Segment 
(CS) region was of 1500 bp, and was noticed in 24 isolates. Sul-l gene was observed in 
eighteen isolates and three isolates were noticed negative for it. Twelve isolates were 
found to carr\ combination of 6/aampc and blacn-M genes and three out of them showed 
the absence of Sul-l gene. A total of five isolates showed the same array of bla genes and 
mobilizing element i.e., blaampc, blacrx-M, Sul-l, ORP5/i, and ISEcpl. Two isolates 
showed the combination of bloampc, blacrx-M, Sul-l, ISEcpl, and IS26. A single isolate 
was noticed that possess the combination of all four mobile genetic elements along with 
bla genes, i.e., the combination of blaampc, blacn-M, Sul-l, ORF5/i, and ISEcpl, and 
IS26 was present. Out of nine bloampc and blacrx-M carrying-Sul-l-posit\\e isolates, 
remaining one showed the presence of ISEcpl as mobilizing agents. Among the three Sul-
7-negaiive isolates, one isolate was found devoid of all mobilizing elements studied and 
carries onl> blomfc and blacrx-M-'" the remaining two isolates, one showed only IS2<5 as 
insertion sequence that can mobilize antibiotic resistance genes, while other one bears 
ORFfJJ and ISEcpl. TTie second most common combination of bla genes observed was 
that ox bla^jrt*:- blocrx-M. and blasm. All the four isolates demonstrating this combination 
of genes, showed similar pattern of mobilizing elements, i.e., the combination of Sul-l 
and lS£cp; was noticed along with blaampc, blacvx-M,^^'^ blasm- Combination of ft/aampc, 
blacTx-M, bloTEM along with Sul-l, ORF513, and ISEcpl was noticed in three isolates. 
The combination of all four bla genes was noticed in two isolates and they both displayed 
combination of mobilizing elements different from each other. One isolate showed 
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combination ofSul-1, ORFi/i, and \SEcpl while other one showed \S26, Sul-1, OKF513 
and ISEcpl as mobile elements. 
Three isolates were found carrying the combination of blaa^pC' *^^TX-M, blaj^>^ and 
blasnv, however, combination of mobile genetic elements varied. Combination of Sul-l 
and ISEcpl was observed in one isolate while in other ORF5/i replaces ISEcpl 
(combination of Sul-1 and ORF57i was noted). Remaining isolate showed the 
combination of all four mobile elements i.e. ISEcpl, Sul-1, OKF513, and IS26 was 
noticed. Single amplicon noticed in CS amplification is shown in Fig. 12a 
Sixty nine isolates showed amplification when PCR was performed for CS region and out 
of them twenty isolates showed two bands. Among the isolates showing two 
amplification bands, eight isolates (largest group) showed the presence of combination of 
all four bla genes (bloampc, blocTx-M, blartM and blasnv) but variation was noted in the 
presence of mobile genetic elements. Three isolates showed similar configuration {Sul-1, 
ORF513, and ISEcpl). Rest five has combination unique in itself. Sul-1 was found absent 
in one isolate. ORF575, Sul-1 + ORF513, Sul-1 + IS26 + ISEcpl, Sul-1 + IS26 -
OKF513, IS26 + Sul-1 + ORF57i + ISEcpl were the combinations of mobile genetic 
elements that were noticed in the remaining five isolates. Combination of bhimpc "" 
blacrx-M was noted in three isolates, of which two possess same configuration of 
mobilizing elements also {Sul-1 + ORF57i + ISEcpl). The remaining one isolate have 
combination of IS26 + Sul-1 + ORF513 + ISEcpl. Combination of Woampc, blocrx-M and 
blasm was noticed in three isolates but all three were showing different combination of 
mobile genetic elements, i.e. IS26 + Sul-1 + ORF513; IS26 + Sul-1 + ORF513 + ISEcpl; 
Sul-1 + ORFJ75 + ISEcpl were the combination observed in the above mentioned 
isolates. Three isolates were found to possess blogmpc along with blacix-u and blctiwi and 
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Fig. 12a: 2% agarose gel showing single amplicon observed in amplification of CS 
region. Lanes marked as M shows molecular weight markers (Bangalore genei, India). 
Lanes 1 to 13 shows the amplified products (single amplicon) of diverse molecular 
weight observed in clinical samples. 
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Fig. 12a 
among them Sul-1 was found absent in one isolate while the other two isolates possess 
Siil-l + ORP5/i + ISEcpl and IS26 + Sul-I. Single isolate that harbors only ft/oampc, also 
showed two bands when amplification was performed for CS region and it was noted to 
possess Sul-1 and \SEcp] as mobile genetic elements. Combination of WOCTX-M- blcnuA 
and blasHw ^as noticed in one isolate and it possessed only ORPJ7i as the element 
resp)onsible for mobilization. Interestingly one isolate that do not harbor an> oi bla genes, 
showed two bands in amplification PCR performed for CS region and it carried Sul-1 
gene also thereby indicating the presence of Class 1 integron. Fig. 12b shows the CS 
amplification pattern of single and double bands observed in study isolates. 
Four isolates showed three bands in CS amplification PCR. /^Oampc alone; 6/aampc. blocTx-
M and */flsHv; blaampc, blocTx-M and blctxEM, bhampc, blocrx-M, bloTEu and blasm were the 
combination of bla genes observed in the above described isolates, i/aaupc-harbouring 
isolates possess Sul-1 and ORF5/3, 6/asHv + Woampc + 6/acTx-M-harboring isolates possess 
IS26 + ORF5/i {Sul-1 gene was absent), while bloampc + blocix-u + blovEM "^  blasnv-
harboring organisms were found to possess IS26 + Sul-1 -^ ORF57i -r ISEcpl. .Another 
type of amplification results were noticed where multiple bands were observed. All the 
four isolates harbor A/oampc along with blocrx-w- blaTEs\ and ^/asH\- -^ far as mobile 
genetic elements' combination is concerned, two isolates were found to possess similar 
profile i.e. combination of IS26 + Sul-1 + ISEcpl, one possess IS26 + Sul-1 -*- ORF5/3 -
ISEcpl, and the remaining one showed presence of ISEcpl only. Fig. 12b shows the 
amplification pattern of single, double and multiple amplicons noticed in CS 
amplification. Details are shown in Table 13. Sequence of CS region is shown in 
Annexure IV. 
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Fig. 12b: 2% agarose gel showing the amplification pattern of single, double and 
multiple amplicons noticed in amplification of CS region. Lanes marked as M shows 
molecular weight markers (Bangalore genei, India). Lanes 1 to 7 shows the single 
amplicon of diverse molecular weight observed in clinical samples. Lanes 8-11 shows the 
double amplicons noticed in CS amplification in clinical isolates, while Lanes 12-13 
shows multiple amplicons of CS noticed in amplification of CS region. 
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Table 13: Genetic organization of integron-positive isolates of £•. coli and Klebsiella 
pneumoniae 
Amplicon size 
Single band 
400 bp 
800 bp 
900 bp 
1500 bp 
Two bands 
Genes 
blaampc, blacm-M, blajEu, blasuv, Sul-J, IS26 
/^oampc, blacTK-M, blaj^M, blosm 
blosHV, IS26 
bloampc, blacTx-M, blajEM, blasHv, Sul-1, ORF513, \SEcpl 
bla^pc, blacTx-M, blajuM, blas»\, Sul-1, ORF5ii 
bla^pc, blocTx-M, blojEM, blasm, Sul-1, IS26 
Wflampc, blacTx-M, bhyEM, Sul-l, ORF513, ISEcp], IS26 
bla^^, bhcTx-M, blaTEM, Sul-1, ORF5J3, IS26 
bla^jc, blacTx-M, bhsm, Sul-1, ORFJii , ISEcpl, IS26 
bloampc, blocTx-u, blomw, Sul-1, ISEcpl, IS26 
bla^pc, blacTx-M, Sul-1, ORF513 
bla^pc, blocTx-u, ISEcpl 
Wflampc, 5M/-1, ORF513, ISEcpl, 1S26 
ORF513 
bla,^fC, blacTx-M, blarEM, bla^n\, Sul-1, ORF57J, ISEcpl 
bla^^, ORF57i, ISEcpl, \S26 
bla^pc, blacTx-u, blasm 
bla^fC, blacTX-M, Sul-1, ORF575, ISEcpl 
bla^fC, blacTx-u, blasm, Sul-1, ISEcpl 
bla^pc, bhcTx-M, blajsu, Sul-1, ORF575, ISEcpl 
bla^pc, blacrx-M, Sul-1, ISEcpl, IS26 
bla^fC, blacTx-M, Sul-7, ORF513, ISEcpl, IS26 
bla^pc, blacTx-M, Sul-1, ISEcpl 
bla^pc blacrx-M, 0RFJ7i , ISEcpl 
bloanfc blacTx-M, IS26 
bla^fC blacrx-M 
bla^fC, blacTx-M, blajEM, i/asHv, Sul-1, ORF575, ISEcpl 
bla^fC, blacTx-M, blajEM, blasm, Sul-1, ORF513, IS26 
bla^pc, blacTx-M, W^TEM, blasm, Sul-1, ORF513, ISEcpl, IS26 
bla^fc, blacTx-M, blajEu, blasm. Sul-1, ORFJ75 
bla^pc, bhcTx-M, blajEM, blasm. Sul-1, ISEcpl 
bla^fc, blacTx-M, blajEM, blasm, Sul-J, ORF513, ISEcpl 
bla^jc, blacTx-M, Sul-1, ORF513, ISEcpl 
Wflampc, blacTx-M, bla-r^M, blasm. Sul-1, ORF57i, IS£cp7, IS26 
Number of 
Isolates 
5 
4 
3 
2 
3 
2 
1 
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Three bands 
Multiple bands 
bla^pc, blocTx-M, blajEM, blasnw. Sul-1, ISEcpl, IS26 
bla^fC, bhcTx-M, bla-rsM, bhsm, Sul-1, ORF57 J 
bla^pc, blacTx-M, blajEM, blasm. Sul-1, ORFJ7 J, IS26 
bla^pc, blacrx-M, blajEu, blosm, ORF513 
bla^pc, blacTx-M, blajEu, Sul-1, ORFJi i , ISEcpl 
W a^mpC; W c^Tx-M' blorEM, SuJ-1, IS26 
bhamvc, blacTx-u, blojEM, ISEcpl 
bla^fC, blacxx-u, bla^m, Sul-1, ORF513,1S26 
bla^pc, blacTx-M, bla^m, Sul-1, ORF513, ISEcpl, IS26 
bla^pc, blacTx-M, bhsm, Sul-1, ORF513, ISEcpl 
bla^pc, blacTx-u, Sul-1, ORF513, ISEcpl, IS26 
bla^pc, Sul-1, ISEcpl 
blacTx-M, blajEM, bhsm, ORF513 
Sul-1 
bhampc, bhcTx-M, blaxEM, bhsm, Sul-1, ORF513, ISEcpl, IS26 
bh^fC, bhcTx-M, bhsm, ORF513, IS26 
bh^pc,Sul-l,ORF513 
bhamfC, bhcTx-M, blojEM, bhsHv, Sul-1, ISEcpl, IS26 
bh^fC, bhcTx-M, blajEM, bhsm, Sul-1, OKF513, ISEcpl, IS26 
bha^fC, bhcTx-M, blajEM, bhsm, iSEcpl 
2 
2 
4.8 Analysis of A/aampc-harboring isolates: The mobile elements, ISEcpl, \S26, 
ORF573 and 5M/-7-integrons, were detected in 32/44 (72.73%), 17/44 (40.91%), 32/44 
(72.73%), and 35/44 (79.55%) isolates respectively (Table 14). More or less similar 
frequency of occurrence of these genetic elements was noticed in the three 6/a-groups 
(CIT + EBC; CIT-alone; and EBC-alone). The isolates were also analyzed in reference to 
various combinations of genetic elements noticed, and we found the combination of 
ISEcpl + ORF573 + 5M/-/-integrons as the most common combination noticed in 12/44 
(27.27%) isolates followed by a combination of ISEcpl + IS26 + ORF57i + Sul-1-
integrons that was noticed in 9/44 (20.45%) isolates. TTiis frequency of occurrence of 
mobile elements-combination was similar in the three 6/a-groups (Table 14). Both 
110 
ISEcpl and Sul-1 were found to be present in 66.67% of the 6/acrr-harboring isolates. 
When A/flEBc-harboring isolates were analyzed for the above described mobile genetic 
elements, then it was observed that ORF5I3 and Sul-1 was present in ma.ximum number 
of isolates (80%), followed by ISEcpl (60%), and IS26 was noticed in least number of 
isolates (50%). The largest fraction of fe/aampc-harboring isolates possesses blacn + blafBc 
combination, and they displayed mobilizing elements array quite different from the 
isolates harboring blacn and A/QEBC alone. Maximum number of isolates showed presence 
Sul-1 (25/31; 80.65%), followed by ISEcpl (24/31; 77.42%) and then ORF513 (23/31; 
74.19%). Out of 31 isolates only 12 showed the presence of IS26 (38.71%). These 
isolates were then analyzed for the combination of mobile genetic elements associated 
with the respective bla^mpc family. The combination of ISEcpl + ORP5/i + Sul-1 was 
found to be most common in both blacn + bla^sc and i/oEBC-harboring isolates, however 
6/acrT-harboring isolates did not show presence of such combination. The combination of 
ISEcpl + \S26 + ORF513 + Sul-1 was observed as second most prevalent combination 
and was noticed in 33.33%, 20% and 19.35% of blacn, bla^sc and blacn + bla^BC-
harboring isolates respectively. 
The Wacrrharboring isolates were found to carry ISEcpl (33.33%), 0RF5/i + 
Sul-1 (33.33%) and ISEcpl + IS26 + ORF513 + Sul-1 (33.33%) as mobile genetic 
elements. Moreover, blacn + A/flEBc-harboring isolates were found to possess ISEcpl + 
IS26 + Sul-1 in 40% isolates and combination of ORF513 + Sul-1 was noticed in 9.68% 
isolates. Interestingly, 3.23% (1/31) isolate was observed devoid of the mobilizing 
elements studied. ISEcpl and ORF573 alone were noticed in 6.45% isolates. Details are 
shown in Table 14. 
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4.8.1 Co-occurrence of various 6/aampc families with class A ESBLs: 
When analyzed for co-occurrence, blacTx-M was found to be associated with all isolates 
that showed presence of blacn or bla^Bc alone. However, the co-occurrence of blacrx-M 
was noticed in 90.32% isolates harboring combination of blaaj + blaEsc- Co-existence of 
blajBM and blusuv was found to be almost equally distributed in the isolates harboring 
only bloEBc and in those showing presence of blacn + blaEBC (60% and 61.29% 
respectively). Moreover, co-occurrence of blaj^u and blasnv was observed in 100% 
isolates that showed presence oi blacn alone. Details are shown in Fig. 13. 
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Fig. 13. Co-occurrence of various blaampC families with AAOESBLS (^ /acTx-ivi, bla^^j^ & 
blasm)-
4.8.2 Association of A/flampc families and various mobile genetic elements: 
All the 6/aciT-harboring isolates were found to be associated with integron (CS) and 50% 
of the 6/aEBC-harboring isolates were found to be associated with CS. Moreover, 77.42% 
of blacn + 6/aEBC-harboring isolates were found to be associated in above described 
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manner. The association of blaampc families with ORFJ/i and Sul-lwas also analyzed. It 
was observed that 66.67% of Z)/acn-harboring isolates were associated with ORF57J. 
80% of WfliEBc-harboring and 74.19% of blacn + 6/aEBC-harboring isolates were noted to 
be in association with ORF57J. Somewhat different pattern was observed for association 
of Sul-I with bloampc families, where maximum association was observed with blacn + 
6/aEBC-harboring isolates (80.65%) and least was noted for /)/aciT-harboring isolates 
(66.67%). 80% of 6/aEBC-harboring isolates showed the association with Sul-1-iype class 
1 integron. 
When the association of bloampc families with ISEcpl was analyzed, then maximum 
association was noticed with blacn + 6/aEBC-harboring isolates (77.42%), followed by 
Z>/flfciT-harboring (66.67%) and then Z)/«EBC-harboring isolates (60%). Furthermore, 
association of 6/aampc-harboring isolates with IS26 was noticed maximum with ZJ/AEBC-
harboring isolates (50%), followed by blacn + WAEBC (38.71%) and least was noticed 
with WaciT-harboring isolates (33.33%). Details are shown in Fig. 14a-e. 
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Fig. 14a: Association of various 6/aa„pc families with integron (Conserved sequence region) 
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Fig. 14c: Association of various 6/a,„pc families with Sul-I-type Class 1 integron 
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4.9 Comparative trend of bla genes and MGEs in 2009 and 2010: 
A downfall in the percent occurrence of both bla^mpc and /^OESBLS was noticed when the 
results were compared for the year 2009 and 2010. A dramatic decrease was observed in 
b/oampc from 64% in 2009 to 21.6% in 2010. Among class A ESBLs, occurrence of 
blacrx-M was noticed to decrease from 56.8% (in the year 2009) to 24% (in the year 
2010). Similarly, 27.2% of WaxEM-harboring isolates were observed in 2009 and this 
frequency of occurrence decrease to 17.6% in 2010. Frequency of blasnv was found to 
decrease from 28% to 20.8%. Comparative trend of occurrence of blaampc and 6/OESBLS in 
the year 2009 and 2010 is shown in Fig. 15a. 
A trend similar to that observed for occurrence of bla genes was also noticed for 
occurrence of mobile genetic elements. Maximum decrease was noticed in occurrence of 
ISEcp] where 48.8% was observed in 2009 and only 11.2% isolates were found to harbor 
ISEcpl in 2010. 5M/-i-harboring isolates were noticed to decrease from 48% to 16.8% in 
the year 2009 to 2010. ORF513 was noted in 45.6% isolates in 2009 and only 12.8% 
isolates were found to harbor ORP513 in 2010. Occurrence of IS26 was observed to 
decrease from 21.6% (2009) to 12% (2010). Fig. 5b shows the comparative occurrence of 
mobile genetic elements in the year 2009 and 2010. 
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and 2010. 
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Piasmid analysis: Plasmid analysis of the cefoxitin-res/stant isolates showed the 
consistent presence of a single plasmid of molecular weight ~ 23 kb (Fig. 16). 
4.10 RAPD-typing: Out of 109 E. coli isolates, 91 could be typed by RAPD, while 18 
were found untypable. Among 91 E. coli isolates, 33 were grouped in 15 clusters (ECl to 
EC15) while the remaining 58 isolates showed unique banding patterns indicating genetic 
unrelatedness. Maximum clustering was noticed in isolates obtained from surgery ward 
(ECl to ECS). Surprisingly, no cluster was noticed in isolates obtained from orthopaedics 
ward, bla gene composition of the isolates grouped in clusters was variable, however, 
occurrence of bloampc was observed in all clusters except one isolate that harbours 
combination of ^/OTEM & blasuv- Among 16 K. pneumoniae isolates, 14 were typed by 
RAPD and 2 isolates were found untypable. Out of 14 isolates, 4 were grouped in two 
clusters (KPl & KP2) and 10 displayed unique banding patterns. Details of occurrence of 
bla genes in different clusters are shown in Table 15. 
Fig. 17-20 shows the RAPD-profile of E. coli isolates. The isolates obtained fi-om the 
wards of Surgery department are shown in Fig. 17a-b, while. Fig. 18 & 19 illustrates the 
RAPD profile of isolates obtained from Gynaecology and Orthopaedics wards, 
respectively. As isolates obtained from Medicine and Paediatrics wards were less in 
number hence they were typed and compared in the same gel (Fig. 20). Klebsiella 
pneumoniae isolates obtained from different wards are shown in Fig. 21. RAPD-typing 
revealed the presence of diverse bacterial population in our hospital environment as no 
predominantly circulating clone was observed in the isolates. However, few bacterial 
isolates from gynaecology, surgery and orthopaedics wards also displayed similar 
banding pattern. We have observed that untypability of isolates is increasing. Clusters 
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Fig. 16: Agarose gel (0.8 %) showing plasmids obtained from E. coli and K. 
pneumoniae isolates. Lanes 1-7 showing ~ 23 kb plasmids isolated from clinical 
samples. Lane marked as M shows molecular weight marker [Lambda DNA double 
digested with Hind III and EcoRI. (Bangalore Genei, India)] along with molecular weight 
(in kilo base pairs). 
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Fig. 16 
Fig. 17a: RAPD profile of E. coli isolates obtained from the wards of Surgery 
department. Lanes marked as M shows molecular weight markers (Fermentas Life 
sciences, USA). Lanes 1 to 28 shows the RAPD pattern observed in clinical samples. 
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Fig. 17b: RAPD profile of E. coli isolates obtained from the wards of Surgery 
department. Lanes marked as M shows molecular weight markers (Fermentas Life 
sciences, USA). Lanes 29 to 43 shows the R.APD pattern observed in clinical samples. 
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Fig. 17b 
Fig. 18: RAPD profile of E. coli isolates obtained from the wards of Gynaecology 
department. Lanes marked as M shows molecular weight markers (Fermentas Life 
sciences, USA). Lanes 1 to 20 shows the RAPD pattern observed in clinical samples. 
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Fig. 19: RAPD profile of E. coli isolates obtained from Orthopaedics wards. Lanes 
marked as M shows molecular weight markers (Fermentas Life sciences, USA). Lanes 1 
to 16 shows the RAPD pattern observed in clinical samples. 
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Fig. 19 
Fig. 20: RAPD profile of E. coli isolates obtained from Medicine and Paediatrics. 
Lanes marked as M shows molecular weight markers (Fermentas Life sciences. USA). 
Lanes 1 to 12 shows the RAPD pattern observed in clinical samples. 
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Fig. 21: RAPD profile of Klebsiella pneumoniae isolates obtained from different 
wards. Lanes marked as M shows molecular weight markers (Fermentas Life sciences, 
USA). Lanes 1 to 15 shows the RAPD panem obser\ed in clinical isolates of K. 
pneumoniae. 
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noticed in E. coli and K. pneumoniae isolates, obtained from various wards of our 
hospital, are shown in Fig, 22. 
Table 15: bla gene composition in various clusters of E, coli and K. pneumoniae 
isolates. 
RAPD 
profile 
ECl 
EC2 
EC3 
EC4 
ECS 
EC6 
EC7 
ECS 
EC9 
EClO 
ECU 
EC12 
EC13 
EC14 
EC15 
KPl 
KP2 
No. of 
Isolates 
3 
2 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
3 
2 
2 
2 
2 
Wards 
Surgery 
Surgery 
Surgery 
Surgery 
Surgery 
Surgery 
Surgery 
Surgery 
Gynaecology 
Gynaecology 
Gynaecology 
Gynaecology 
Medicine 
Medicine 
Medicine & 
Paediatrics 
Surgery 
Surgery 
bla genes 
^/Cfampc ; */«ampC + blOcTX-M + blOjEM ', bla^^Q + fc/flcTX-M 
bla^pc + blasnw; bla^^ 
bla^pc ; bla^pc + blacjx.M + blosm 
*/OainpC+ blOcrx-M + blOy^M + */aSHV 
bla^pc + blacTx-M ; */aampC + */acTx-M + ^/OSHV 
/^OampC + blaciX-M + '^^ 'SHV ', bla^pc+ blOcTX-M + blOYEM + blasHV 
blajEM + WosHv ; */aampC+ blacrx-M + bloYUM + blosm 
bla^mpc + blacix-M ; bla^pc+ blocix-M + bloTEu + blosny 
bla^mpC + */«CTX-M 
bla^^pc + bhcTx-M + bla^EM ', bla^pc + blocrxM + WASHV 
^/oampc + blacTx-M 5 bla^j^+ blacTx.M + blajEM + blosm 
bla^mpc + blacrx-M ; blam,pc+ blacTx-M + ^/OTEM + */asHv 
bla^mpc+ bhcTx-M + bla-^^ + A/ASHV ; ^'aampc + blocTx-M + ^/OTEM ; 
/^Campc + blaojx-M + bla^m 
bla^mpc+ blocxx-M + ^/ATEM + A/asHv ; bla^^ + blocrx-u + */asHv 
bla^mfC+ blOcjX-M + ^/OTEM + WflsHV 
'^/flampC ; */«ampC+ blOcTX-M + blajEM + blOsuy 
bla^fC + WOTEM + */asHv ; bla^fc+ */flcTx-M + 6/«TEM + WOSHV 
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Fig. 22: Clusters noticed in E. coli and K. pneumoniae isolates obtained from various 
wards of our hospital. 

(Discussion 
5. DISCUSSION 
The beneficial aspects of the introduction of antibiotics in the treatment of human infectious diseases are hampered by the emergence of bacteria! resistance and have become an ever-increasing problem that threatens the 
clinical usefulness of these drugs. The prevalence of antibiotic resistance is 
mainly due to the horizontal transfer of antibiotic-resistance genes, expressed by mobile 
genetic elements such as plasmids and transposons. Today, an increase in bacterial 
population resistant to antimicrobial agents has become a major problem. During the past 
few years, increasing rates of ESBL-producing bacterial isolates has greatly limited the 
use of non-carbapenem p-lactam antibiotics. The co-transmission of antibiotic resistance 
genes via plasmids may also compromise the effectiveness of many individual antibiotics. 
Rising antibiotic resistance rates among clinical isolates have resulted in increased 
morbidity and mortality along with extended period of hospitalization. 
One way for the spread of antibiotic resistance-encoding genes involves integrons. 
Integrons are a class of site-specific recombination elements which insert and excise 
mobile antibiotic resistance gene cassettes, and are located on plasmids and/or 
transposons. All class 1 integrons consist of two conserved sequences (CS) flanking a 
variable central region that encompasses antibiotic resistance gene cassettes (Hall & 
CoUis, 1995). The 5'CS region is highly conserved and includes an intlJ gene encoding 
an integrase, an adjacent recombination site attll and a promoter region, while the 3'CS is 
more variable. Several classes of integrons have been identified based on the type of 
integrase, the most prevalent being class 1 integrons. 
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In our study isolates, among 3'^ '^ -Generation cephalosporins, maximum resistance was 
noticed for cefotaxime followed by ceftriaxone and cefixime. Resistance to 
aminoglycosides was noticed comparatively low (38.33% and 55.74% resistance was 
observed for amikacin and gentamicLn, respectively) indicating that resistance to 
aminoglycosides is not prevailing in our clinical environmenL However, resistance to 
fluoroquinolones was also noticed high (85.45% for gatifloxacin and 89.47^o for 
ofloxacin) in our study isolates. ESBL-producing bacteria are also firequentlv reported to 
be resistant to other non-beta-lactam antibiotics, as genes encoding to these patterns are 
also frequently located in the same mobile genetic platform (plasmid, integron andor 
transposons) carrying WOESBLS genes (Paterson & Bonomo, 2005; Canton et al.. 2008). 
This situation makes more difficult the therapy of infections caused by ESBL-producers. 
Resistance to cefotaxime was found in maximum number of isolates obtained from wards 
of gynaecology and surgery (95.45% in isolates from both the wards). All the isolates 
obtained from paediatrics wards were found resistant to cefcto.\ime. indicating that 
probably there is overuse of cefotaxime in gynaecology, surgery and paediatrics wards 
and hence due to selection pressure we observed such a hidi resistance rate for 
cefotaxime. Resistance to ceftriaxone and cefoperazone was also high. In general, it w as 
observed that resistance to 3GC, aztreonam and fluoroquinolones was high in isolates 
obtained from different wards. 
Unlike ESBLs, the detection method of AmpC ^-lactamase has not been standardized by 
CLSI and hence it is a major barrier in defining the actual prevalence and epidemiology 
of these p-lactamases. The isolates producing this group of p-lactamase are typically 
designated as ESBL-negative and would not be tested further or sometimes they are 
categorized as ESBL producers (Sidjabat et al., 2009). Hence, in the present study the 
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cefoxitin resistant isolates were subjected to MTDET for phenotypic confirmation of 
AmpC-producers. On phenotypic detection by MTDET. we observed 60.80% isolates as 
AmpC-producers, 26.40% as AmpC-intermediate and 12.80% isolates were found AmpC 
non-producers in a total of 125 cefoxitin-resistant enterobacterial isolates. Among E. coli, 
59.63% isolates were deteaed as .AmpC-producers, 26.61% and 13.76% isolates were 
noticed as AmpC-intermediate and AmpC non-producers, respectively. Relatively higher 
fraction (68.75%) of K. pneumoniae isolates were noticed as Amp)C-producers while, 
25% were observed as ArapC-intermediate and only 6.25% isolate were characterized as 
AmpC non-producers. Occurrence of AmpC-producers has been described from India but 
those reports were based on phenotvpic detection methods only. 37.50 % and 47.80 % 
isolates have been reported as AmpC-producers from Chennai and Kolkata, respectively 
(Subha et al., 2003; Arora & Manjusri, 2005). In 2005. Singhal et al. (from various 
referral hospitals including that of Delhi, .Aligarh. Varanasi and Hubli) have reported 
prevalence of AmpC beta-i^tamases as 8 %. while. 43 ?«> of isolates were described, 
from Delhi, by Manchanda et al. (2006). In 2007. Hemlaiha et al. from Chennai reported 
47.3 % AmpC-producers in E. coli and Klebsiella isolates. Sinha et al. (2008) have 
reported 24.00 % AmpC-producers in E. coli isolated from tertiary care hospital of Jaipur. 
Sinha et al. (2008) also found 2''.45 *• of .AmpC non-producers as cefoxitin resistant. 
Vandana & Honnavar (2009) ha\e reported 70.7°o E. coli and 91% K. pneumoniae 
isolates as AmpC-producers. Recently in 2010, Upadhyay et al. reported 59.4% isolates 
as AmpC producers in clinical isolates from Varanasi. In the same year, Mohamudha et 
al. (2010) have reported 93.6% clinical isolates as AmpC-producers (detected by three 
dimensional extraction method) from South India. They have also reported that 77.9% of 
the total AmpC-producers (67/86) were cefoxitin-resistant while 22% were found 
cefoxitin sensitive. Thus, although studies indicate that screening methods which use 
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cefoxitin in standardized methods to detect AmpC-harboring isolates are useful, they are 
not perfect (Manchanda et al.. 2003). 
In the present study, we genotypically analyzed our isolates for the presence of blaampc-
Out of 60.8% (76/125) that were categorized as AmpC-producers, only 52.80% (66; 58 E. 
coli and 8 Al pntrumoniae) were found to harbour bloampc. Similarly, out of 26.40% 
(33/125) .AmpC-intermediate isolates 6/oampC was detected in 21.6% (27; 26 E. coli and 1 
K. pneumoniae). Probably, some other enzyme is being produced by bacterial isolates that 
mimics the .AmpC ^-lactamase, that's why we noticed AmpC production in MTDET 
(phenot>pic detection method where crude enzyme extract was used) in those isolates 
found devoid of bloampc gene (as detected by PCR). Surprisingly, ft/oampc gene was 
observed in 1.2% (14; 13 E. coli and 1 K. pneumoniae) isolates while they were 
categorized as .\mpC non-producers. Most likely, blaampc gene remains unexpressed or it 
ma> also be possible that non-functional enzyme was produced by these isolates and 
hence they were not delected by phenotypic test solely based on activity of enzyme on 
cefoxitin. 
These isolates were then characterized for bloampc families by multiplex PCR. We 
observed somewhat ditlerent pattern of amplification in multiplex PCR described by 
Perez-Perez & Han>on (2002). We have observed the presence of plasmid-mediated 
AmpC P-lactamase in 44/125 isolates. Most likely, the mobilization of Woampc was of 
same chromosomal origin so it was not detected by the protocol of Perez-Perez & Hanson 
(2002) and hence we observed variation in results of occurrence of bloampc noticed in 
monoplex and multiplex PCRs. Among these 44 isolates, the concurrent occurrence of 
two bhampc families {blacn and bloEBc) was noticed in 31/44 isolates. NOEBC was 
observed in 10/44 isolates while only 3/44 were found to harbour blocn- In contrast to 
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this finding, bloampc of CIT-family only were noticed to be present in 27.4% of Indian 
Enterobacterial isolates as reported in previous studies from our laboratory (Shahid et al., 
2009). We were unable to find any report, in our search of the literature, using the Entrez 
PubMed database provided by the National Centre for Biotechnology Information 
(www.ncbi.nlm.nih.gov/entrez) that specifically reported the simultaneous occurrence of 
two Wflampc families except one of our recent report (submitted for publication). In our 
study isolates, where concurrent occurrence of CIT and EBC-family of bloampc was 
observed, the amplification of Wocrr was noticed at its expected position but the bla^sc 
fragment amplifies at 200 bp, however amplified at its expected molecular weight (302 
bp) on performing monoplex PCR for EBC-family. Based on these observations, we drew 
inference that perhaps the co-existence of two A/aampc families, when present together 
hinders the proper amplification of bloEBC families. We have also observed that 10/44 
isolate that were showing EBC band at 302 bp (when lysate was used as DNA template in 
PCR reaction) did not show amplification in multiplex P*CR (when purified plasm id was 
used as template). But when we performed 6/OEBC monoplex PCR, an amplified product 
of 302 bp was observed. This fmding is suggestive of the situation, that has already been 
described in the protocol of Perez-Perez & Hanson (2002), stating that if the ampC gene 
is of same chromosomal origin then it could not be detected in multiplex PCR. Since 
more than one plasmid-mediated AmpC families were observed in single bacterial isolate 
in the present study. It denotes an alarming state because the present situation Is 
indicating an emerging complexity in the bacterial resistance mechanisms by 
accumulation of antibiotic resistance genes in a single organism. Due to selective 
pressure, bacteria now start evolving in a manner accumulating multiple bla genes, which 
are not only of different resistance mechanisms (Class A and Class C) but also by 
concurrent incorporation oibla genes of the related family {blocn and bloEBc), which is a 
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rarer phenomenon. This is the first report describing the simultaneous occurrence of two 
bloampc genes in Enterobacteriaceae as confirmed through gene sequencing (GenBank 
Accession numbers for CMY-2 is JF918434, and for MIR-l-like is JF918435). This is 
also the premier report describing the frequent presence of 6/OEBC from Indian 
subcontinent. Most of the isolates were giving 2 bands. CIT & EBC, and onh b few 
isolates we found single band corresponding to the molecular size of EBC, therefore we 
performed blind testing for CIT in these isolates also, but we didn't get any amplification 
for CIT family. The protocol of Perez-Perez & Hanson can therefore be re-defined based 
on the findings of the present study that a variation in the position of EBC-ampIicon ma\ 
occur when CIT and EBC are present together in the single strain. 
AmpC-producers were reported in 49% E. coli and 55% Klebsiella spp., of which sixt\' 
isolates produced Wocrr-type enzymes, 14 had bloKcc types, 11 had blomx types and 
three showed WODHA families of Woampc P-lactamases (Woodford et al., 2006). Oteo et al. 
(2010), from Spain, have reported the occurrence of plasm id-mediated bloan^ in 38^o 
isolates. In Algeria and England, the prevalence of AmpC was reported to be 1 * o and 
7.15% respectively. 
BIL-I like and CMY-4 were reported by British and Swedish researchers trom incian 
isolates (Cao et al., 2000; M'Zali et al., 1997). In 2008, da Silva Dias et al.. reported 
41.7% ofE. coli as AmpC-producers in Brazil. In the same year, occurrence of plasmid-
mediated AmpC p-lactamase was reported by Ding et al. in 10.1% of ^. pneumoniae and 
2.0% of E. coli from China. Tan et al., (from Singapore) reported 49.8% isolates as 
AmpC-producers and observed bla^aa^c gene in 47% isolates. Very recently, ACC-1 was 
reported from India by Gokul et al. (2010) in Salmonella isolate In a study performed in 
India (Wattal et al., 2010), incidence of AmpC has been noted in 72.4% E. coli and 
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80.6% K. pneumoniae isolates. In the previous studies from our lab, bla^mpc was detected 
in 43.5% (20/40) cefoxitin-resistant isolates and CIT family was observed in 20% 
(22/110) of total isolates studied. It was revealed by the sequence analyses of 
representative isolates that Woampc carrying isolates were having blacMY-6 (Shahid ei ah, 
2009). 
Simultaneous occurrence of AmpC beta-lactamases and ESBLs pose a therapeutic 
challenge as they together confers resistance to third as well as fourth-generation 
cephalosporins and aztreonam and hence narrowed down treatment options. We have 
observed the presence of 6/aampc in 85.60% isolates, while among class A ESBLs, 
fi-equency of blacn-u genes was highest followed by blasm and /^OTEM. blocxx-u was 
noticed to be present in 80.81% isolates (91 E. coli and 10 K. pneumoniae), blasuv in 
48.80% isolates (49 were E. coli and 12 were K. pneumoniae). Least occurrence was 
observed for bla-xEu as it was noticed in 44.80% isolates (47 E. coli and 9 K. 
pneumoniae). A study from Tanzania performed by Mshana et al. (2009) have reported 
the ESBL rate in K. pneumoniae, E. coli, Acinetobacter spp. Proteus spp. and other 
enterobacteria as 63.7%, 24.4%, 17.7%, 6.4% and 27.9% respectively. Hussain et al. 
(2011), from Pakistan, have reported the maximum prevalence of blocrx-M (57.7%), 
followed by WOTEM (20.3%) and then blasnv (15.4%). Among Class C, blacn and blouox 
each were reported in 16/48 isolates, blame was noted in 4/48 isolates, and bla^ox was 
reported to be present in 2/48 isolates. Several Indian studies (based on phenotypic 
detection only) have reported the presence of ESBLs in clinical isolates; rates vary from 
12.6% to 81% (Datta et al, 2004; Umadevi et al., 2011). Tankhiwale et al., (2004) from 
Nagpur have reported 48.3% of cefotaxune-resistant isolates as ESBL producers from 
Nagpur. Akram et al. (2007) have reported the occurrence of ESBLs in 42% of 
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Enterobacterial isolates, of which 34.42% were E. coli. Taneja et al. (2008) have reported 
the ESBL production in 36.5% isolates and among these, maximum occurrence was noted 
in Klebsiella spp. (51.2%), followed by E. coli (40.2%), Enterobacter aerogenes (33.4%) 
and Pseudomonas aeruginosa (27.9%). They have also reported the occurrence of AmpC 
p-lactamase in 53 isolates. Sasirekha et al. (2010), from Bangalore (South India), have 
revealed the occurrence of ESBL producers in E. coli (61.1%) and K. pneumoniae 
(40.6%) isolates. Bhattachaijee et al. (2010) observed 46% (63/136) K. pneumoniae 
isolates as ESBL-producers. Among these, blasiw was reported as most prevalent (68%; 
43/63), followed by blacrx-M (67%; 42/63) and the least frequency was noticed for A/QTEM 
(14%; 9/63). Chaudhuri et al. (2011) have reported 79% E. coli and 70% Klebsiella spp. 
as ESBL-producers in Gram-negative bacteria isolated from intra-abdominal infections. 
ESBL-production was reported from Mumbai in 20% each of £. coli and K. pneumoniae 
isolates (Varsha et al., 2011). In another study from South India (Cheimai) performed by 
Narayanaswamy et al. (2011), prevalence of ESBL-producers was reported as 60% in E. 
coli isolates. In the same year, Umadevi et al. (2011) have reported ESBL production in 
81% £•. coli, 74% K. pneumoniae, and 14% Pseudomonas isolates from Pondicherry. 
In India, the very first report on the presence of CTX-M P-lactamase came from New 
Delhi, where the bacterial isolates collected in the year 2000 were investigated by a 
French group, and only blocix-u-xs was reported (Karim et al., 2001). A systematic survey 
from our lab was performed on 130 3"* Generation cephalosporin-resistant enterobacterial 
isolates collected during 2003-2005 and 6/acTx-M-is was reported in 73% isolates (Ensor 
et al. 2006). In 2007, Walsh et al. also reported high prevalence of CTX-M P-lactamase 
in Indian isolates. Moreover, they have also reported the occurrence of /^OTEM in 
maximum number of enterobacterial isolates followed by WOCTX-M and the least 
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occurrence was reported for blasHv (Walsh et al. 2007). Jemima and Verghese (2008), 
from South India, have reported prevalence of WOCTX-M in 58.3% isolates. Recently, 
6/acTX-M-28 was reported for the first time from India (Kingsley & Verghese. 2008). 
Shahid et al. (2011) reported the maximum prevalence of WOCTX-M (28.8%), followed by 
hlasH\- (13.7%) and then blorstA (10.9%) in E. coli and Al pneumoniae isolates collected 
during 2007-2008. When we compare the occurrence of WOESBLS in collection of isolates 
from our lab, we have observed a drastic downfall in /^OCTX-M occurrence (73% in 2003-
2005 to 28.8% in 2007-2008) and then a steep rise was noted in the collection of year 
2009 (67.5%) and 2010 (80.81%). Furthermore, blasm (13.7%) was more prevalent than 
WoTEM (10.9%) in collection of 2007-2008 and 2009-2010 (WasHv; 61% and WOTEM; 
56%), but in Citrobacter spp., collected during 2008, MOJEM (40%) was more prevalent 
than WflsHv (25%). 
Moreover, in our study isolates, maximum co-carriage of bhampc was noticed with blacn-
M (88.79%) followed by blasuv (49.53%) and blorm (46.73%). These observations 
indicate that the frequency of bla^mpc and other class A ESBLs (A/OCTX-M blasuv, ^/OTEM) 
is quite high in our area. Even the co-existence of Woampc with WOESBLS is also high. 
However, the detailed periodic analyses indicate that the prevalence of these bla 
genes and their combination is on decrease that could be due to implementation of 
stringent antibiotic prescription policy. Combination of WOTEM-I, blasnv-n, WOCTX-MO 
and blooHA-i was reported to be present in K. pneumoniae isolate from China (Wei et al. 
2005). In 2008, Sabtcheva et al. (from Bulgaria) have reported the co-production of 
chromosomal AmpC p-lactamase and ESBLs in 37 enterobacterial isolates, out of which 
37.8% were CTX-M-3, 24.3% were TEM-3, while 21.6% were reported to be SHV-2. 
When analyzed for co-occurrence, they observed CTX-M-15 in 10.8% AmpC-producers 
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and TEM-15 in 2.7% isolates. They have also reported that the most prevalent ESBLs 
were CTX-M type P-lactamases followed by TEM-3 and SHV-2 in AmpC-producing 
isolates (Sabtcheva et al., 2008), which is in contrast to results obtained in our isolates as 
we have observed least prevalence of WOTEM in ft/oampc-harboring isolates. The prevalence 
of AmpC beta-lactamases was reported as 2.18% (comprising of 8 CMY-2 and 3 DHA-1 
enzymes) by Labadene et al. (2009). They have reported co-production of CTX-M-15 
with CMY-2 in three isolates and with DHA-1 in single isolate. SHV-12 was reported to 
be co-produced with two 2 DHA-1 producing isolates. Wei-Feng et al. (2009) reported 
77.8% occurrence of TEM P-lactamase genes, with co-expression of A/ODHA-I and blojEM 
in 66.7% isolates. In addition, they have reported co-occurrence ofblajEM and blocrx-M in 
50.0% isolates. Kalantar et al. (2010) reported the occurrence of A/OTEM, blasiw, and 
blacTX-M in 63.80%, 51% and 23.4% isolates respectively. They have reported the 
combination of MOTEM + blasnv + blocrx-M in 10.6% isolates; while, simultaneous co-
production of bloampc and A/OESBLS was reported in 6.5% isolates only. Moreover, in a 
study from our lab, out of 46 cefoxitin-resistant isolates, presence of ft/ocrx-M was noticed 
in 39 (84.8%) isolates. In those isolates, co-carriage ofbhampc and A/OCTX-M was observed 
in 77.3% isolates (Shahid et al., 2009). Simultaneous occurrence of multiple bla genes 
including ZJ/OCTX-H blajEM, blasm, and Z>/aampc (67.5%, 40%, 25%, and 40*/o. 
respectively) has been also recently reported in Citrobacter spp. (Shahid, 2010) from our 
lab. 
Among Insertion Sequences, we observe that Z>/aampc-harbouring isolates showed 
maximum association with ISEcpl (68.22%) and it was followed by \SCR1 (ORFJii). 
ISEcpl has previously been found to be associated with several CMY alleles (CMY-2, 
CMY-4, CMY-5, CMY-7, CMY-12, to CMY-16, CMY-31, and CMY-36) and also ACC-
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1 and ACC-4. It was presumed that it helps in mobilization of chromosomal ampC genes 
to plasmids and it also provide a promoter which in turn results in high level expression 
of these genes (Jacoby, 2009). However, in previous reports, ISEcpI was described to be 
associated mainly with WOCTX-M (Poirel et al., 2003) but we also observed its association 
with isolates harbouring bloampc- Moreover, its maximum association was noted in the 
group of isolates possessing bla^„^ + blacjx-» (73.33%). 
Association of ISC/?/ was described in majority of ampC genes (Toleman et al.. 2006). 
more specifically with CMY-1, CMY-8. to CMY-11, and CNrj-19. DRA-1. and MOX-1 
and ORFJ/i is considered to be responsible for their incorporation in complex Class 1 
integrons and also their mobilization (Jacoby, 2009). We noticed occurrence of ORFi/i 
in 64.49% of ft/oampc-harbouring isolates. On sequence analyses, ORF5/5 \Nas noticed to 
be associated with blacMY-2 in our isolates. The isolates that harbour bla^n,^ alone, 
showed the association of ORF5/i in 75% (maximum association among mobile genetic 
elements) of isolates. Its occurrence was noticed highest also in the group possessing 
combination of A/oampc + blocTx-M + blor^yi 
The best characterized and the most frequently detected are Class 1 integrons (also 
referred to as type 1 or Sul-1 type integrons) (Hall & Collis. 19^8). All CIas> I integrv^ ns 
consist of two conserved sequences (CS) flanking a variable central region encompassing 
antibiotic resistance gene cassettes (Hall & Collis, 1995). We noticed occurrence of 
integrons (as detected by amplifying 5'CS-3'CS region) in 55.20% enterobacterial 
isolates. However, the presence of integrons from community and nosocomial 
environment has been frequently reported (Hall et al., 2002; Schmitz et al., 2004; Mathai 
et al., 2004; Fonseca et al., 2005; Solberg et al., 2006; Machado et al., 2007). Other 
reports have shown the prevalence of Class 1 integrons in 43% from western and central 
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Europe (Martinez et al., 1998). Only 22% and 15% of isolates were found to carry Class 
1 integrons in a Swiss (Cocchi et al., 2007) and Australian study (Sidjabat et al., 2006) 
respectively. One US study reported 30/34 (88%) nosocomial isolates harbouring Class 1 
integrons and those isolates were found resistant to more than one antibacterial drug 
(Santhez et al, 2002). Bhattacharjee et al. (2010) observed that among 63 ESBL-
producing K. pneumoniae isolates, 58 (92%) carried Class 1 integrons and 6 isolates were 
found to harbour Class 1 as well as Class 2 integron. 
Sul-l was reported to be present in 3'CS (Carattoli, 2001), but we also observe 14 isolates 
(out of 69) that showed amplification for 5'CS-3'CS region but did not show presence of 
Sul-l (when detected by PCR). Similar type of results was observed by Jin & Ling 
(2009). It was suggested by Jin & Ling (2009) that using sulfamethoxazole resistance as a 
marker for integrons could either misses the isolates or overestimates the prevalence of 
integrons. Insertion of dfrA12-orfF-aadA2 or or/F leads to excision of qacEAl and Sul-l 
in 3'CS and hence integron without Sul-l gene were observed. Such excision has been 
reported in previous studies in some environmental bacteria (Rosser & Young, 1999). We 
also noticed 22 isolates that were integron-negative but were found to harbor Sul-l gene. 
It may be possible that the Sul-l gene detected in these isolates was present in the second 
copy of 3'CS i.e. 3'CS2 which was not detected by integron PCR as we have used the 
reverse primer that is specific for first copy of 3'CS. 
Since integrons can be located on plasmids and transposons, they spread rapidly among 
bacterial species (Carattoli, 2001). The resistance genes that are present in gene cassettes 
can be excised and then integrated at another site by a site specific recombination 
mechanism. This phenomenon may be important in the spread of resistance genes. 
Laverstein-van Hall et al. (2003) noticed a significant association of multiple resistance 
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genes with the presence of an integron and that the transfer of integron among bacterial 
species plays an important role in the development of multiple antibiotics resistance. 
In our study isolates, single band was observed at variable position when PCR was 
performed by using primers specific for 5'CS and 3'CS. Similar type of results were 
observed b> Peng et al. (2007) as they reported amplicons ranging from 0.7 to 3.0 kb 
obtained by PCR amplification of gene cassette region by using 5'CS-3'CS primers. It 
has been suggested that the deletion in the 3'CS segment or acquisition of different 
antibiotic resistance genes results in differences observed in molecular weight of 
amplicons. 
It has been reported in the literature that ORF573 get integrated in the Sul-1-type integron 
and thus form a mobilizing genetic structure termed as complex Class 1 integrons. In the 
complex Class 1 integrons, downstream of ORF5/3 can have one or more resistance gene 
cassettes, and Sul-3'CS. A recombination cross over site (33 bp DNA sequence 
containing orilS) at which insertion of resistance genes into complex class 1 integrons 
containing ISCR] takes place was noticed downstream of ISC/?/ (Bennett, 2008). We 
observe such intricate structure in 44% (55/125) isolates, of which 48 were E. coli and 7 
were Al pneumonuje. Complex Class 1 integrons are supposed to be an efficient mode for 
dissemination antibiotic resistance genes that were found associated with it, as they have 
rolling circle transposition which may transpose adjacent DNA sequences (Toleman et 
al.. 2006). The occurrence of such situation in clinical isolates indicates an evolutionary 
trend in our bacterial isolates. 
IS26 has also been reported to be associated with blocrx-u and more specifically it has 
been found inserted within ISEcpl, although the insertion was reported varying from 
strain to strain (Eckert et al., 2006). In our study isolates, IS26 was noticed in 33.60% 
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isolates (37 E. coli and 5 K. pneumoniae) showing high diversity in molecular size of 
amplicons (ranging from 350 bp to 1500 bp) and even two bands were also noticed in our 
isolates. We have observed the largest fraction of isolates showing amplicon at 800 bp 
(30.95%; 13/42) and the second most prevalent amplicon was observed at 350 bp 
(19.05%; 8/42). Contrary to this, association of \S26 was noticed in 41.7% isolates: 
moreover, amplicons of 650 bp, 750 bp, 850 bp, 950 bp, 1100 bp, and > 1400 bp were 
reported in previous studies (Ensor et al., 2006). IS26 insertion was also reported in 
48.2% of WocTX-M harbouring isolates ofCilrobacter spp. (Shahid, 2010). Most prevalent 
1S26 amplicon was observed at 850 bp (Shahid et al., 2011). Moreover, in our study 
isolates, two bands were noticed to demonstrate exactly similar banding pattern (bands 
were observed at 250 bp and 350 bp). The variation in molecular weight of IS26 
amplicons noticed in our bacterial isolates is similar to that observed in previous studies 
from our lab in collaboration with British group (Ensor et al., 2006), however it is in 
contrast to the findings reported in Citrobacter spp., where no diversity in the insertion 
points of IS26 elements was noticed and all isolates produced an amplicon of 400bp. 
similar to the clone A that was predominant in isolates from UK (Shahid, 2010). 
We observed insertion of IS2d in ISEcpI in 21.60% isolates, of which 25 were E. coli and 
2 were K. pneumoniae. However, we have also noticed occurrence of IS26 without 
ISEcpl in 15 isolates (12 were E. coli and 3 were K. pneumoniae) and also 48/125 
isolates (44 E. coli &4 K. pneumoniae) were observed to harbour ISEcpl but insertion of 
IS26 was not noticed. 
It has been evident from periodic analysis that the frequency of these mobile elements in 
our clinical isolates is on dovmfall. 
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Plasmid analysis of the clinical cefoxitin-resistant isolates showed the consistent presence 
of a single plasmid of molecular weight ~ 23 kb similar to that observed in previous 
studies from our lab (Shahid et aL, 2003; Shahid et al., 2009; Sobia et al.. 2011). On 
performing RAPD-typing, we have observed that untypability of isolates is increasing. 
However, few bacterial isolates from gvnaecologv. surgery and ortfiopaedics wards 
displayed similar banding pattern. It can be concluded that probably the ver>' same clone 
is circulating in the gynaecology, surgery and orthopaedics wards as these wards are 
sharing the same building block in our hospital and hence the chances of cross-
contamination are high. As some isolates from different wards were found matching, so it 
can be concluded that proper sterilization conditions are not maintained in our hospital 
wards/operation theaters; however, variability among isolates is still maintained. 
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6. SUMMARY 
In our study cohort, maximum number of cefoxitin-resistant E. coli and K. pneumoniae were obtained from the patients lying in the age group 20-29 years (38.40%) and least were obtained from that of 70-79 years (0.8%). Furthermore, 
maximum number of isolates were obtained frxMti pus samples (52.8%). followed by urine 
(32%) and then drain (5.60%). 
The resistance rates in our isolates varied considerably. fix>m nil for imipenem to 94.40% 
for cefotaxime. Along with rising resistance to cephalosporins, fluoroquinolone resistance 
was also very common (89.47% for ofloxacin and 85.45% for gatifloxacin); however, 
aminoglycosides' resistance rates in our isolates were not so high (33.34% for amikacin 
and 60% for gentamicin) as compared with cephalosporins and fluoroquinolones. The co-
existence of bloampc and bloESBts results in resistance to 3^- as well as 4*-generation 
cephalosporins. We have noticed resistance tc 4'''-generation cephalosporins also (64% 
for cefepime; 79.61% for cefpirome). The problem of multiple drug resistance in our 
clinical isolates is quite alarming. The cause for increased incidence of resistant bacteria 
has been considered as multifactorial but antibiotic use has been regarded as the major 
factor (Livermore. 2003). Althoudi no reliable data were availabie. it is well known that 
many persons in the community self-medicate or obtain prescription for drugs which were 
taken without any antibiotic susceptibility testing of the bacterial strain causing infection. 
Such practices are also responsible for antimicrobial drug resistance. We have observed 
variation in the antibiotic resistance rates and patterns in the isolates obtained from 
different wards; since, the isolates obtained from gynaecology ward showed maximum 
resistance for cefotaxime (95.45%), followed by cefixime (88.46%) and then ceftriaxone 
(87.50%), whereas the isolates obtained from surgery ward showed maximum resistance 
for cefotaxime (95.45%), followed by ceftriaxone (93.48%) and then cefixime (89.13%). 
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On performing MTDET, cefoxitin-resistant isolates were categorized as AmpC-producers 
(60.80%), AmpC-intermediate (26.40%), and AmpC non-producers (12.80%). Out of 76 
AmpC-poducer isolates, 66 were found to harbour blaampc, while among 33 AmpC-
intermediate. 27 harbours Woampc gene. Most probably, some other enzyme/protein 
mimics the activity of AmpC p-lactamases, that's why we detected AmpC P-lactamases 
b> phenotypic detection method in more number of isolates while bloampc gene was not 
noticed in all such isolates. Interestingly, out of 16 AmpC non-producers, 14 showed the 
presence of bla^rncc- Such situation may arise because of the fact that, probably the ampC 
gene remain une.xpressed or may be non-functional enzyme was produced. 
On performing monoplex PCR for the gene encoding AmpC p-lactamase, we have 
noticed occurrence of 6/aampc in 107 isolates (85.60%), out of which 97 were E. coli and 
10 were K. pneumoniae. Whereas, only 44 (35.2%) isolates (38 E. coli and 6 K. 
pneumoniae) were detected by muhiplex PCR (performed to detect plasmid-mediated 
.AjnpC ^-lactamase families). U'e observe variation in the occurrence of blaampc by 
monoplex and multiplex PCR because, probably the bloampc gene was mobilized from the 
same chromosome to plasmid and hence was not detected by multiplex PCR as it has 
ah-eady been mentioned in protocol of Perez-Perez & Hanson (2002) that if the Woampc is 
of same chromosomal origin, the it ill not be detected in multiplex PCR. 
Moreover, we for the first time have noticed the simultaneous occurrence of two bloampc 
families in a single bacterial strain. In our study cohort showing amplification in 
multiplex PCR, 31 isolates (27 E. coli and 4 K. pneumoniae) showed two bands, upper 
one corresponded to ClT-family (450 bp) while the lower one was observed at 200 bp 
corresponding to FOX-family, but on performing monoplex PCR for individual family, it 
was proved to be of EBC-family. Probably, the simultaneous occurrence of two Woampc 
families hinders in the proper amplification of lower band because the isolates that 
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showed occurrence of 6/OCIT (3/44) and bloEsc (10/44) alone displayed their amplicon at 
the expected position, blocn was noticed in 2 E. coli and 1 K. pneumoniae, while bloEBC 
was observed in 9 E. coli and 1 K. pneumoniae isolate. 
The presence of A/oampc genes on plasmids was analyzed by performing PCR using 
purified plasmid as template DNA. The isolates that showed two bands in multiplex PCR 
(when lysate was used as template DNA) also showed similar pattern of amplification 
here but, when monoplex PCR was performed for CIT- and EBC-families, only the CIT 
amplicon was observed. This suggests that WOEBC resides on chromosome and not on 
plasmids. However, two isolates showed the amplification in monoplex PCR for both 
blacTT and blaEsc suggesting their occurrence on plasmid. 
Moreover, the isolates that showed the amplification of /^OEBC (when lysate was used as 
template DNA) did not show amplification in multiplex I*CR (when purified plasmid was 
used as template DNA), but displayed A/OEBC amplicon on monoplex PCR for EBC 
family. It further confirms the chromosomal origin of blame as it has been clearly stated 
in the protocol of Perez-Perez & Hanson (2002), that the multiplex protocol can detect 
plasm id-mediated ampC gene as long as plasmid-mediated AmpC p-lactamase is not 
from same chromosomal origin. 
The study isolates were also screened for the presence of ZJ/OESBU- Maximum occurrence 
was noticed for blacrx-u (80.81%), followed by WOSHV (48.80%) and then blctxEu 
(44.80%). This series of occtirrence of A/OESBLS is in accordance with the previous reports 
from our lab (Shahid et al., 2011). Co-occurrence of 6/flampc with bloESBis was analyzed 
and it was found with A/OCTX-M, WOTEM, and blasm in 88.79%, 46.73%, & 49.53% 
isolates respectively. 
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Distribution of isolates harbouring various combinations of bloampc and A/AESBLS in 
different wards was analyzed and it was observed that the isolates carrying only Woampc 
(8/107) were obtained from surgery (n=7) and gynaecology (n=l) wards only. Largest 
fraction of isolates (33/107) harbours combination ofbloampc + blacTx-M+ W<?rEM+ blasm 
and among these, maximum number of isolates were obtained from surgery (13/33). 
followed by gynaecology (8/33). orthopaedics (6/33), medicine (5/33) and the least from 
the paediatrics (1/33). This pattern indicates more prevalence of bloampc- and A/OESBLS-
harbouring isolates in surgery and gynaecology wards. 
Among mobile genetic elements, the occurrence of ORF5/J, Sul-l, ISEcpI, and IS26 was 
noticed in 58.4%, 64.80%, 60%, and 33.60% isolates respectively. It indicates maximum 
occurrence of Sul-l in our clinical isolates, whereas, occurrence of ISEcpl and ORFi/5 
was noticed in almost equal number of isolates {ISEcpl in 75; ORF57i in 73 isolates). 
Integration of ORF57i in Sul-l type integrons was observed in 44% of our clinical 
isolates. Moreover, insertion of IS2<5 in ISEcpl was observed in 21.60% isolates only. 
On analyzing association of bloampc with mobile genetic elements (MGEs), it was 
observed that Sul-l was present in 71.03%, ISEcpl in 68.22%, ORF5/i in 64.49% and 
IS26 in 35.51% Woampc-harbouring isolates. Maximum association with SuI-1 t>pe 
integron indicates that probably the mobilization of these clinical isolates is mediated by 
integrons. Furthermore, association of Sul-l, ORF5/i and ISEcpl was noticed ui isolates 
harbouring all possible combinations of W^ ampc and WOESBLS (WOCTX-M, blortM, and 
WflsHv). Whereas, ISEcpl was not detected in the isolates harbouring combination of 
blasmpc & blctTEM- The isolates that possess combination of bla^mpc + blajEM + */asHv 
were found devoid of the MGEs screened here in this study. 
The insertion of IS26 has been reported at various positions and hence on amplification, 
fragments of variable molecular weights were observed. In our clinical isolates, 
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amplicons of IS2<5 were noticed at 350 bp (8/42), 500 bp (6/42), 650 bp (5/42), 700 bp 
(5/42), 800 bp (13/42), 900 bp (1/42), and 1500 bp (2/42). Furthermore, two bands were 
also observed in two clinical isolates that with exactly similar banding pattern (one band 
at 250 bp and other one at 350 bp). In our study isolates fragment of 800 bp was found to 
be the most frequent. 
The isolates were screened for the presence of conserved sequence. We have observed 
presence of conserved sequence in 55.20% (69/125) of our clinical isolates. Fragments of 
variable sizes were observed; variability could be due to insertion/integration of gene 
cassettes. Single band was observed in forty one isolates, two bands in twenty isolates, 
and three & multiple bands were observed in four isolates each. Among the isolates 
showing single band, largest fraction showed amplicon at 1500 bp (25/41), followed by 
800 bp (11/41) and amplicons of 400 bp (lowest) & 900 bp were observed in three 
isolates each. Sul-1 was reported to be present in 3'CS (Carattoli, 2001), but we also 
observe 14 isolates (out of 69) that showed amplification for 5'CS-3'CS region but did 
not show presence of SuI-1 (when detected by PCR). Similar types of results were 
observed by Jin & Ling (2009). It has been suggested that the insertion of dfrA12-orfF-
aadA2 or orfF leads to excision of qacE/S.1 and Sul-1 in 3'CS and hence integron without 
Sul-1 gene were observed (Jin & Ling, 2009). We also noticed 22 isolates that were 
integron-negative but were found to harbor Sul-1 gene. Perhaps the Sul-1 gene detected in 
these isolates may be present in the second copy of 3'CS which was not detected by 
integron PCR as we have used the reverse primer that is specific for first copy of 3'CS. 
Woampc families were analyzed for their association with mobile genetic elements. Sul-1-
type integrons were detected in 35/44 (79.55%), lS>Ecpl and ORF5/5 each were in 32/44 
(72.73%) and IS2<J was detected in 17/44 (40.91%) plasmid-mediated AmpC P-
lactamase-harbouring isolates respectively. Waampc families (blocn, bloEBc, combination 
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of blacn and bloEoc) also showed almost similar pattern for occurrence of various mobile 
genetic elements. Both ISEcpl and Sul-1 were found to be present in 66.67% of the 
^/ocrr-harboring isolates. In WoEBC-harbouring isolates, it was observed that ORF513 and 
Sul-1 was present in maximum number of isolates (80%), followed by ISEcpl (60%), and 
IS2<5 was noticed in least number of isolates (50%). Whereas, in the isolates having 
combination of blacn and blosac- ma.vimuro number of isolates showed presence Sul-l 
(25/31; 80.65%), followed by ISEcpl (24/31; 77.42%) and then ORF513 (23/31; 
74.19%). 
Combination of IS£cp7 + OKF513 -^ SuZ-Z-integrons was the most common combination 
noticed in 12/44 (27.27%) isolates followed by a combination of ISEcpl + IS26 + 
ORF513 + 5«/-7-integrons that was noticed in 9/44 (20.45%) isolates. The combination of 
ISEcpl + ORF513 + Sul-1 was found to be most common in both, Wocrr + bloEBC and 
ft/oEBC-harboring isolates, but it was not observed in ft/iatrrharboring isolates. Moreover, 
the combination of ISEcpl + IS2<5 + ORF513 + Sul-1 was observed as second most 
prevalent combination and it was observed in 33.33% of blacn; 20% of bla^sc- and 
19.35% of blacn "*" ft/oEBC-harboring isolates respectively. 
Among bloESBU,- blocrxA* was noticed to be associated with all blocn- or bla^sc-
harbouring isolates, while the co-occurrence of blocrx-s* was noticed in 90.32% isolates 
harboring combination of blacn ^ bioEsc- Co-occurrence of A/OTEM and WOSHV was found 
in 60% of A/oEBC-harbouring and in 61.29% blacn + WoEBc-harbouring isolates, whereas 
it was noticed all A/ocrr-harbouring isolates. 
Among Z)/oampc families, maximum association with integron (CS) was observed in blacn 
(100%) followed by combination of blacn + bla^sc (77.42%) and then MOEBC (50%). 
Similarly association of these families with 0RF5/i and Sul-\ was noticed. 66.67% of 
blacn-, 80% of A/OEBC-, 74.19% of blacn + bloEBc- harboring isolates were associated 
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with ORF5I3, while 66.67% blacn-, 80% A/OEBC-, and 80.65% blacn + 6/oEBC-harboring 
isolates showed the association with 5M/-I. Association with ISEcpl was observed 
maximum in blacn + /^flEBc-harboring isolates (77.42%) and least with ft/oEBc-harboring 
isolates (60%). In addition, association of IS26 was noticed maximum (50%) with bla^sc-
harboring isolates, and least (33.33%) was noticed with 6/acrrharboring isolates. 
A remarkable decrease was observed in the occurrence of Woampc in clinical isolates 
obtained in the year 2009 (64%) to that in 2010 (21.6%). Among WOESBL^ , occurrence of 
blacT<-M >*as observed to decrease from 56.8% to 24%, while, W^TEM decrease from to 
17.6% and 6/asHv decreases from 28% to 20.8%, in the year 2009 and 2010 respectively. 
Among mobile genetic elements, maximum decrease was noticed in occurrence of 
ISEcpl (48.8% in 2009 to 11.2% in 2010), whereas, Sul-\ was found to decrease from 
48% to 16.8% in the year 2009 to 2010. Occurrence of ORF57i was observed to decrease 
from 45.6% to 12.8%, while, comparatively less downfall was observed in occurrence of 
\S26 in the isolates obtained in 2009 (21.6%) to that obtained in 2010 (12%). 
Out of 109 £ coli isolates, 91 were typed by RAPD, while 18 were found untypable. Out 
of these 91 £. coli isolates, 33 were grouped in 15 clusters, while remaining 58 isolates 
v^ erc found genetically unrelated. Among K. pneumoniae isolates, 14 were typed by 
R,APD where. 4 were grouped in two clusters (KPl & KP2) and 10 displayed banding 
pattern thai did not match with each other. Two isolates were found untypable. 
In nutshell, based on the present study, we reached the following conclusions: 
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ConcCusion 
7. CONCLUSION 
• We report here quite high 3'''-generation cephalosporins resistance rate in our 
clinical isolates 
• This is amongst the premier systematic reports from India characterizing the 
occurrence and prevalence of AmpC P-lactamases. 
• Occurrence of ft/oampc was detected in 85.60% cefoxitin-resistant isolates (by 
monoplex PCR) and 35.2% isolates were found positive for plasmid-mediated 
AmpC beta-lactamases by multiplex PCR. 
• The mobilization of Woampc was of same chromosomal origin and hence it was not 
detected by the protocol of Perez-Perez & Hanson (2002). Hence, variation in our 
results for occurrence of A/oampc was observed (when detected by monoplex & 
multiplex PCR). 
• This is the first report describing simultaneous occurrence of two bloampc genes 
(blacTv and WOEBC) in Enterobacteriaceae as confirmed through gene sequencing. 
• This is amongst the premier reports describing the frequent presence of bloEBC 
from Indian subcontinent. Moreover, WOCMY-2 is reported for the first time from 
India. 
• Based on the observations of the present study, we drew an inference that perhaps 
the co-existence of two bloampc gene families, when present together, hinders in 
the proper amplification of blame in multiplex PCR. 
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• Among Class A ESBLs, maximum co-existence of blaampc was observed with 
blacTXM, indicating their concomitant carriage on the plasmid of-23 kb. 
• The occurrence of multiple bla genes (A/OESBU and bla,unpc) and even the 
identification of two blaampc families in single strain indicate that antibiotic 
resistance genes are accumulating in single organism, hence demonstrating the 
emerging complexity in Indian resistance mechanisms. 
• This is also the first systematic survey in Indian isolates looking for the presence 
of mobile genetic elements {ISEcpl, IS26, ORF513 and Sul-J t>pe integrons). 
• We observed that combination of ISEcpl + ORFJ7i + 5M/-7-integrons was the 
most common combination, followed by a combination of ISEcpl + \S26 + 
ORF513 + S'ttZ-y-integrons in Waampc-harbouring isolates. Probably, these were 
the mobile genetic elements which were responsible for mobilization of our 
clinical Waampc-harbouring isolates. 
• To the best of our knowledge, this would be the first report describing association 
of 6/acMY-2 with ORf 573. 
• This is also the first report describing presence of complex class 1 integron in 
Indian Enterobacterial clinical (44%) isolates. 
• Association of bloampc with various mobile genetic elements like ISEcpl, IS26, 
ISCRl, and Sul-l-typc Class 1 integrons observed in this study demonstrated that 
a complex structure carrying combinations of bloampc and other resistance genes 
exist in Indian Enterobacterial isolates. 
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• Association of mobile elements including 0RP5/i, Sul-1, ISC/?/, and IS2<5 is 
frequent in our isolates, and reflects the complex evolution of resistance 
mechanism in our isolates. 
• Detailed periodic analyses indicate that the prevalence of bloampc & blassBL genes 
is on decrease that could be due to implementation of stringent antibiotic policies 
in recent past. 
• We also noticed a downfall in the pre\alence of mobile genetic elements in the 
year 2010 as compared to 2009. 
• It was evident from RAPD-typing that most patients in our hospital were infected 
with different clades of organisms, thereby demonstrating clonal diversity among 
isolates suggesting horizontal transmission of bla genes. 
• RAPD-typing demonstrated that unt>pabilit> of isolates is increasing. However, 
few isolates from gynaecolog>, surgery and orthopedics wards displayed similar 
banding patterns. Most probably, the same clone is circulating in these wards as 
the above described wards are sharing the same building block in our hospital and 
the chances of cross contaminarion increases. 
• The matching of isolates of different wards indicates towards the need of stringent 
sterilization in our hospital wards/operation theaters; however variability is still 
maintained. 
• Surveillance of antimicrobial resistance and use is an essential prerequisite to 
monitor situation, for effective prevention and containment of antimicrobial 
resistance and rational antimicrobial use. 
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• Our report suggests that there is an urgent need to implement strict antibiotic 
prescription policy to limit the irrational use of antibiotics (including 
cephalosporins) so that antibiotic selective pressure can be minimized. 
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